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Abstract 
Antibiotic resistance is one of the greatest health concerns worldwide.  Data shows within the 
last 50 years, the number of species and strains of pathogenic and commensal bacteria resistant 
to antibiotics, has increased virtually monotonically worldwide. 
Research presented here shows successful synthesis of polymeric drug composites for 
antibacterial drug delivery, using the electro hydrodynamic atomization technique (EHDA). A 
biodegradable polymer poly (lactic-co-glycolic acid) (PLGA) proved to be suitable for 
sustained drug delivery. Materials added to the polymeric composites included the active agent 
amoxicillin (AMX) and metallic nanoparticles varying in size and morphology. Upon 
successful synthesis, the drug release, antibacterial efficacy and cell culture data, collated, 
confirmed the EHDA process is a good alternative method for synthesising antibacterial 
composite formulations. It is an easy one step process, regardless of the number of excipients 
added, and also allows for encapsulation of poorly soluble drugs.  
The first step was to synthesise metallic nanoparticles; varying in shape and size, this would 
help determine if differences in shape and size of nanoparticles will have an effect on drug 
content and release data, as well as antibacterial efficacy. Therefore, three types of metals were 
chosen for their varying antibacterial activity; silver, gold and copper. Silver was synthesised 
varying in shape and size, including spherical, wire and polygonal or edged. Upon successful 
synthesis, the next step was to formulate suspensions, made up of PLGA and AMX, along with 
the varying metallic nanoparticles to electrospray. Two different solvents were used acetone 
and dichloromethane (DCM), the varying differences in characteristic qualities like electrical 
conductivity and viscosity, allowed for determination of a stable spray. Results showed the best 
solvent to use between the two was acetone due to a much higher electrical conductivity and 
lower viscosity.  
Thereafter, the composite samples collected were analysed. Drug loading for the formulation 
containing PLGA and AMX (F2) only was 1.18%, but with the addition of different metallic 
nanoparticles it increased up to 2.57%. Drug release for F2 was at 18.6% and increased up to 
56.1% depending on metallic nanoparticle added.   
Metallic nanoparticles exhibit antibacterial efficacy, with AgNPs showing the greatest 
antibacterial activity, confirmed through disk diffusion zone sizes. Antibacterial activity 
enhancement was proved by formulations containing silver nanoparticles, showing increased 
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activity against S. aureus through increased disk diffusion zones compared to using AMX and 
silver nanoparticles on their own. AgNPs against S. aureus gave an average inhibition zone of 
18.8 mm when compared to CuNP which only gave an average inhibition zone size of 
16.07mm. Full formulation containing PLGA AMX and edge shaped silver nanoparticles (F5) 
proved to have the highest antibacterial efficacy when compared to the other formulations. This 
was explained through an increase in surface area to volume ratio of the silver nanoparticles, 
when compared to the spherical and wire shaped nanoparticles. Cell culture data namely the 
MTT assay also showed (F5) had a cell viability of 71%, this displays promising signs for this 
formulation for future use as an antibacterial agent.  
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Chapter 1 - Literature Review 
 
1.1 Microorganisms 
Bacteria and fungi are both friends and enemies of humans and mammals alike. They have the 
ability to protect and boost the immune system and purify living environments, whilst having 
the potential to cause disease, death and epidemics (Hu et al, 2018, Fischbach and Walsh, 2009, 
Lin et al, 2013, Richter et al, 2017.). After the body is exposed to an infectious agent, the body 
will generate antibodies or other means of resistance. Bacteria, fungi and viruses start an 
infection by firstly infecting a cell or a tissue causing a subsequent spread around the body into 
more cells or tissues, which can cause severe consequences in many cases. A shared symptom 
of bacterial, fungal and viral infections is fever (Cole and Kramer, 2016). Therefore, it is 
important to have selective and sensitive identification of the microorganisms in order to 
prevent and treat infections (Hu et al, 2018). 
 
1.1.1 Bacteria 
Bacteria is a large group of prokaryotic microorganisms which can be found in various shapes, 
most commonly bacilli (rod shaped), cocci (spherical) and spirochaetes (spiral shaped), in the 
microscale range (Zikalala et al, 2018). 
Bacteria is found ubiquitously in the environment; air, soil, water, land and food (Zikalala et 
al, 2018, Iravani, 2014). Bacteria are generally commensal organisms (bacteria living in 
harmony with the host; where the bacteria benefit whilst the host is neither harmed nor left 
unbenefited) allowing cutaneous homeostasis or immune competence (Parlet et al, 2019). 
Bacteria adapt easily to their surroundings, even in severe conditions whilst multiplying and 
growing rapidly. They are inexpensive to cultivate and easy to manipulate (Zikalala et al, 2018) 
and therefore often selected for their use in industry, as growth conditions i.e. temperature, 
oxygenation and incubation can all be easily controlled (Pantidos, 2014).  
Bacteria are responsible for many of the most serious infections and foodborne illnesses 
worldwide, especially in developing countries where medical resources and general hygiene is 
poor (Zhang et al, 2018). Morbidity and mortality rates and the cost of healthcare is increased 
as a result of bacterial infections (Xia et al, 2019). Rapid detection and identification of the 
2 
 
bacteria is very important in order for treatment to be given and control measures to be put in 
place (Zhang et al, 2018).  
Bacteria produce toxins (usually infectious and poisonous), which are generally heat-resistant 
and subsist even when the bacterium itself is killed by heat (Fleurot et al, 2014). Toxins also 
tend to be resistant to low pH, drying and freezing (Hennekinne et al, 2012, Kadariya et al, 
2014). Therefore toxin-producing bacteria are a significant threat to food industries as they can 
survive the production process (Rubab et al, 2018). 
These infections can be treated well with antibiotics, however the emergence of resistant strains 
of bacteria have outpaced the development of new antibiotics (Xia et al, 2019). Resistance to 
the first line antibiotics complicates the treatment of the infections (Schindler and Kaatz, 2016). 
Metal based nanoparticles are now being thoroughly investigated as possible antibacterial 
agents due to their large antimicrobial activity (Xia et al, 2019). 
Most metal ions are toxic to bacteria, to which bacteria has a defence mechanism. Many 
bacteria have the capability of manufacturing specialised inorganic nanostructures (Zikalala et 
al, 2018). Bacteria convert metal ions to nanoparticles to overcome the toxicity. Bacteria then 
secretes proteins which are used to stabilise the nanoparticles. The ability for bacterial strains 
to perform this defence mechanism is due to intracellular proteins and enzymes (Iravani, 2014). 
The advantages of using mediated bacterial synthesis to produce metal oxide nanoparticles is 
that it reduces the use of toxic and expensive chemicals and produces nanoparticles without 
additional impurities. This method can also be scaled up without difficulty (Agarwal et al, 
2017). The disadvantages are however, due to the screening of the bacteria it means the process 
is prolonged. Careful handling and inspection of bacteria is required in order to prevent 
contamination. Also, there is always difficulty in controlling the morphology and crystallinity 
of the nanoparticles (Zikalala et al, 2018, Agarwal et al, 2017). 
 
1.1.1.1 Bacterial controlled synthesis of metal oxide nanoparticles 
In this synthesis, bacteria synthesise iron oxide nanoparticles which are entrapped in 
phospholipid membrane-bound vesicles (magnetosome). Ferric iron is reduced on the cell 
surface and transported into the magnetosome, the ferrous ions are then oxidised and 
precipitated to produce iron oxide nanoparticles which are crystallised. The iron oxide 
nanoparticles are of high chemical purity, obtain a narrow size distribution and have similar 
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morphologies. Only iron-reducing bacteria (magnetotactic bacteria) can carry out this type of 
synthesis (Zikalala et al, 2018). 
 
1.1.1.2 Bacterial induced synthesis of metal oxide nanoparticles 
In this synthesis, bacteria alter to their environment and generate conditions suitable for 
extracellular synthesis of nanoparticles in order to degenerate the toxicity. The bacteria modify 
the solubility by changing their redox state, complexation and precipitation of the metal ions 
(Zikalala et al, 2018). Jha et al, 2009 synthesised titanium dioxide (TiO2) nanoparticles using 
Lactobacillus cells whilst heating on a steam bath at 60 °C for 10-20 minutes. Figure 1.1 shows 
the TiO2 nanoparticles and aggregates. 
 
Figure 1. 1: TiO2 nanoparticles synthesised by Lactobacillus cells (Jha et al, 2009). 
 
1.1.1.3 Gram-positive bacteria 
The key difference between gram-positive and gram-negative bacteria is the cell wall 
composition and thickness. The cell walls of gram-positive bacteria have thicker peptidoglycan 
layers (Zyoud et al, 2019). Gram-positive bacteria have one cytoplasmic membrane with a 
cross linked 20-80 nm thick peptidoglycan layer with acidic residues on the exterior (Hu et al, 
2018). Irrespective of the thickness of the peptidoglycan layer, due to its relative porosity it 
doesn’t act as a permeability barrier (Agel et al, 2019, Maisch et al, 2004).  
Gram-positive bacteria are responsible for many devastating worldwide infections with high 
morbidity and mortality rates (Hu et al, 2018). Bacterial infections caused by gram-positive 
bacteria can lead to sepsis, bacteraemia, pneumonia, osteomyelitis and endocarditis (Xia et al, 
2019).  
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Commonly known gram-positive bacteria important to human medicine include: 
Staphylococcus aureus, Staphylococcus epidermis, Staphylococcus haemolyticus, 
Enterococcus faecalis, Enterococcus faecium, Streptococcus pneumoniae and Clostridium 
difficile (Schindler and Kaatz, 2016).   
 
1.1.1.3.1 Staphylococcus aureus (S. aureus) 
S. aureus is a commensal gram-positive round-shaped bacterium (Figure 1.2) found commonly 
in the upper respiratory tract and on the skin (El-Shahawy et al, 2018, Seyyed Mousavi et al, 
2017, Argudín et al, 2012.).  
 
 
 
 
 
 
Figure 1. 2: SEM images of S. aureus grown on agar at low and high magnifications (Zubair et al, 
2015). 
S. aureus also frequently exists in perineum, rectum, axilla and genitals (Miao et al, 2017). The 
bacterium also naturally exists in in the anterior nares of animals and likewise humans (Yadav 
et al, 2018). It is a facultative anaerobe, non-spore-forming (Rubab et al, 2018) which can grow 
without oxygen and is capable of surviving in hot, dry and saline environments 
(Chaibenjawong and Foster, 2010, Shahbaz et al, 2015). S. aureus has a round shape and 
approximately 1 µm. S. aureus is often a cause of skin infections (e.g. abscesses), respiratory 
infections (e.g. sinusitis, pneumonia), food poisoning (El-Shahawy et al, 2018.) osteomyelitis, 
endocarditis (Seyyed Mousavi et al, 2017, Rubab et al, 2018) and can lead to the development 
of septicaemia (Fluit, 2012). Toxic shock syndrome and staphylococcal scarlet fever is a result 
of the toxic shock syndrome toxin (TSST-1) produced by S. aureus which is often fatal (Seyyed 
Mousavi et al, 2017, Otto, 2014). Several stains can cause infections by producing virulence 
factors (potent protein toxins) which are expressed on the cell surface to bind and activate 
antibodies (El-Shahawy et al, 2018.). S. aureus is a major burden in both communities and 
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hospitals but also a serious problem regarding animals and farming. Dairy cows are known to 
develop mastitis due to S. aureus outbreaks and it is also a detriment to chickens (Fluit, 2012). 
S. aureus is generally the most problematic bacterium of the Staphylococcus genus (Parlet et 
al, 2019, Miao et al, 2017). S. aureus is responsible for a greater number of deaths than acquired 
immunodeficiency syndrome (AIDS), tuberculosis and viral hepatitis combined (Yang et al, 
2019, van Hal et al, 2012). There are more than 40 antimicrobial resistant genes located on 
plasmids and transposons have been identified which plays an important role in making non-
resistant bacteria resistant (Yadav et al, 2018). 
S. aureus is an easily adaptable bacterium and can gain strong antibiotic resistance quickly 
(Pantosti et al, 2007, Yadav et al, 2018). World Health Organisation (WHO) reports S. aureus 
is a major threat to both human animal health (Hu et al, 2018, Nordmann et al, 2007, Zhang et 
al, 2014, O'Connell et al, 2013). Therefore, fast detection of this bacterium is vital in order to 
avoid major outbreaks and widespread infections (Yang et al, 2019) and reduce the threats 
regarding public health and food safety (Rubab et al, 2018). 
The largest and most exposed organ of the human body is the skin. The organ is densely 
populated with bacteria which compete with each other for survival. The skin is predominantly 
occupied by members of Staphylococcus, Corynebacterium, Streptococcus, and 
Propionibacterium (Parlet et al, 2019, Christensen and Brüggemann, 2014, Grice and Segre, 
2011, Byrd et al, 2018). 
 S. aureus produces virulence factors both inside and out of the cell, leading to damage to the 
hosts biological membranes and ultimately cell death (Rubab et al, 2018). Many virulence 
factors are encoded on mobile genetic elements e.g. plasmids or prophages which can be 
transferred between strains by horizontal gene transfer (HGT) (Otto, 2014).  
S. aureus withholds many adhesins (surface-bound proteins which adhere to other cells/tissues) 
and thus can attach and persist on a multitude of the hosts tissues (e.g. heart tissues and bones) 
and also implant materials (e.g. catheters, prosthetic joints and pacemakers) and thus cause 
bdetrimental infections (Raafat et al, 2019, Miao et al, 2017).  
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1.1.1.3.1.1 Membrane-damaging toxins 
The cytoplasmic membrane is a target for bacterial toxins. The toxins initiate pore formation 
in the membrane causing the efflux of vital molecules and metabolites. Membrane-damaging 
toxins can be split into receptor mediated and non-receptor mediated. Receptor mediated has 
high target cell specificity, where the lysis is dependent on initial receptor interaction. Non-
receptor mediated is less specific and relies only on interacting with the membranes (Figure 
1.3). 
 
Figure 1. 3: Membrane damaging toxin mechanisms (Otto, 2014). 
 
1.1.1.3.1.2 Enzymes 
There are many enzymes that are secreted by S. aureus which degrade host molecules or 
interfere with the hosts metabolic or signalling pathways. Proteases are often secreted to break 
down the hosts proteins which ultimately leads to tissue destruction. Secreted staphylokinase 
activates plasminogen to plasmin, which breaks down fibrin networks, therefore deteriorating 
the function of the fibrin network which is meant to keep the staphylococcal infection localised. 
Although staphylokinase allows bacterial penetration through the skin barrier, it actually 
reduces the severity of skin lesions by promoting the opening and draining of skin lesions (Otto, 
2014, Kwiecinski et al, 2013). 
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1.1.1.3.2.1 Methicillin-resistant S. aureus (MRSA) outbreak 
During the pre-antibiotic era, the mortality rate of invasive S. aureus was intense. Penicillin 
was introduced onto the market and the treatment of infections was greatly successful. 
However, shortly after S. aureus became resistant to penicillin due to the production of β-
lactamase (enzyme which destroys the β-lactam ring of penicillin). Methicillin (a semi-
synthetic penicillin) was then developed and first used in the early 1960’s against penicillin-
resistant S. aureus (Miao et al, 2017). In 1961, reports suggest that penicillin-resistant S. aureus 
had now acquired resistance to methicillin (methicillin-resistant S. aureus, (MRSA)) (Rubab 
et al, 2018, David et al, 2017). Outbreaks of MRSA were predominantly a problem confined 
within hospitals and immunocompromised patients (Ibelings and Bruining, 2003), however 
recent outbreaks have emerged into communities and caused pandemic infections amongst 
immunocompromised populations and increasingly into populations of healthy individuals 
(Parlet et al, 2019, Chambers and DeLeo, 2009, Otto, 2010, DeLeo et al, 2010). It has now 
become increasingly difficult to treat MRSA associated infections due to the strength of 
resistance the bacteria has to a wide spectrum of antibiotics (Rubab et al, 2018, Stevens, 2003). 
MRSA has been present in a variety of animals, from pets to farmed animals (typically found 
in meat, fish and dairy products) which therefore directly affects any humans who has 
consumed or been in close with these animals (van Loo et al, 2007, Leonard and Markey, 
2008). MRSA is currently associated with skin and soft tissue infections more than respiratory 
infections (Zetola et al, 2005, Crago et al, 2012). Since 2013, a few number of new 
antimicrobial agents have been developed and approved by North American and European 
regulatory agencies for the treatment of MRSA. However, these drugs have been generally 
approved for the treatment of complicated soft-tissue infections rather than more complicated 
infections such as bacteraemia, osteomyelitis or endocarditis (David et al, 2017). 
 
1.1.1.3.2.2 Toxic shock syndrome (TSS) 
TSS is a rare (Biglari et al, 2019.), multi-system, toxin-mediated and potentially deadly disease. 
It is a severe illness that results in fever, hypotension, shock and multiple organ failures 
(Gottlieb et al, 2018). TSS is mostly concerned with women of childbearing age, long-term use 
of tampons and the subsequent bacterial growth, in particular of S. aureus (Sada et al, 2017, 
Lappin et al, 2009). The heat resistant (Biglari et al, 2019) toxic shock syndrome toxin (TSST-
1) is produced by very few strains of S. aureus (Wilson et al, 2011). The TTST-1 toxin induces 
the mass production of cytokines which is believed to be the key in the pathogenesis of TSS 
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(Kum et al, 2001, Lappin et al, 2009). The toxins interfere with leukocyte receptors to prevent 
recognition and subsequent activation of the immune system (Otto, 2014). Repetitive cycles of 
cell stimulation and cytokine release results in tissue damage and organ dysfunction.  
TSS was first reported in 1978 with the association of highly absorbent tampons in young 
women and found high percentages of vaginal cultures yielding S. aureus. Therapy requires 
early identification of the disease, control of the source and administration of the relevant 
antibiotics and drugs to suppress toxin production (Lappin et al, 2009). Although the disease 
is quick to be lethal it is usually treatable (Gottlieb et al, 2018). 
Non-menstrual TSS can still result from a primary staphylococcal infection or colonisation of 
a toxin producing strain of S. aureus. This can occur after disruption to skin or mucous 
membranes (skin abscesses/burns or after surgical procedures) (Lappin et al, 2009). 
Recent changes in the manufacturing and use of tampon has led to a significant decline in the 
frequency of menstrual-related TSS, however the incidences of non-menstrual TSS has 
increased (Gottlieb et al, 2018, Chuang et al, 2005, Reingold et al, 1989, Hajjeh et al, 1999). 
 
1.1.1.4 Gram-negative bacteria 
Gram-negative bacteria’s cell envelope is comprised by two membranes; an inner membrane 
and an outer membrane which are separated by a periplasmic space containing peptidoglycan 
(Zheng et al, 2017). Gram-negatives withhold a thinner peptidoglycan layer than gram-positive 
bacteria (Hu et al, 2018). 
This second membrane has a strong negative charge due to the presence of lipopolysaccharides 
(LPS) and porins (Agel et al, 2019, Maisch et al, 2004, Malik et al, 1992). The LPS in the outer 
membrane of a gram-negative bacteria is a key component and can be used to identify the 
bacteria due to its unique pathogen-associated molecular pattern (Zhang et al, 2018, 
Ramachandran, 2013, Ulevitch and Tobias, 1999). The LPS is recognised by macrophages 
(Mathison et al, 1992), granulocytes (Fang et al, 2013) and dendritic cells (Barrientos et al, 
2014) which triggers the intracellular signal transduction and therefore activates the host 
defence against the invasion of gram-negative bacteria (Zhang et al, 2018). 
It is known that gram-negative bacteria are harder to kill than gram-positive bacteria, due to 
the presence of two cytoplasmic membranes, when compared to the single cytoplasmic 
membrane that gram-positive bacteria withhold; hence making it more difficult for 
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antibacterials to cross the membranes and cause an inhibitory effect (Agel et al, 2019). Gram-
negative bacteria are normally found in the environment (Zhang et al, 2018, Kaye and Pogue, 
2015). 
 
1.1.1.4.1 Escherichia Coli (E. coli) 
E. coli is the most common commensal aero-anaerobic gram-negative rod-shaped bacterium of 
the gut (Tenaillon et al, 2010), where it is found in the intestinal flora (Ahmadian-Fard-Fini et 
al, 2018).  
 
 
 
 
 
 
Figure 1. 4: SEM image of E. coli grown on agar (Keerthana, 2016). 
If the bacterium reaches any tissues outside the intestinal flora, the bacterium becomes 
pathogenic and infections may arise. These infections often occur within the urinary tract, 
biliary tract and can even spread to the bloodstream, prostate gland, lungs, bones and eyes (El-
Shahawy et al, 2018). Many food and water borne diseases are a consequence due to the 
exposure of E. coli strains (Gupta et al, 2019, Mathelié-Guinlet et al, 2017). E. coli is passed 
into the environment through faecal matter leading to water-related diseases where waste water 
and drinking water are not treated effectively. Therefore, E. coli is used as a faecal indicator 
which monitors the quality of recreational water at freshwater beaches (Shrestha, A. and 
Dorevitch, S., 2019).  
E. coli was first discovered by German bacteriologist Theodor Escherich in 1885 in the human 
colon (Feng et al, 2002). E. coli has a cytoplasmic membrane and a peptidoglycan layer and 
holds an outer membrane composed of a phospholipid bilayer containing lipopolysaccharide 
(LPS) molecules and proteins (Mathelié-Guinlet et al, 2017). E. coli has become one of the 
greatest host organisms for metabolic engineering and synthetic biology due to its rapid growth 
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(short replication time), easy culture conditions and its ability to thrive under various growth 
conditions, metabolic manipulability and due to the immense knowledge in the biochemical 
and physiological properties of the bacterium. E. coli can be genetically manipulated easily 
which allows new phenotypes to be developed and its physiology to be explored. Numerous 
molecular cloning and genetic tools have been developed using E. coli (Pontrelli et al, 2018, 
Meyer and Schmidhalter, 2012). 
Although E. coli is selected a one of the greatest host organisms there are also disadvantages 
which accompany E. coli as a host organism. E. coli is unable to be cultured at high (Tao et al, 
2005) and low pH (Wernick et al, 2016) and also at high temperatures (Hasunuma and Kondo, 
2012, Bhalla et al, 2013) due to the rise of contamination resistance (Tao et al, 2005, 11). E. 
coli is incapable of producing glycosylated biopharmaceutical products, proteins that require 
complex assembly or proteins with a high number of disulphide bonds (Meyer and 
Schmidhalter, 2012). The use of E. coli or bacteria in general in industry will always present 
as a threat to production, due to phage contamination where used in non-sterile conditions (de 
Melo et al, 2018, Samson and Moineau, 2013). 
E. coli strain K-12 is classified into Risk Group 1 which suggests there is no threat of to a 
healthy human adult. This is due to the lack of O-antigens, virulence factors, colonisation 
factors. Therefore, these strains are useful in the productions of pharmaceutics, food, chemicals 
and fuels (Pontrelli et al, 2018). 
Chest and blood infections can result from the exposure of E. coli strain MRE 162. Mathelié-
Guinlet et al, 2017 used MRE 162 in their work to understand the interaction between silica 
nanoparticles and the E. coli strain to mimic real biological attacks and to see how populations 
exposed to the strain are at risk of contracting infections. 
 
1.1.1.4.1.1 Urinary tract infections (UTI) 
A UTI refers to any infection in the urinary tract; in the urethra (urethritis), bladder (cystitis) 
or more severely kidneys (pyelonephritis) (Sheerin, 2011). The infection causes frequent and 
painful urination (Foxman, 2013), and although brings about distress they rarely present a 
threat to life (Sussman, 2013). UTIs are a result of pathogenic bacteria (most commonly faecal 
bacteria) colonising the urethra and moving to the bladder to multiply due to the lack of 
protective flora present. The virulence factors of the bacteria and host defence mechanisms 
determine the development of a UTI. E. coli has the ability to bind to specific receptors on the 
11 
 
epithelial cells in the urinary tract mucosa using surface adhesins in order to overcome the flow 
of urine (Sheerin, 2011). Whilst the host defence mechanism includes the production of 
glycosaminoglycans to coat the uroepithelium to provide a barrier against bacterial attachment 
(Zimmel, 2014). Women are more susceptible to contracting a UTI than men, which is due to 
the periurethral area (the area surrounding the urethral opening) in women providing more 
places for bacterial growth than in men, in combination with the shorter distance from the 
urethral opening to the bladder which fortifies the risk in women (Norrby, 2010). UTIs are 
easily treatable with a short course of antibiotics for an acute UTI; which means the chance for 
selecting antibiotic resistance in an individual is low. However due to the large number of 
women being treated for a UTI with antibiotics (e.g. nitrofurantoin and fosfomycin), there is a 
high chance that resistance can arise and spread. UTIs tend to reoccur; after the first seemingly 
cured UTI, about 20% of women will contract another within 6 months. The rise of resistance 
to antibiotics has pushed to the research of alternative treatments for UTIs which include the 
use of cranberry products (Foxman, 2013). UTIs rank among the most common infections in 
humans along with respiratory and gastrointestinal infections (Sussman, 2015). 
 
1.1.1.4.1.2 E. coli O157:H7 
Although many strains or E. coli are generally harmless (Pontrelli et al, 2018), several strains 
can produce toxins. for example, strain O157:H7 produces a potent toxin known as Shiga toxin 
which is detrimental to the lining of the small intestine (El-Shahawy et al, 2018) which can 
cause lethal effects (Pennington, 2010). The E. coli bacteria adhere to the epithelial cells and 
create lesions therein through producing these Shiga toxins (Mead and Griffin, 1998). The first 
outbreak of E. coli O157:H7 was observed in 1982 when it was isolated from individuals who 
developed bloody diarrhoea and abdominal cramps after consuming hamburgers from a 
restaurant. E. coli O157:H7 is the most common cause of haemolytic uremic syndrome (HUS) 
and therefore early diagnosis is essential. Once infection has been established, the development 
of HUS cannot be prevented. An infection of E. coli O157:H7 must be considered for any 
person who reports bloody diarrhoea. Faecal to oral transmission can occur through many 
routes and therefore many barriers are needed to prevent infection (Pennington, 2010). 
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1.1.2 Fungi 
Fungi are ubiquitous eukaryotic microorganisms (Bartemes and Kita, 2018) which includes 
yeasts and moulds (Zikalala et al, 2018, Jeevanandam et al, 2016). Fungi are heterotrophs and 
therefore are unable to make their own nutrients so depend on other organisms to provide their 
food (Twaroch et al, 2015). Fungi extracellularly digest their food by secreting enzymes and 
then take it up as nutrients once broken down (Bartemes and Kita, 2018). Fungi are encased in 
thick cell walls (Limon et al, 2017) largely made up of proteins (Hu et al, 2018).  
Fungal products are biological molecules produced by fungi either associated with the fungal 
cell wall or secreted extracellularly (Bartemes and Kita, 2018). Fungi produce spores which 
remain dormant until they are ready to germinate, through doing this they swell and send out 
hyphae (branching, filamentous body of fungus) (Templeton et al, 2010). Fungal growth 
depends majorly on temperature; Alternaria and Cladosporium species grow well in moderate 
climates around 20-30°C; because they do not grow well at body temperatures, they rarely 
cause infections in humans. However, their airborne fragments and secreted fungal products 
can cause respiratory allergies (i.e. asthma) (Bartemes and Kita, 2018). Thermotolerant fungi; 
Candida, Penicillium and Aspergillus species have the capability of growing at human body 
temperature and serves as part of the microbiome and as a cause of infections (37°C) 
(Rodrigues et al, 2016.). 
Fungal spores are greatly variable in size; they can range between less than 2 μm to 250 μm in 
diameter (Bartemes and Kita, 2018). Spores that are larger than 10 μm (i.e. Alternaria species) 
deposit in the upper airways – where the temperature is less than 37°C; however, spores that 
are less than 10 μm can reach the lower airways (i.e. Aspergillus and Penicillium). Aspergillus 
species is the most prominent fungus to infect the lungs and they have the ability to colonise 
and germinate in the respiratory mucosa, unlike other respiratory allergens which are unable to 
grow within the host (grass and tree pollens) (Rick et al, 2016). Fungi can be found at all levels 
of the respiratory tract (Limon et al, 2017). Fungi are naturally present in the intestinal tract 
(Bartemes and Kita, 2018, Iliev et al, 2012), intestinal fungal dysbiosis influences the 
development of gastrointestinal diseases (Leonardi et al, 2018), this fungal can then go on to 
cause inflammation of the lungs (Wheeler et al, 2016).  
Humans are at constant exposure to environmental fungal spores, often at levels 1000-fold 
greater than grass or tree pollen (Bartemes and Kita, 2018, Peay et al, 2016, Denning, 2006). 
Healthy hosts are often unaffected and resistant to fungal spores as a close relationship and 
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immunity has been established between the host and fungi at barrier surfaces (Casadevall, 
2012). However, fungi can stimulate immune responses and cause pathologic changes in 
organs. In immunocompromised hosts, fungi often colonise and infect the lungs and other 
organs, leading to an increase in morbidity and mortality rates (Bartemes and Kita, 2018). 
Commonly known fungal genera which are related to allergies in humans are Alternaria, 
Cladosporium, Penicillium and Aspergillus (Mari et al, 2003). 
Although numerous environmental factors are involved in developing asthma and allergies, 
exposure to airborne allergens from animals, arthropods and moulds is considered a risk factor 
(Knutsen et al, 2012). An association between developing allergic asthma and fungal exposure 
has been found in human subjects, especially regarding the Alternaria and Aspergillus species 
(Denning, 2006). Downs et al, 2001 found an association between severe asthma with an 
increase exposure of the Alternaria species in their study.  
Water damage can lead to an increase in the growth of fungi, for example Stachybotrys 
chartarum, which affects the air quality and can often lead to airway inflammation (Chung et 
al, 2010). 
Fungi can be found on the skin. Lipophillic fungus Malassezia is a dominant fungal found on 
the skin in adults (Findley et al, 2013, Paulino et al, 2006). The Malassezia species require long 
chain fatty acids for optimal growth; they are commonly found on most skin areas however are 
more commonly found with lipid-rich sebum secreted from the sebaceous glands (Gaitanis et 
al, 2012). In children where there is less sebaceous gland activity, the fungal communities are 
more diverse, including species of Aspergillus, Epicoccum and Phoma (as well as Malassezia) 
(Jo et al, 2016). The role of Malassezia is unknown regarding the benefits on the skin, however 
it has been studied that the aryl hydrocarbon receptor ligands they produce may encourage 
epithelial cell health and protecting cells from UV radiation (Velegraki et al, 2015). 
Fungi has been used in food and drink production since the ancient times, especially regarding 
the production of alcoholic beverages and breads. Moulds and yeasts are used today for large 
scale fermentation or synthesis of many other ingredients (e.g. enzymes, organic acids, 
vitamins, pigments and fatty acids). Fungi that are used in fermentation processes to convert 
solid or liquid substrates into various products. Key points for the fermentation processes 
include producing the desired bioproduct with the highest consistent yield at the fastest rate in 
the cheapest and possible way (Copetti, 2019). 
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1.1.3 Viruses 
Viruses are the most abundant entities on Earth, withholding a large reservoir of genetic 
diversity (Paez-Espino et al, 2016). Depending on the environment, bacterial activity and 
colonisation results in the abundance and diversity of the viruses (Lima et al, 2019).  
The human gut harbours a complex microbial ecosystem which includes the presence of viruses 
(virobiota) (Lima et al, 2019). 
Viruses can be transmitted in many ways, but predominantly through the mucosal surfaces. 
The virus can be transported through the gastrointestinal tract during faecal-oral transmission. 
The virus can be transported through the genital mucosa during sexual transmission. The virus 
can be transported through infected aerosol particles which is inhaled and deposited in the 
upper airways by a vulnerable person during aerosol transmission. Blood-borne viruses require 
arthropod vectors (e.g. mosquitoes, flies, fleas) to carry and disseminate the virus into the host 
during feeding on blood (Wilks et al, 2013). 
The host’s microbiota can influence viral infections. The presence of microbiota could be 
neutral, hinder viral infections or it could promote viral infection (Wilks et al, 2013). 
 
1.1.3.1 Influenza virus 
Influenza viruses are from the family Orthomyxoviridae. Influenza A and B viruses are held 
responsible for epidemics which cause up to half a million deaths globally each year. Influenza 
C viruses are less common and cause only mild infections. Influenza D viruses are not known 
to infect humans (Walker and Fodor, 2019, Krammer and Palese, 2013). 
Vaccines against influenza viruses are available, however many vaccines are often ineffective 
due to the variation in surface proteins on the virus (Houser and Subbarao, 2015, Krammer and 
Palese, 2015).  
Influenza viruses have a genome consisting of eight viral RNA (vRNA) segments, each 
encoding one or two major viral proteins. Each genome segment is packaged with viral 
ribonucleoprotein complexes (vRNPs). Influenza virions must contain full set of vRNPs to be 
actively infectious (Walker and Fodor, 2019). 
The illness is characterised by the sudden onset of respiratory symptoms, including fever, 
myalgia, headache, malaise, non-productive cough, sore throat and rhinitis. Acute influenza 
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typically resolves after 3-7 days, however, the cough and malaise can persist for more than 2 
weeks (Nichols and LeDuc, 2009). The majority of influenza illnesses are acute but in 
immunocompromised patients severe infections which can last multiple months can occur 
(Nichols et al, 2004, Vigil et al, 2010, Memoli et al, 2013). In these immunocompromised 
hosts, their immune responses are either weakened or absent (Xue et al, 2018) and these 
infections are treated with a long course of antiviral drugs (Nichols et al, 2004, Vigil et al, 
2010, Memoli et al, 2013.). Due to the much longer viral infection in chronic influenza, the 
influenza viruses can replicate and quickly mutate and therefore generate genetically diverse 
populations simultaneously. The influenza virus is usually found co-occurring with other 
respiratory pathogens (Xue et al, 2018) and in most severe cases associated with pneumonia 
which is induced by bacterial co-infection (Wilks et al, 2013). 
 
1.1.3.2 Human Immunodeficiency Virus (HIV) 
HIV is an RNA retrovirus that infects T-lymphocytes in human hosts. The virus is transmitted 
through contaminated bodily fluids. The virus remains dormant for a period of 5-10 years 
before it diminishes the immunological function of the body it manifests to AIDS (Weledji, 
2013). 
HIV is a sexually transmitted organism which can affect the anorectum. Other viral organisms 
include herpes simplex virus and cytomegalovirus which can also arise due to the suppressed 
immune system. Symptoms caused by the presence of one or more of the organisms often 
results in fever, diarrhoea, rectal bleeding and even visible lesions in the anus and perineum 
(Weledji, 2013, Beck and Wexner, 1990). 
Injecting drugs has created international public-health problems, especially regarding the 
transmission of blood-borne viruses (Hladik and McElrath, 2008). HIV can be transmitted 
through sharing needles to inject drugs (Des Jarlais, 2013) and contributes to the morbidity and 
mortality of illicit drug use (Hladik and McElrath, 2008). In order to reduce the transmission 
of HIV through needle sharing, it is imperitave that clean injection equipment is available for 
drug users (Des Jarlais, 2013). 
There is currently no cure for HIV/AIDS but highly active antiretroviral treatment prolongs the 
survival in many patients (Weledji, 2013) and some achieve near-normal life expectancy 
(Bloomfield et al, 2015, Johnson et al, 2013, Sabin, 2013). 
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1.1.3.3 Dengue virus 
Dengue virus are the cause of dengue fever in humans (Gubler, 1998). There are four 
antigenically distinct dengue virus serotypes (DENV1, DENV2, DENV3 and DENV4) which 
are part of the family Flaviviridae (Yacoub and Farrar, 2014). This virus is largely transmitted 
by the Aedes aegypti mosquito. The virus is taken up by the mosquito through dengue laden 
blood, which firstly infects the mosquito gut tissue and migrates to the salivary gland where it 
will transmit to another host during feeding (Gubler, 1998). 
Currently, there are no available antiviral drugs or vaccines for dengue, and the management 
relies solely on fluid replacement of the severe cases (Yacoub and Farrar, 2014).  The main 
strategy currently is vector control to reduce the incidence of dengue fever, which will 
potentially reduce medical costs, productivity losses and premature deaths (Undurraga et al, 
2016). 
Dengue fever can range from a mild form of illness to severe dengue, which is characterised 
by capillary leakage, leading to hypoyolaemic shock, organ impairment and bleeding 
complications (Yacoub and Farrar, 2014). 
Dengue fever is presented by 3-5 days of high fever, intense headache, myalgia, nausea, 
vomiting, muscle joint pain, seizures and rashes (Qureshi, 2016, Naides, 2012, Tulchinsky and 
Varavikova, 2014). Severe dengue fever is a lethal complication causing fluid accumulation, 
plasma leakage, respiratory problems, severe bleeding or organ impairment and this is often 
presented by symptoms of continuous vomiting, rapid breathing, severe abdominal pain and 
bleeding gums (Tulchinsky and Varavikova, 2014).  
 
1.2 Antibacterial Agents 
An antibacterial agent is a chemically enhanced natural substance with the potential to kill 
(bactericidal effect) or slow down the growth or multiplication (bacteriostatic effect) of a 
bacterial organism without affecting the host functions (Hajipour et al, 2012). The latter 
working synergistically with the host’s own immune system to control and eradicate an 
infectious bacterial population. Almost all of the different antibiotics available currently on the 
market are based on the structure of antibacterial agents naturally found in environmental 
microorganisms; with many of these antibiotics being synthetic derivatives of these discovered 
microorganisms (e.g. the discovery of penicillin) (Qiao et al, 2018).   
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At the beginning of the last century, the major cause of death worldwide was mainly attributed 
to infectious diseases e.g. tuberculosis (Huh and Kwon, 2011), in 1928, Sir Alexander Fleming 
discovered the natural antibacterial agent ‘penicillin’ which came into use in the 1940s (Conly 
and Johnston, 2005). Since the introduction of antibiotics onto the drug market, considerable 
improvement on the health and wellbeing of the mass population in many major countries has 
been observed, as well as the dramatic rise in the population’s life expectancy and improved 
general health.  
Antibacterial agents have been used in industries, from house hold products, to agricultural use 
as well as in livestock and farming. In livestock they play a therapeutic role to treat bacterial 
infections in animals, as well as having a prophylactic use when there is risk of infection and 
finally, added in small quantities in feed and water to promote the growth of the animal 
(Marshall and Levy, 2011). 
From the 1950's to the 1970's, new classes of antibiotics were developed (Abed and Couvreur, 
2014) e.g. tetracyclines, rifamycins, nitroimidazoles, quinolones and trimethoprim. However, 
for the majority of the years after 1985 there has been a severe drop in novel antibiotic drug 
discovery (oxazolidinones and lipopeptides were discovered in 2000 and 2003, respectively) 
(Conly and Johnston, 2005). Moreover, with the increase in cases regarding bacterial resistance 
and with the rise of disease-causing organisms, increased effort is needed in the discovery of 
new and potent antibacterial agents.  
For further development in the discovery of novel antibacterial agents, understanding the 
mechanism of action is paramount, listed are some of the modes of action of antibacterial 
agents: (I) inhibition of cell membrane function and permeability (e.g. polymyxins); work best 
against gram-negative bacteria due to increased number of lipopolysaccharides (LPS) in the 
outer cell membrane. The mode of action involves disrupting the LPS in the cell membrane, 
hence increasing the permeability to antibacterial agents.  (II) interfere with ribosome function 
(e.g. aminoglycosides and chloramphenicol); aminoglycosides achieve irreversible inhibition 
of bacterial protein synthesis, this is achieved through interfering with the translation of 
mRNA. (III) block folate synthesis and metabolism (e.g. sulphonamides); these are structural 
analogues of para-amino benzoic acid, in bacterial cells act as antagonists and block synthesis 
of folic acid. (IV) inhibit nucleic acid synthesis (e.g. nitroimidazoles). (V) inhibit the cell wall 
synthesis (e.g. penicillin’s and cephalosporin’s); penicillin’s inhibit cell wall synthesis, through 
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inhibition of the enzyme transpeptidase, leading to the prevention of peptidoglycan forming 
and therefore cell wall synthesis (Byarugaba, 2010). 
 
1.2.1 Antibiotic Resistance 
The discovery and benefits of antibiotics have led to improved healthcare worldwide over the 
past century, however the inappropriate and lack of infection controlled resources of the 
antibacterial agents (Santos et al, 2013), and some mutations in the pathogens have stimulated 
the rise in resistance to antimicrobial drugs. Antimicrobial resistance itself has been around for 
a very long time. 
Antibacterial resistance itself can be acquired or inherent (characteristic of all species of that 
isolate), an example of inherent resistance is the resistance of Pseudomonas aeruginosa to a 
wide range of antibiotics, acquired bacterial resistance is where bacteria gain the genes 
encoding resistance, through a mutation or due to the transfer of genetic material from other 
bacteria (MacGowan and Macnaughton, 2013). Mutations cause changes to the gene target of 
the antibiotic, causing it to no longer have an effect on the targeted bacteria. Genetic material 
transferring from bacteria to bacteria (I) prevents entry of an antibiotic; (II) allows the removal 
of an antibiotic once it has entered the cell; (III) neutralises the antibiotic. These processes are 
labelled horizontal gene transfer (HGT). HGT is defined as the uptake of DNA into the genome 
of the bacteria through transfer from its surrounding area. This can be achieved through, 
transformation uptake of the DNA from the environment, transduction transfer of DNA through 
the use of a bacteriophage (a bacterial virus that replicates inside a cell and incorporates 
bacterial DNA and conjugation direct cell to cell transfer through a plasmid).  
Furthermore, the overuse and misuse of antibacterial agents has led to the emergence of 
antibiotic resistant genes, which further reduce the therapeutic effect of an antimicrobial agent, 
and renders it ineffective. Some examples include the resistance of all gram-positive organisms 
to colistin, and the resistance of Enterobacteriaceae to glycopeptides and linezolid 
(MacGowan and MacNaughton, 2013).  
Bacterial resistance has now reached pandemic levels as various bacteria have developed 
resistance to many antibacterial agents (e.g. Staphylococcus aureus is resistant to Methicillin 
and Staphylococci is resistant to vancomycin) (Kandi and Kandi, 2015). Illnesses develop when 
bacteria enters the human body and is not treated properly, ranging from mild to life threatening 
conditions such as wound infections, abscess infections, endocarditis or blood stream infection 
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(Muñoz-Bonilla and Fernández-García, 2012). The increasing evolution of antibacterial 
resistant strains of pathogenic bacteria has enforced the need to discover alternative and 
effective approaches, which can fight microbial resistance and treat infectious diseases 
(Allahverdiyev et al, 2011). 
Along with mutation’s and HGT another reason for the rise in bacterial resistance is the 
insufficient understanding of the numerous bacteria and their antimicrobial susceptibility 
patterns, for patients with bacterial infections this poses a risk, as knowledge of bacteria is 
deficient, to counter this the overuse and misuse of broad spectrum antibacterials occurs.   
Bacteria have evolved and developed several mechanisms of bacterial resistance which include 
(I) producing degradable enzymes to antibacterial agents (including cephalosporin’s and 
penicillin’s); in this case the bacteria (e.g. E-coli) release the enzyme β-lactamase, which 
cleaves of the lactam ring in penicillin causing it to become ineffective; (II) reducing the 
bacterial membrane permeability to antibiotics (including chloramphenicol and quinolones); 
chloramphenicol (Cm) is a broad spectrum antibacterial, inhibition of bacterial protein 
biosynthesis by Cm is largely due to the prevention of peptide chain elongation. Its 
bacteriostatic action is centred on a reversible binding to the peptidyltransferase centre at the 
50S ribosomal subunit of 70S ribosomes; however bacteria since have developed resistance to 
Cm through acetylation of the drug and through the use of different chloramphenicol 
acetyltransferases enzymes (Schwarz et al, 2004); (III) alteration of an antibiotic target protein 
(including penicillin binding protein) (Dever and Dermody 1991). Other mechanisms of 
resistance include increased efflux of drug particles out of the cell and altering drug binding 
sites on the bacterial cell surface. Some conventional antibacterial agents have encountered 
bacterial resistance due to the inaccurate or even high dosage administered which also leads to 
adverse side effects and intolerable toxicity. 
The lack of discovery of novel antibiotics are partially due to the insufficient resources 
available in discovering new antibacterial agents. However, a larger responsibility lies on 
pharmaceutical companies, for not finding investments into new synthetic antimicrobials 
research, financially rewarding. Furthermore the rise in the number of antimicrobial resistant 
strains, has led to a need of an alternative formulation to common antimicrobials, it is known 
that over 70% of bacterial infections are resistant to one or more of the antibiotics that are 
commonly used to eliminate the infection, which can in severe cases lead to death, in the US 
over 2 million people contract an infection resistant to antibiotics yearly, leading to the death 
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of around 23,000 people (Akova 2016), therefore now more than ever advancements in novel 
and effective antimicrobial agents are of great importance (Dizaja et al, 2014). 
Some of the antibacterial agents are hydrophilic in nature leading to absolute restriction to 
cellular penetration for such drugs (e.g. aminoglycosides). However, other hydrophobic 
antibacterial agents (e.g. macrolides) suffer from low intracellular retention (Conly and 
Johnston, 2005). Beta-lactams are considered acidic by nature, allowing them to diffuse to the 
infection site but not accumulate to give the antibacterial action (Tulkens 1991). With so many 
antibacterial agents available with varying properties, it is essential when developing a novel 
antibacterial formulation to consider targeting the intracellular bacteria, this includes 
intracellular penetration, accumulation and distribution (Kandi and Kandi 2015).  
 
1.3 Nanotechnology 
With the introduction of nanotechnology involving the development, management and 
application of structures in the nanometer size range, it allows for the new advances in scientific 
fields including molecular treatment and rapid detection of diseases (Farokhzad and Langer, 
2006). Nanosized drug delivery systems can overcome biological barriers and instead direct 
the drug to the specific targets. Nanotubes, nanoparticles and nanofibers have already proven 
to be effective drug delivery systems (Faraji and Wipf, 2009, Brandelli et al, 2017). 
 
1.3.1 Nanoparticles 
Nanoparticles have attracted a lot of attention due to their unique physical and chemical 
properties, which derives from the high area to volume ratio they possess and large quantity of 
surface atoms, which makes them ideal candidates for biomedical applications as many 
biological processes occur at the nanometer level (Sharma et al, 2009). Heavy metals such as 
copper, silver and gold have been widely used for centuries for the control and treatment of 
infectious diseases. Silver in particular, has been recognised for its antimicrobial properties and 
use as an antimicrobial agent. Silver also shows potential activity against antibiotic-resistant 
microorganisms, which is a frontline concern for the public healthcare (Prabhu and Poulose, 
2012).  
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1.3.2 Metal nanoparticles as antibacterial agents 
Recent years has seen resistance to antibiotics ever increasing. Many organic antimicrobial 
agents are toxic to humans and other animals and therefore inorganic antibacterial agents have 
attracted interest for bacterial control due to their known safety, sustainability, heat tolerance 
and stability (Rajawat and Qureshi, 2012, Hossain et al, 2015). Studies have shown that metal 
oxide nanoparticles exhibit bactericidal action against both gram-positive and gram-negative 
bacteria (Ravishankar and Jamuna, 2011). The biochemistry of all organisms is pivotal on the 
essential metal ions; however, an excess of these ions or the presence of non-essential ions can 
be lethal to cells due to oxidative stress and membrane damage (Lemire et al, 2013). 
 
1.3.3 Silver nanoparticles 
Due to silver nanoparticles possessing a low cytotoxicity, it has been used against gram-
positive and gram-negative bacteria. The bactericidal action of silver nanoparticles is not 
completely understood, however considerable amounts of research is reviewing the mechanism 
(Ravishankar and Jamuna, 2011). It is thought that the high affinity of silver towards sulphur 
and nitrogen can disrupt the protein structure through binding to the thiol and amino groups, 
thus affecting the bacterial cell viability (Beyth et al, 2015). The silver ions from the 
nanoparticles interact with the phosphorus fraction of DNA which results in the inactivation of 
DNA replication (León-Silva et al, 2016). Silver compounds with or without combination of 
antibiotics provide broad spectrum antimicrobial activity against Escherichia coli, 
Staphylococcus aureus, Staphylococcus epidermis, Salmonella typhi, Klebsiella pneumoniae 
and many others (Chopade et al, 2014, Wang et al, 2014). Silver nanoparticles have already 
been incorporated into systems including bandages, surgical dressings and catheters to control 
bacterial colonisation to prevent infections (Maiti et al, 2014, Franci et al, 2015). The 
antimicrobial properties of silver nanoparticles mean they are being selected and incorporated 
into household items; bedding, toothpaste, shampoo, deodorant and paints (Ravishankar and 
Jamuna, 2011). The use of silver in food items is restricted, but through washing fruit and 
vegetables with suspensions containing silver nanoparticles, there may be residual silver 
contents. Silver nanoparticles have the ability to extend shelf life of foodstuffs, however due 
to inconclusive reports on toxicity, their use in food packaging is regulated in the EU and US 
and should be used cautiously (Carbone et al, 2016). Faria et al, 2015, incorporated silver 
nanoparticles into graphene nanosheets to measure the antibacterial activity against 
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Pseudomonas aeruginosa. The results shown a minimum inhibitory concentration range from 
2.5 to 5 µg/mL and a 100% inhibition rate towards the bacterial cells adhered to the surface. 
 
1.3.4 Gold nanoparticles 
Gold nanoparticles are considered safe to human cells. Gold nanoparticles can be used to kill 
multi-resistant pathogens and cancer cells when combined with photosensitisers (León-Silva 
et al, 2016). Tuning the gold nanoparticles so that they can absorb near-infrared radiation (NIR) 
allows them to cause irreparable cell damage once attached to bacterial cells, through the 
transfer of heat from the NIR irradiation (Norman et al, 2008, Beyth et al, 2015). Gold 
nanoparticles have a high antibacterial activity which can be used in combination with 
antibiotics such as vancomycin, ampicillin and cefaclor for both gram-positive and gram-
negative bacteria (Zhang, 2015, Payne et al, 2016). Ravishankar and Jamuna, 2011, studied the 
mode of action of cefaclor when combined with gold nanoparticles; cefaclor inhibits the 
synthesis of the peptidoglycan layer itself however when bound to gold nanoparticles, holes 
are produced in the cell wall leading to the leakage of the cell contents and cell death. Gold has 
been used for many applications for thousands of years; for the treatment of mental disorders, 
syphilis, lepra, epilepsy and diarrhoea. Gold nanoparticles in recent years have been used in 
many medical and hygiene applications, including sensitizers in radiotherapy, targeted drug 
delivery systems and detection of cancer cells (Dykmana and Khlebtsov, 2012, Zhang, 2015). 
Lima et al, 2013, dispersed gold nanoparticles onto zeolite and found it was an effective 
antimicrobial agent against food pathogens Escherichia coli and Salmonella typhi. 
 
1.3.5 Copper nanoparticles 
Copper compounds are often toxic to some organisms and can cause environmental concerns, 
however using copper nanoparticles can reduce the hazard (Ingle et al, 2014). Copper 
nanoparticles are cheap and can readily mix with polymers (Gawande et al, 2016). Although 
copper nanoparticles antimicrobial efficacy is inferior to silver, it is still effective against many 
bacterium’s including, Escherichia coli, Staphylococcus aureus (Cubillo et al, 2006), Bacillus 
subtilis (Ruparelia et al, 2008). It is shown that copper nanoparticles have a high antimicrobial 
activity against Bacillus subtilis and Bacillus anthracis due to the profusion of amines and 
carboxyl groups on the cell surface which has a high affinity for copper. The exact mechanism 
for the antimicrobial activity is not fully understood, however it is thought that it occurs through 
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membrane disruption and reactive oxygen species (ROS) production (Beyth et al, 2015). 
Lemire et al, 2013, found that with an increase of copper uptake into bacterial cells there was 
a decrease in cell viability, whilst the production of ROS increased. Ingle et al, 2014, found 
that copper nanoparticles have the ability for drug loading and photoluminescence and 
therefore can be used in the delivery of anticancer drugs. Although copper nanoparticles can 
be used for a variety of applications, their use is restricted by coppers inherent instability of 
oxidising under atmospheric conditions (Gawande et al, 2016). The oxidation issue can be 
overcome through using inert gas such as argon or nitrogen or through using reducing or 
capping agents (Umer et al, 2014). 
 
1.4 Electrohydrodynamic atomisation (EHDA) 
Electro hydrodynamic atomization (EHDA) is a multipurpose approach to fabricate materials 
for numerous applications especially in the pharmaceutical industry. Since the 1990s, this 
process has gained the attention of researchers to produce nano- and micro-structured fibers 
and particles (Xie et al, 2015). The main principle for the EHDA process utilises a high voltage 
applied to a capillary filled with solution. The resultant fibers or particles are collected on a 
grounded collector plate which is often covered by a material (i.e. paper, fabric, microscope 
slides) to make collection easier (Frenot and Chronakis, 2003). EHDA is a very simple, one-
step process for fabricating highly functional nanofibers and nanoparticles which can be used 
for a wide range of applications. EHDA processes are practicable at room temperature with 
atmospheric conditions (Bhardwaj and Kundu, 2010). 
 
1.4.1 EHDA process 
The EHDA process is very simple and requires few apparatuses (Frenot and Chronakis, 2003, 
Bhardwaj and Kundu, 2010). A medical syringe is filled with the solution and fitted into the 
syringe pump which controls the flow rate of the solution. Here, the solution flows through to 
the capillary needle where the solution is held at the nozzle by its surface tension. An electric 
field is applied to the nozzle which induces a charge on the surface of the liquid (Frenot and 
Chronakis, 2003). The charge repulsion causes a force to act directly opposite to the surface 
tension (Doshi and Reneker, 1995). The intensity of the electric field is increased and the 
solution forms a Taylor cone (hemispherical surface of the fluid elongates to form a conical 
shape). Increasing the intensity further till the critical value is reached, where the repulsive 
electrostatic force overcomes the surface tension and a charged jet of fluid is ejected from the 
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tip of the Taylor cone. The jet is broken during electrospraying to form fine droplets. Whereas 
the jet stretches and undergoes a whipping process in electrospinning. In both of these 
processes the solvent evaporates leaving behind solid droplets or fibers respectively on the 
grounded collector plate (Frenot and Chronakis, 2003, Bhardwaj and Kundu, 2010, Sill and 
von Recum, 2008). 
 
The parameter determining whether electrospinning or electrospraying will occur is the 
concentration of the polymer solution. When the solution concentration is high, the jet from 
the Taylor cone is stabilized and elongation takes place by whipping instability mechanism. If 
the solution concentration is low, the jet is destabilized due to the varicose instability and fine 
particles are formed (Anu Bhushani and Anandharamakrishnan, 2014). 
 
 
 
 
 
 
 
 
 
 
 
 
1.4.2 Electrospraying 
Electrospraying is the liquid atomisation by an applied electric field. It is a simple, versatile 
and cost-effective one-step process used for the fabrication of micro and nanoparticles (Anu 
Bhushani and Anandharamakrishnan, 2014, Zong et al, 2018).  
 
The principle of electrospraying is based on the theory of charged droplets. An electric field 
applied to a liquid droplet exiting a capillary is able to deform the interface of the droplet (Min 
et al, 2004). An electrostatic force inside the droplet competes with the surface tension of the 
droplet, forming the Taylor cone (characteristic of a charged droplet). When the electrostatic 
force overcomes the surface tension, excess charge needs to be dissipated and small charged 
Figure 1. 5: Schematic representation of EHDA set-up. 
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droplets are ejected from the initial droplet which are of micro and nano-scale; this reduces the 
charge without significantly reducing its mass (Bock et al, 2012). The particles are self-
dispersing in space due to the Coulomb repulsion of the charges which therefore reduces 
agglomeration and coalescence of the particles. The evaporation of the solvent results in 
contraction and solidification of the droplets which result in polymeric particles deposited on 
the grounded collector (Anu Bhushani and Anandharamakrishnan, 2014). 
 
1.4.2.1 Processing parameters of electrospraying 
1.4.2.1.1 Electrical conductivity 
Electrospraying depends on the electrostatic attraction of charged particles to the grounded 
collector plate and therefore the electrical conductivity of the solution is an important parameter 
for optimising the process (Bock et al, 2012). An increased conductivity of a solution means 
that more charge can be carried by the electrospraying jet. A low electrical conductivity is 
preferred as a higher conductivity favours elongated particles and even fibers if the polymer 
concentration is high enough. Changes to the electrical conductivity can be altered by changing 
the solvent (Meng et al, 2009). When the electrical conductivity of the solution is lower than 
0.01 μS/m, current flow is insufficient, and it is likely electrospraying cannot occur. However, 
an electrical conductivity too high can lead to unstable electrospraying (Ding et al, 2005). The 
deposition pattern of the particles are dependent on the electrical conductivity; with a higher 
electrical conductivity, the Coulombic repulsion forces are higher and compete with the 
viscoelastic forces of the solution and unravelling the polymeric network and allowing the 
solution to be broken up into smaller droplets (Bock et al, 2012). 
 
1.4.2.1.2 Flow rate 
Flow rate influences the morphology and particle size and must be selected depending on the 
anticipated particles (Boda et al, 2018). A suitable flow rate should be selected to allow for 
complete solvent evaporation, this is not possible with flow rates that are too high. If the 
particles land on the collector plate partially solvated it can lead to deformed and non-consistent 
morphologies (Xie et al, 2006). In order for spherical morphologies and monodispersity to be 
fabricated, it is important for sufficient polymeric chain entanglements to occur, which can 
only occur if the flow rate is low (Bock et al, 2012). 
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1.4.2.1.3 Applied voltage 
Applied voltage does not significantly affect the size of the resultant particles; it has only been 
found to slightly decrease the particle size when the applied voltage is increased (Hong et al, 
2008). Shenoy et al., found that as the voltage increased, the morphology of the particles 
changed from spherical to elongated or even beaded fibers, if the polymer concentration is high 
enough (Shenoy et al, 2005). With an increased applied voltage there is more charge acting on 
the droplet which leads to the stretching and elongation of the droplet (Bock et al, 2012, Boda 
et al, 2018). 
 
1.4.2.1.4 Capillary tip to collector distance 
The distance between the capillary tip and collector plate influences the particles morphology. 
If the distance is too small, there will be insufficient evaporation of the solvent and therefore 
wet droplets will result on the collector plate; this leads to collapsing and coalescing of the 
droplet which therefore leads to large size distributions (Arya et al, 2009, Boda et al, 2018). 
Through increasing the distance, more spherical particles are formed due to the ability of the 
polymer chains to diffuse sufficiently in the droplet before they land. An increased distance 
also allows sufficient time for the solvent to evaporate from the droplets exterior (Bock et al, 
2012). 
 
1.4.2.1.5 Temperature 
Temperature affects the vaporisation of the solvent from the liquid droplets which are 
fabricated during electrospraying. A higher temperature speeds up the drying and solidification 
of the electrospun particles, but also enhances the mobility of the polymeric chains within the 
droplets which decreases the particle size (Nguyen et al, 2016, Boda et al, 2018). 
 
1.4.2.1.6 Humidity  
A high relative humidity can change the morphology of the nanoparticles from solid to porous. 
This results from the from condensation, adsorption and diffusion of water from water vapour 
into the particle and then followed by a phase separation between the solvent and non-solvent 
phases during the drying process (Ikeuchi et al, 2011). 
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1.4.2.2 Applications of electrospraying 
Electrospraying has presented itself as a novel and appreciable technique for the synthesis of 
nanoparticles at a lab scale and now up-scaling to major production (Nguyen et al, 2016). 
Electrospraying has the advantage over other conventional techniques which includes easy 
instrumental set up, utilising fewer resources, ability to produce a wide range of particle sizes 
with a narrow size distribution and low chance of particle aggregation. A wide range of 
materials can be used for electrospraying which might not work with other processes, including 
thermally sensitive and labile materials because of the ambient conditions needed (Pawar et al, 
2018). 
 
1.4.2.2.1 Antibacterial drugs 
Curcumin is an anti-septic, analgesic and anti-inflammatory molecule (Sood and Nagpal, 
2013). Mai et al, 2017, loaded curcumin into poly-lactic (PLA) microcapsules. The composite 
electrosprayed microparticles exhibited broad spectrum antibacterial activity against gram-
positive S. aureus and gram-negative E. coli, which didn’t affect the viability of human dermal 
fibroblasts or induce haemolysis and was shown to have excellent biocompatibility. 
Ghayempour and Mortazavi, 2014, used coaxial electrospray to encapsulate peppermint 
essential oil which withholds broad spectrum antibacterial activity. The peppermint was 
emulsified with polyoxyethylene sorbitan monolaureate surfactant in the core and sodium 
alginate in the sheath. These nanocapsules lead to the complete eradication of S. aureus and E. 
coli colonies in comparison to the empty sodium alginate capsules (Boda et al, 2018).  
 
1.4.2.2.2 Anti-inflammatory drugs 
Inflammation of the tissues is caused by the over-oxidation and the generation of free radicals 
(Pham-Huy et al, 2008). Alpha-lipoic acid is a naturally occurring antioxidant and free radical 
scavenger which has been studied for their anti-inflammatory properties in diseases like type 
II diabetes and neurodegenerative diseases (Packer et al, 1995). Bai and Hu, 2014, loaded ALA 
into chitosan with polyethylene oxide (PEO) plasticiser to form composite nanoparticles using 
electrospraying. Confocal microscopy results proved that the uptake of the composite 
nanoparticles by LPS treated RAW 264.7 macrophage cells and initiated an anti-inflammatory 
effect by the alpha-lipoic acid due to the sustained release from the composite nanoparticles 
(Boda et al, 2018). 
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1.4.2.2.3 Food coatings 
Food coatings enhance the shelf life through acting as a barrier for the food product. Spray 
coating is commonly used as the method for food coating, however electrospraying can also be 
employed due to the coating uniformity on large areas of food surfaces with sufficient control 
on the deposition rate and film thickness (Anu Bhushani and Anandharamakrishnan, 2014). 
For example, chocolate coating is used in the snack and confectionary industry. The complexity 
of chocolate coating is due to the rheological properties of the chocolate solution having a 
direct effect on the processing and ultimate quality of the product. Electrospraying chocolate 
has been studied and it is found that parameters including the viscosity and electrical 
conductivity play a significant role on the spray quality. Through manipulating the fat content, 
temperature and quantity of added lecithin these values can be decreased and thus droplet size 
decreases and which provides a more uniform coating to the product. Gorty and Barringer, 
2011, achieved good quality of chocolate electrospraying through using samples with high fat 
content and an addition of less than 1.5% lecithin concentration. Marthina and Barringer, 2012, 
also studied these parameters with three different types of fats, cocoa butter, cocoa butter 
equivalent and lauric butter to determine the effect of the lecithin content on the viscosity and 
the electrical conductivity and how it affects the droplet size and overall coverage of the 
product. With an increase in lecithin content, the named parameters decreased providing fine 
droplets of a narrow size distribution which created a more even coverage than conventional 
methods which ultimately would be beneficial to the confectionary industry. For circumstances 
where the coating is essential for the protection of the product, electrospraying for thin film 
coating can be employed over the use of conventional spray coating methods. Electrospraying 
is a one step, low-energy and low-cost processing method and produces products with unique 
characteristics, which can benefit the confectionary industry (Anu Bhushani and 
Anandharamakrishnan, 2014).  
 
1.4.3 Electrospinning 
Electrospinning process is a fiber fabrication process utilised by applying an electrostatic field 
onto a liquid (polymeric solution). This approach has gained much attention because of its 
capability and feasibility in the fabrication of large quantities of fibres to be used in tissue 
engineering, filtration, drug delivery, biosensors, and wound dressings (Bhardwaj and Kundu, 
2010). Their high surface area, small pore size and possibility of fabricating three dimensional 
29 
 
structures for the development of advanced technologies is very attractive to current research 
in many fields (Frenot and Chronakis, 2003). 
 
The electrospinning process fabricates polymeric nanofibers (often with a diameter of less than 
100 nm) which is produced by an electrostatically driven jet of polymeric solution. The 
alignment of the electrospun nanofibers can construct unique and highly functional 
nanostructures. The deposition of the nanofibers can be controlled and aligned through 
manipulating the electrospinning process, in order to form complex and continuous three-
dimensional structures (i.e. nanowires and nanotubes). Nanofibers can also be laced together 
to create ultrathin layered polymeric fibrous sheets. Small insoluble particles can be 
incorporated in the polymeric solutions so they are encapsulated within the electrospun 
nanofibers. Likewise, soluble drugs or bacterial agents can also be incorporated (Frenot and 
Chronakis, 2003). A variety of cross-sectional shapes and sizes can also be fabricated using the 
electrospinning process. Koombhongse et al, 2001 used electrospinning to produce a variety of 
shapes and structures including branched fibers, flat ribbons and bent ribbons. Their research 
on the properties of these structures indicated that the selected polymer and solvent used 
affected the fluid mechanics, electrical properties of the solution and evaporation of the solvent 
which therefore contributed to the resultant structure of the nanofibers. 
 
Research on the fundamental aspects of the process and the correct conditions is at the forefront 
to understand nanofiber morphology, structure, surface functionality and strategies to assemble 
the nanofibers, for their applications as multifunctional membranes, biomedical structures (i.e. 
scaffolding in tissue engineering, wound dressings, artificial organs or vascular grafts), filter 
media, fabrication of speciality fabrics etc (Frenot and Chronakis, 2003). 
 
Conventional fiber spinning methods, (i.e. wet spinning, dry spinning, melt spinning and gel 
spinning) typically only produces fibers down to the microscale. However, electrospinning has 
the ability to produce fibers of the nanoscale. The nanofibers are solid fibers exhibiting a 
diameter of less than 100 nm and therefore noted for their large surface area per unit mass and 
small pore size (Frenot and Chronakis, 2003, Bhardwaj and Kundu, 2010). 
 
Porosity is a geometric parameter and the porosity and pore size of the nanofibers are important 
considerations for the applications for which the nanofibers will be used for; i.e. filtration, 
tissue engineering etc (Zussman et al, 2002, Schreuder-Gibson et al, 2002., Li et al, 2002). The 
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porosity can easily be manipulated through changing process parameters (Bhardwaj and 
Kundu, 2010). 
 
Nanofibers obtained currently are only found in non-woven form, which is useful for many 
applications such as filtration (Gibson et al, 1999), tissue engineering (Fertala et al, 2001) and 
wound dressings (Jin et al, 2002). It is a very difficult target to achieve a continuous single 
nanofiber due to the polymer jet trajectory in the complicated ‘whipping’ motion. If this target 
were to be achieved the applications for these nanofibers would be endless (Huang et al, 2003). 
However, approaches to achieving a continuous single nanofiber are being researched through 
different techniques; a cylinder collector with high rotating speed (Boland et al, 2001), an 
auxiliary electric field (Bornat, 1987) and an electrostatic field-assisted assembly collector 
(Theron et al, 2001). 
 
1.4.3.1 Processing parameters for electrospinning 
The electrospinning process relies on numerous parameters, which are classified into solution 
parameter, process parameter and ambient parameters. Solution parameters include solution 
concentration, polymeric molecular weight, viscosity, surface tension, electrical conductivity. 
Process parameters include applied voltage, flow rate and capillary tip to collector plate 
distance. Ambient parameters include temperate and humidity. Each of these parameters have 
an effect the fibers morphology, and through manipulating these parameters fibers of desired 
morphology can be collected (Chong et al, 2007). 
 
1.4.3.1.1 Solution concentration  
A minimum solution concentration is required in order for the electrospinning process to 
happen and consequently fiber formation to occur. When the solution concentration is low, a 
mixture of beads and fibers is attained. With increasing the solution concentration, the shape 
of the beads alters from spherical to spindle-like and then ultimately to uniform fibers with 
increased diameters due to the increase in viscosity. At too high concentrations it is difficult to 
form continuous fibers due to the failure to maintain the flow of solution and therefore unstable 
large average diameter fibers are formed. The concentration of the solution inevitably effects 
the solution surface tension and viscosity (Bhardwaj and Kundu, 2010). 
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1.4.3.1.2 Molecular weight  
The molecular weight of the polymer has a significant effect on the rheological (viscosity, 
surface tension) and electrical properties (electrical conductivity and dielectric strength) of the 
solution. At too low a molecular weight, beads are typically formed rather than fibers; and at 
too high a molecular weight fibers with large average diameters are formed. The molecular 
weight of the polymer effects the number of entanglements of the polymer chains, which is an 
important aspect of the electrospinning process. However, it is observed that high molecular 
weights are not always essential if there are sufficient intermolecular interactions which 
substitutes chain entanglements (Bhardwaj and Kundu, 2010). 
 
1.4.3.1.3 Viscosity 
The viscosity of a solution is an important parameter in determining fiber size and morphology 
of the electrospun fibers. An optimum viscosity is required in order for the electrospinning 
process to happen and consequently fiber formation to occur. When there is very low viscosity, 
there is a high generation of beads and no continuous fiber formation. When the viscosity is 
too high, it is too difficult for the ejection of jets from the polymeric solution. The viscosity of 
the solution plays a significant role in determining the range of concentrations in which 
continuous fibers can be fabricated (Bhardwaj and Kundu, 2010). 
 
1.4.3.1.4 Surface tension 
The surface tension of a solution tends to be a function of the selected solvent and plays a 
critical role in the electrospinning process. There is no conclusive correlation between surface 
tension and the fiber morphology. A solution with a high surface tension tends to inhibit the 
electrospinning process due to the instability of jets and therefore large sprayed droplets are 
formed. Using a solution with a low surface tension allows the electrospinning process to occur 
at a lower electric field but doesn’t always confirm stability of the jets (Bhardwaj and Kundu, 
2010). 
 
1.4.3.1.5 Electrical conductivity 
The solution conductivity is a combination of the selected polymer, solvent and the availability 
of ionisable salts which are all vastly influential in the jet formation. With an increase in 
electrical conductivity there is a decrease in the fiber diameter, however with a low electrical 
conductivity there is insufficient elongation of the jet and thus non-uniform fibers withholding 
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beads. Adding salts to the formulation increases the uniformity of fibers and decreases the 
presence of beads (Bhardwaj and Kundu, 2010). 
 
1.4.3.1.6 Applied voltage 
The applied voltage is a crucial parameter for electrospinning. Only after the threshold voltage 
has been reached, fiber formation occurs through inducing the necessary charges on the 
solution. Through manipulating the applied voltage, experimentally the shape of the initial drop 
changes; from dripping mode to stable Taylor cone to unstable jetting mode (Bhardwaj and 
Kundu, 2010, Sill and von Recum, 2008). Although most research shows that with increasing 
the applied voltage causes greater stretching of the solution due to greater columbic forces in 
the jet and in turn reduces the fiber diameter, some research suggests a conflicting statement. 
Reneker and Chun, 1996, suggest that there was no correlation on the effect of the electric field 
with the fiber diameter of their PEO fibers. Zhang et al, 2005, suggests that with an increase in 
applied voltage, polymer ejection is greater and therefore facilitating fibers of a larger diameter. 
It is also shown that at a higher applied voltage there is a greater probability of bead formation 
(Buchko et al, 1999). 
 
1.4.3.1.7 Flow rate 
The flow rate is another important process parameter as it influences the jet velocity and 
material transfer rate. A lower flower rate is more desirable as it allows the solvent in solution 
enough time to evaporate from the jet before reaching the collector plate. It is observed that the 
morphology of the fiber and pore diameter increases with an increase in flow rate for 
polystyrene fibers. High flow rates often result in beaded fibers due to the incomplete drying 
prior to reaching the collector plate (Bhardwaj and Kundu, 2010, Sill and von Recum, 2008). 
 
1.4.3.1.8 Capillary tip to collector distance 
The distance between the capillary tip and the collector plate influences the fiber morphology 
and diameters, however is not as significant as other parameters. A minimum distance is 
required in order to provide the fibers with enough time to dry (solvent evaporation) prior to 
reaching the collector plate. When the distance is too small, beads are observed on the resultant 
fibers (Bhardwaj and Kundu, 2010, Sill and von Recum, 2008). (Buchko et al, 1999) observed 
that the fibers produced at closer distances are flatter than the fibers produced at increased 
distance which had a rounder morphology. 
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1.4.3.1.9 Temperature 
It has been found that with an increase in ambient temperatures there has been a decrease in 
the resultant fiber diameter. Mit-Uppatham et al, 2004, investigated the effect of temperature 
on electrospun polyamide-6 fibers ranging from 25-60°C, the results concluded that with the 
increase in temperature there is a decrease in the yielded fiber diameters. The researchers 
credited this finding to the decrease in viscosity of the polymer solution at increased 
temperatures (Bhardwaj and Kundu, 2010). 
 
1.4.3.1.10 Humidity 
Baumgarten, 1971, found that their electrospun fibers dried faster at very low humidity’s, 
which is due to the ability of the solvent to evaporate faster than at higher humidity’s. If the 
evaporation rate of the solvent is too fast, evaporation of the solvent would take place at the 
end of the needle and the electrospinning process would only take place for a few minutes 
before the needle tip is clogged up (Bhardwaj and Kundu, 2010). Therefore, the choice of 
solvent is an important parameter as it strongly influences whether fibers are capable of 
forming as well as affecting fiber porosity. A volatile solvent is often selected in order for 
sufficient solvent evaporation to occur between the capillary tip and the collector plate and 
therefore for solid polymeric fibers or particles to be deposited (Sill and von Recum, 2008). 
 
1.4.3.2 Applications of electrospinning 
Use of electrospun nanofibers are very attractive due to their advantageous high surface area 
to volume ratio, high porosity and capability to manipulate the fibers into achieving desirable 
attributes, through changing solution and process parameters. Therefore, electrospun fibers are 
increasingly being used in a wide variety of applications, including biomedical applications, 
wound healing, drug delivery, filtration and cosmetics (Bhardwaj and Kundu, 2010). 
 
1.4.3.2.1 Tissue engineering applications 
Tissue engineering is about the restoration, maintenance or improvement of tissue (cartilages, 
dermal tissue, bones, blood vessels, heart, nerves) function (Bhardwaj and Kundu, 2010). 
Electrospinning as a means of producing fibrous scaffolds is a simpler and more cost-effective 
procedure when compared to other fiber forming processes such as self-assembly and phase 
separation and meets all the essential design criteria of an ideal tissue engineered scaffold. 
Scaffolds for cellular growth, proliferation and new tissue formation in three-dimensions are a 
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crucial element for tissue engineering. Electrospinning is now the most extensively used 
fabrication method for the preparation of nanofibrous scaffolds due to the positive promotion 
of cell-matrix and cell-cell interactions with the cells possessing a normal phenotypic shape 
and gene expression (Frenot and Chronakis, 2003). The diameter of the electrospun fibers is of 
similar diameter of the fibrils in the extracellular matrix and therefore mimics the environment 
of the natural tissue (Friess, 1998). However, the pore size of the nanofibrous scaffolds are 
often very low and often cell infiltration is inhibited. Natural polymers are often selected for 
nanofibrous scaffold due to their enhanced biocompatibility. Biopolymers such as collagen, 
alginate, silk, hyaluronic acid, fibrinogen and starch have all been used to fabricate scaffolds 
and their ability to blend with synthetic polymers can improve the cytocompatibility of the 
scaffold (Park et al, 2006, Almany and Seliktar, 2005, Wayne et al, 2005, Yoo et al, 2005).  
 
1.4.3.2.2 Wound dressings 
An ideal dressing for wound healing is to have haemostatic ability, efficiency as a bacterial 
barrier, absorption ability of excess exudates (wound fluid and pus), suitable water vapour 
transmission rate, suitable gaseous exchange ability, ability to conform to the contour of the 
wound area, adherence to healthy tissue and non-adherent to wound tissue and inexpensive 
(Bhardwaj and Kundu, 2010, Huang et al, 2003). The use of electrospun nanofibrous materials 
for wound dressings are still in their infancy, however they meet most of the requirements for 
an effective dressing due to their desirable nanofibrous structure and reports of 
cytocompatibility (Huang et al, 2003). Jia et al, 2007, used electrospinning to prepare an 
antibacterial polyvinyl alcohol (PVA) membrane using silver loaded zirconium phosphate 
nanoparticles for use as a wound dressing. Antimicrobial tests demonstrated the efficacy of the 
nanofibers against tested strains.  
 
1.4.3.2.3 Drug delivery 
Nanofiber mats have been used as drug carriers in drug delivery systems. These drug delivery 
systems are fabricated using a biocompatible delivery matrix of polymer and biodegradable 
polymers and the particular active pharmaceutical ingredient (API) (Kost and Langer, 2001). 
There are various fabrication methods to develop the drug delivery systems; 1) API as particles 
attached to the surface of the carrier (nanofibers); 2) both API and carrier are in nanofiber form 
and interlace each other; 3) blend of API and carrier materials integrated into the nanofiber; 4) 
API is encapsulated in the carrier material using coaxial electrospinning. It relies on the 
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principle that the dissolution rate of a particulate drug increases with increasing surface area of 
the drug and corresponding carrier. Their large surface area allows for fast solvent evaporation 
which provides limited time for the incorporated drug to recrystallize which then favours the 
formation of amorphous dispersions or solid solutions (Verreck et al, 2003). The release rate 
of the API can be designed as rapid, intermediate, delayed or modified dissolution, all 
depending on the chosen polymeric carrier used. Many researched have successfully 
encapsulated API’s within an electrospun fibrous mat (Zeng et al, 2003, Zong et al, 2002, Luu 
et al 2003, Kenawy et al 2002). Many API’s have been successfully electrospun; lipophilic 
drugs such as ibuprofen (Jiang et al, 2004), cefazolin (Katti et al, 2004) and hydrophilic drugs 
such as mefoxin (Kim et al, 2004, Zong et al, 2002) and tetracycline hydrochloride (Kenawy 
et al, 2002). Coaxial electrospinning to develop drug loaded polymeric nanofibers and has been 
successful using two medically pure drugs Resveratrol and Gentamycin sulphate (Huang et al, 
2006). 
 
1.4.3.2.4 Filtration 
For over a decade, polymeric nanofibers have been used in air filtration applications. The 
channels of the filtration device must match the scale of the particles or droplets that are to be 
captured in the filter. The nano-sized fibers produced by electrospinning provide an advantage 
for use as filtration membranes. The very large surface area to volume ratio and high surface 
cohesion allow small particles in the order of < 0.5 mm to be easily trapped in the nanofibrous 
membranes (Bhardwaj and Kundu, 2010). Non-woven mats produced by electrospinning have 
already been successfully used as high-performance air filters which demonstrates an 
extremely effective removal of airborne particles with diameters between 1 µm and 5 µm 
(approximately 100% removal) (Kattamuri et al, 2005, Ramakrishna et al, 2006). Filtration 
efficiency is closely associated with fiber fineness and is an important concern for filter 
performance. Ahn et al, 2006 evaluated the filtration efficiency of nylon 6 nanofilters using 
nanofibers with diameters between 80 and 200 nm and found an efficiency of 99.993% greater 
than commercialised high efficiency particulate air filter (HEPA) (Frenot and Chronakis, 
2003). Jeong et al, 2007, synthesised polyurethane cationomers containing different amounts 
of quaternary ammonium groups into nanofiber mats for use as antimicrobial nanofilters 
applications. The results showed there were successful antimicrobial activities against 
Staphylococcus aureus and Escherichia coli. Charged fibers can also be produced from 
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electrospinning and this can be used for filtration media; the charge retention characteristics 
can be modified through the polymeric material selected (Tsai and Schreuder-Gibson, 2001). 
 
1.4.3.2.5 Cosmetics 
Electrospun polymeric nanofibers have been utilised as a cosmetic skin care mask with the 
addition of skin-revitalising factors for skin healing treatments, skin cleansing and other 
therapeutic and medical properties. The skin mask has the advantage of a high surface area and 
very small interstices which facilitates the transfer and transfer rate of additives to the skin 
(Huang et al, 2003, Smith et al, 2001). The skin mask can be applied gently and painlessly and 
can provide a three-dimensional topography of the skin (Huang et al, 2003).   
 
1.4.4 Polymer choice 
The selection of the polymer is an important parameter as it is able to influence the strength, 
weight, porosity and surface functionality of the resultant nanofiber or particles (Frenot and 
Chronakis, 2003). Selected polymers for the EHDA process are dissolved in the solvent 
forming a polymeric solution. Many polymers emit unpleasant or toxic smells and therefore a 
fume chamber must be used for the process (Bhardwaj and Kundu, 2010). The use of a variety 
of polymers are applicable for the electrospinning process, like those used in conventional 
spinning (i.e. polyamides, polyester, acrylic as well as biopolymers like proteins, DNA and 
polypeptides) (Frenot and Chronakis, 2003, Bhardwaj and Kundu, 2010). 
 
Depending on the electrical properties of the selected polymer, the resultant polymeric 
nanofibers may dissipate or retain electrostatic charges. These charges can be manipulated by 
electric fields and the electrical polarity of the fibers are influenced by the polarity of the 
applied voltage (Frenot and Chronakis, 2003). The charges can be removed however through 
the presence of ions carried in the air or neutralised through contact with the collector plate 
(Reneker, and Chun, 1996). Tsai and Schreuder-Gibson, 2001, have researched the effect of 
electrospinning material and conditions upon the residual electrostatic charge of polymeric 
nanofibers; polymers including PEO, polycarbonate and polystyrene where evaluated on their 
charge induction and retention properties and ranked by their inherent polarity (Frenot and 
Chronakis, 2003). 
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Natural polymers often display better biocompatibility and low immunogenicity and therefore 
typically selected for biomedical applications (Bhardwaj and Kundu, 2010). Proteins of 
collagen, gelatin, elastin and silk fibroin have all been used previously for the electrospinning 
process (Li et al, 2005, Li et al, 2006a, Li et al 2006b, Zhang et al, 2006, Zhong et al, 2006). 
The fabrication of electrospun scaffolds using natural polymers provide better clinical 
functionality, however the main concern is the partial denaturation of the natural polymers. For 
example, Zeugolis et al, 2008, found that through the production of nanofibers by the 
electrospinning process the properties of collagen are often affected (i.e. the denaturation 
temperature and the loss of the triple helical structure). 
 
Synthetic polymers are often selected over natural polymers due to their ability to be fabricate 
materials with a wider range of properties; including mechanical properties like strength and 
viscoelasticity and withhold a desirable degradation rate. 
 
Copolymers enhance the properties of polymeric materials including the thermal stability, 
mechanical strength and barrier properties. The electrospun scaffolds fabricated from 
copolymers rather than homopolymers are often significantly better regarding their 
performance as desirable properties (mechanical, morphology, structure, pore size and 
distribution, biodegradability) can be tailored.  
 
The chosen polymer for electrospraying can influence the particles size and morphology. It has 
been found that the particles diameter increases with increasing polymer concentration. 
Increased polymeric concentration leads to an increase in the viscosity and surface tension of 
the solution, this can form an unstable jet from the capillary tip (Pawar et al, 2018, Shao et al, 
2015). Choosing a polymer with a high molecular weight can cause the formation of larger 
particles due to the increase of viscosity (Felder et al, 2003, Tapia-Hernández et al, 2003, 
Hazeri et al, 2012). A polymer with a high molecular weight can also increase the surface 
tension which can cause unstable jetting at the capillary tip and therefore a higher voltage 
would need to be applied for electrospraying to occur (Pawar et al, 2018). 
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1.4.5 Solvent choice 
The chosen solvent for electrospraying can affect the particles morphology and size and also 
the surface morphology. If the solvent is not volatile it can lead to the formation of ribbon-like 
fibers and even fuse the fibers together, due to the solvent retention. A solvent with too high 
volatility can cause an increase to the diameter of the particles and affect the surface 
morphology and porosity as the evaporation rate is too high (Chakraborty et al, 2009). 
Electrospraying solvents which are too volatile are also a problem as they may clog the 
capillary, as they begin to evaporate at the Taylor cone itself, this creates a problem with the 
spraying (Pawar et al, 2018). 
 
1.4.6 Physical characterisation 
Physical characterisation is associated with the structure and morphology of the nanofibers 
which contributes to the physical and mechanical properties. Geometric properties include the 
fiber diameter, diameter distribution, fiber orientation and fiber morphology (cross-section 
shape and surface roughness). Scanning electron microscopy (SEM), transmission electron 
microscopy (TEM) and atomic force microscopy (AFM) are all techniques that can be used to 
show these geometric properties (Huang et al, 2003, Bhardwaj and Kundu, 2010). SEM is a 
quick method for detecting fiber diameters and morphologies with only a small sample size 
required. TEM also obtains fiber diameters but for extremely small fibers (< 300 nm). AFM is 
also used to measure fiber diameters but is more difficult to obtain an accurate measurement 
due to tip convolution. However, AFM is the best technique to observe surface morphology 
and descriptions of the fiber surface (Bhardwaj and Kundu, 2010). 
 
1.4.7 Chemical characterisation 
Details of the molecular structure of the nanofiber can be collected from Fourier transform 
infrared (FTIR) and nuclear magnetic resonance (NMR). The configuration of the 
macromolecules in the nanofiber can be characterised by X-ray diffraction (XRD) and 
differential scanning calorimeter (DSC). The surface chemical properties of the nanofibers can 
be assessed by its hydrophilicity through using water contact angle analysis (Huang et al, 2003, 
Bhardwaj and Kundu, 2010). 
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1.4.8 Coaxial EHDA 
Coaxial EHDA is a nozzle configuration which allows for the simultaneous coaxial 
electrospinning or electrospraying of two different solutions. Two separate solutions flow 
through two capillary needles which are coaxial with a smaller capillary inside a larger 
capillary (Sill and von Recum, 2008). The materials used for this configuration are immiscible 
in order to be encapsulated. This technique is useful for materials that are susceptible to 
degradation as the shell can protect the contents of the core as well as releasing the contents of 
the core as when needed; i.e. through drug delivery systems. 
 
 
 
 
 
 
 
 
 
 
 
 
1.4.8.1 Coaxial electrospraying 
Using the coaxial configuration during electrospraying allows for the one-step encapsulation 
of APIs inside a polymeric shell, producing a defined shell with a defined core. This 
configuration still produces particles with a narrow particle size distribution in the micro and 
nanometer range (Sill and von Recum, 2008). These multi-layered nanoparticles have been 
utilised for many applications due to high encapsulation efficiency, uniform size distribution 
and effective protection of the core (Pawar et al, 2018). 
 
1.4.8.2 Coaxial electrospinning 
Using the coaxial configuration during electrospinning, a smaller fiber can essentially be 
encapsulated within a larger fiber, leading to a core-shell morphology. Coaxial electrospinning 
is particularly useful for materials that cannot be spun (i.e. non-conductive materials); the 
material can flow through the inner capillary needle to be encapsulated by a polymeric shell to 
Figure 1. 6: Schematic representation of coaxial EHDA set-up (Alharbi et al, 2016).  
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produce a core-shell nanofiber (Sill and von Recum, 2008). Townsend-Nicholson and 
Jayasinghe, 2006, successfully encapsulated living cells within a poly(dimethylsiloxane) 
(PDMS) fiber; cell viability remained high throughout the process with approximately 67.6% 
of cell surviving the electrospinning process. The electrospun cells were reported to show no 
observable difference in cell morphology or rate of growth with the control cells over a period 
of 6 days. 
 
1.4.9 History 
This technique was first observed in 1897 by Rayleigh; Zeleny further studied the 
electrospraying process in 1914 and was patented by Formhals in 1934 (Frenot and Chronakis, 
2003, Bhardwaj and Kundu, 2010), in which he described the experimental set-up for the 
production of polymer filaments using an electrostatic force. In 1969, Taylor focussed on 
electrically driven jets as the groundwork for electrospinning (Bhardwaj and Kundu, 2010). In 
1934, Formhals patented the experimental set-up and process that used an electrostatic force to 
spin polymeric nanofibers. Formhals used a movable thread-collecting device, which collected 
fibers in a stretched state which allowed for the collection of aligned fibers. Formhals spun 
cellulose acetate fibers using acetone/alcohol as the solvent. However, there were some issues 
with the electrospinning method; due to the close proximity between the collector plate and the 
tip of charged polymer solution, there was not enough time for the solvent to completely 
evaporate by the time the fiber jet reached the collector plate, which resulted in a loose web 
structure. These fibers were sticking to the collector plate as well as to each other which made 
the removal of fibers difficult. In Formhals second patent, a new process was detailed where 
there is a greater distance between the tip of the charged polymer solution and the collector 
plate, allowing enough time for evaporation and therefore relieving the issues Formhals had 
observed prior. Formhals also detailed the use of multiple nozzles for simultaneous spinning 
of the polymer solution as well as directing the jets towards the collector plate. In 1940, 
Formhals patented another process to create composite fibers by electrospraying directly onto 
a moving base. In 1969, Taylor published his work on the jet forming process, which examines 
the polymer droplet at the end of the capillary needle and how it behaves when an electric field 
is applied. When the surface tension is balanced by electrostatic forces the Taylor cone is 
formed. Taylor also established that the fiber jet is emitted from the apex of the cone, which 
generates fibers of a significantly small diameter. In 1971, Baumgarten investigated the 
relationship between varying solution and processing parameters and the resulting fiber 
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morphology. Baumgarten used a high-speed camera to allow him to determine that a single 
fiber was being drawn from the electrically charged drop at the end of the processing needle. 
Baumgarten also found that there was a relationship between solution viscosity and the fiber 
diameter; the higher the viscosity, the larger the resulting fiber diameter. He also found that the 
fiber diameter does not decrease with increasing the electric field, however it decreases initially 
to a minimum with an increase in applied voltage, however the fiber diameter increases further 
when the applied voltage increases further. Through varying the solution and processing 
parameters Baumgarten was able to produce fibers of varying diameters (Sill and von Recum, 
2008). Reneker and Chun, 1996, revived the interest in the EHDA process in the early 1990’s 
through electrospinning various polymers to produce nanofibers of various diameters. 
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Chapter 2 – Materials and methods 
 
2.1 Materials 
2.1.1 Polymer 
2.1.1.1 Poly(lactic-co-glycolic acid) (PLGA) 
PLGA is a synthetic copolymer comprised of monomers of glycolic acid and lactic acid 
(Figure 2.1). The degradation rate is affected by the sequence of monomers; random PLGA 
shows rapid degradation in comparison with sequenced PLGA. Sequenced PLGA are 
considered valuable for controlled drug delivery due to their release kinetics caused by the 
degradation. The ratio between the monomer components in the polymer chain influences the 
PLGA degree of crystallinity, mechanical strength, glass transition temperature and its ability 
to hydrolyse. PLGA with 50:50 ratio of the two monomers hydrolyse much faster in 
comparison with PLGA containing a higher ratio of either two monomers. PLGA terminal 
groups are either an acid or an ester - an ester terminal group allows resistance to hydrolysis. 
Many solvents can be used to dissolve PLGA depending on their composition. Higher lactide 
polymers can be dissolved using chlorinated solvents, however higher glycolide materials 
require the use of fluorinated solvents. The ester linkages of PLGA degrade with the presence 
of water. PLGA undergoes hydrolysis in the body which produces the original monomers. The 
body can metabolise the two monomers and therefore there is minimal systematic toxicity with 
using PLGA for biomaterial applications (Mir et al, 2017). 
 
 
 
 
 
 
       Figure 2. 1: Structure of PLGA 50:50 ester. 
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2.1.2 Drug 
2.1.2.1 Amoxicillin (AMX) 
AMX is a semi-synthetic, penicillin-derived, broad spectrum, bactericidal, β-lactam antibiotic 
used for the treatment for various bacterial infections (Figure 2.2). It is most commonly taken 
orally and thereafter it is well absorbed in the intestinal tract with the possession of very low 
toxicity. AMX has bactericidal actions against a wide variety of gram-positive and a fewer 
variety of gram-negative microorganisms (E. coli is highly resistant to AMX (Kibret and 
Abera, 2011)) through inhibiting the biosynthesis and repair of the bacterial cell wall (owing 
to the β-lactam ring (Figure 2.3)), leading to bacterial death. AMX has excellent diffusion 
capability into infected tissues (Resnik and Cillo, 2018, Karaman, 2015.). Prevalence studies 
suggest that the rate of resistance to AMX in humans is very high (Riley and Lizotte-
Waniewski, 2009). Semi-synthetic β-lactam antibiotics like AMX are mostly produced through 
chemical synthesis. Although this process has successfully high yields, it is often criticised for 
its costly steps, toxic organic solvents and high volumes of waste and by-products which is 
harmful to the environment making the process undesirable (Wegman et al, 2001).  
 
 
 
 
 
 
 
 
 
Figure 2. 2: Structure of AMX. 
  
  
 
 
 
 
Figure 2. 3: β-lactam ring of AMX. 
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2.1.3 Solvent 
2.1.3.1 Dichloromethane (DCM) 
DCM is an organochloride compound (Figure 2.4). It is a colourless, volatile liquid 
withholding a mildly sweet aroma. DCM is widely used as a solvent. It is not miscible in water, 
however due to its polarity it is miscible in many organic solvents. DCM is produced through 
the treatment of methane or chloromethane with chlorine gas at 400-500°C where it undergoes 
a series of reactions to produce more chlorinated products i.e. DCM. DCM is a useful solvent 
for many chemical processes due to its volatility and its capability to dissolve many organic 
compounds. DCM is commonly used as a paint stripper and is the main component of plastic 
welding adhesives due to its ability to chemically weld plastics. Of all the simple 
chlorohydrocarbons, it is the least toxic – however due to its high volatility, it is an acute 
inhalation hazard. DCM can also be absorbed through the skin in which long contact can lead 
to the dissolving of some fatty tissues in the skin. Medical studies in the 1980’s suggest that 
exposure to DCM has the potential to cause cancer, however research does not suggest to what 
level of exposure is carcinogenic (Hahn et al, 2019, Monette, 2009, Hurst and Martin, 2017). 
 
 
 
 
 
 
 
 
 
Figure 2. 4: Structure of DCM. 
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2.1.3.2 Acetone 
Acetone is an organic compound (Figure 2.5). It is a colourless, volatile and an extremely 
flammable liquid, which is the simplest ketone. Acetone is miscible in water and is widely used 
as a solvent; it is a good solvent for many plastics and many synthetic fibers. It is also an 
excellent solvent for alcohols due to the lone pair of electrons on the carbonyl groups, which 
act as hydrogen bond acceptors. It is commonly used for cleaning purposes in laboratories and 
as the active ingredient in nail polish remover and paint thinner. Acetone is naturally produced 
and disposed of in the human body through regular metabolic processes. It is often present in 
the blood and urine; diabetics produce it in larger measures. Acetone has been studied 
extensively regarding health concerns and is found to have low toxicity regarding normal use 
and safety precautions are followed. With prolonged use, acetone can cause mild skin irritations 
and up to severe eye irritations. The high vapor concentrations can depress the central nervous 
system. Acetone is not currently recognised as a carcinogen (Ouellette and Rawn, 2014, 
Bradberry, 2007). 
 
 
 
 
 
 
 
 
  
 
 
Figure 2. 5: Structure of acetone. 
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2.1.4 Precursor materials 
2.1.4.1 Silver nitrate (AgNO3) 
AgNO3 is an inorganic compound and is a versatile precursor for many silver compounds 
(Figure 2.6). In the 13th century, nitric acid was used to separate gold from silver, leaving 
behind a solution of AgNO3 which was found to blacken skin. AgNO3 is the least expensive 
salt of silver, it non-hygroscopic and relatively stable to light. AgNO3 readily dissolves in many 
solvents which also includes water. AgNO3 is often used for silver staining in histology, 
presenting proteins and nucleic acids, and is also used as a stain in scanning electron 
microscopy. AgNO3 is effective against many strains of Staphylococcus and against many 
Gram-negative aerobes which can colonise wounds. Due to silvers antimicrobial activity there 
has been a lot of research evaluating the ability of the silver ion to inactivate Escherichia coli 
and was used for many applications prior to modern antibiotics. One-half percent AgNO3 
solution was commonly used as an effective topical agent in the 1960’s for wounds and warts 
Although AgNO3 is often used in low concentration, it is still very toxic and corrosive. Brief 
exposure may only leave purple/black stains on the skin, but through constant exposure to high 
concentrations, skin burns and eye damage may occur. AgNO3 is not currently recognised as a 
carcinogen (Bessey, 2007, Kunio and Schreiber, 2013). 
 
 
 
 
 
 
 
 
 
 
Figure 2. 6: Structure of AgNO3. 
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2.1.4.2 Gold (III) chloride trihydrate (HAuCl4 x 3H2O) 
HAuCl4 x 3H2O is a precursor for the synthesis of gold nanoparticles (Figure 2.7). It exhibits 
a very high catalytic activity. Gold nanoparticles are often studied due to their unique synthetic 
properties, chemical inertness, high electron density and compatibility with living tissues. Gold 
possesses many effective properties against diseases and were used historically to cure various 
infections. Gold nanoparticles have been used in microorganism control, drug delivery, 
genomics, clinical chemistry, vaccine development and cancer-cell imaging. The Turkevich 
method is a routine protocol for synthesising gold nanoparticles; this is through the reduction 
of HAuCl4 x 3H2O with sodium citrate (Jazayeri et al, 2016, Ahmad et al, 2017). 
 
 
 
 
 
 
 
 
 
 
Figure 2. 7: Structure of HAuCl4 x 3H2O. 
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2.1.4.3 Copper (II) sulphate (CuSO4) 
CuSO4 is a bright blue, inorganic compound, used as a precursor to make copper nanoparticles 
(Figure 2.8). It is highly soluble in water. CuSO4 has shown potential as an antibacterial agent; 
for thousands of years CuSO4 has been used to prevent wound infections and in recent years, 
the use of copper as an antimicrobial in hospital has amplified and in which can reduce the 
burden of antibiotic use. Copper nanoparticles are described as more active and more 
economical compared to bulk copper. Through the release of copper ions, bacterial membranes 
and DNA can be damaged due to the disruption of vital charge transports within the cells 
leading to cell death. Many chemical tests utilise CuSO4; Fehling’s solution to test for reducing 
sugars, Biuret reagent to test for proteins and to test blood for anaemia. It is often used as a 
fungicide; however, some fungi are able to adapt to elevated levels of copper ions. Due to its 
bright blue colour, CuSO4 is often used as a colourant in artworks and also used in firework 
manufacturing. Previously, CuSO4 was used as an emetic, however it is now considered too 
toxic for this use due to its irritating effect on the gastrointestinal tract. CuSO4 is an irritant to 
the skin and eyes; prolonged skin contact can lead to itching or eczema and eye contact can 
cause conjunctivitis and inflammation to the eyelid lining (Betts et al, 2018, Ramos et al, 2019).  
 
 
 
 
 
 
 
 
 
 
Figure 2. 8: Structure of CuSO4. 
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2.1.5 Capping agents 
2.1.5.1 Trisodium citrate (Na3C6H5O7) 
Na3C6H5O7 is largely used as a food additive often seen as E number, E331 (Figure 2.9). It 
possesses a saline and mildly tart flavour. In food, it is used as a flavouring agent in beverages 
and also ice creams, yoghurt and cheeses. It can also be used as an emulsifier in cheese 
production to allow the cheese to melt without becoming greasy. Na3C6H5O7 has been used as 
an anticoagulant in blood transfusions in 1915, and is still used today for the preservation of 
blood in blood banks. The citrate ion chelates calcium ions in the blood to form calcium citrate 
complexes to disrupt the natural blood clotting mechanism. Na3C6H5O7 acts as a capping agent 
during the synthesis of nanoparticles. Capping agents are used to control the growth rate and 
particle size of the nanoparticles and prevent uncontrollable growth and particle aggregation. 
 
 
 
 
 
 
 
 
 
Figure 2. 9: Structure of Na3C6H5O7. 
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2.1.5.2 Polyvinylpyrrolidone (PVP) 
PVP is a water-soluble polymer, made from the monomer N-vinylpyrrolidone (Figure 2.10). 
PVP is also soluble in other polar solvents such as alcohols and urea. Dry PVP is a light flaky 
hygroscopic powder able to readily absorb up to 40% its weight in atmospheric water. It has 
admirable wetting properties and can readily form films thus making it ideal for use as coatings. 
Due to these admirable properties, PVP was used as a blood plasma expander for trauma 
victims. PVP is also used as a binder in many pharmaceutical tablets in wet granulation or used 
to stabilise an amorphous API in a solid dispersion application. PVP is used as a lubricant or 
wetting agent in contact lenses and their packaging in order to reduce friction. PVP has been 
approved by the US Food and Drug Administration (FDA) for many uses and generally 
considered safe (Kariduraganavar et al, 2014, Narang et al, 2017). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 10: Structure of PVP. 
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2.1.5.3 Sodium bromide (NaBr) 
NaBr is an inorganic compound usually encountered as a white microcrystalline powder. It is 
effectively used as a reducing agent, with its relatively low cost and ease of handling 
contributing to its popularity. NaBr is soluble in water (although it slowly hydrolyses), alcohols 
and some ethers. It is a salt and exists in three polymorphs; α, β and γ, which changes upon 
changes in pressure. NaBr reduces many organic carbonyls depending on the conditions; 
typically used to convert ketones and aldehydes into alcohols. NaBr reacts with water and 
alcohols to produce hydrogen gas (Kabalka and Varma, 1991, Szekely and Didaskalou, 2016). 
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2.1.6 Reducing agent 
2.1.6.1 Ascorbic acid 
Ascorbic acid, also commonly known as vitamin C, is an essential nutrient found in various 
fruits and vegetables (citrus fruits, kiwi, broccoli, raw bell peppers) (Figure 2.11). It is required 
for the repair of tissues and enzymatic production of many neurotransmitters. Ascorbic acid 
also functions as an antioxidant due to its high reducing potential. It has been shown that 
ascorbic acid is an efficient reductant of CuSO4 (along with other metal ions) and often used 
for the synthesis of copper nanoparticles. The hydroxyl groups of ascorbic acid are responsible 
for the antioxidant activity of the molecule, donating hydrogen atoms to other molecules. This 
reaction is reversible forming dehydroascorbic acid which is relatively stable (Luty-Błocho et 
al, 2013, Rucker et al, 2008, Duncan and Chang, 2012, Avendaño and Menéndez, 2008).  
 
 
 
 
 
 
 
 
 
 
    Figure 2. 11: Structure of ascorbic acid. 
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2.1.7 Vehicles 
2.1.7.1 Ethylene glycol (EG) 
EG is a non-volatile, colourless, organic compound found as a viscous liquid (Figure 2.12). 
Ethylene is mainly used for two purposes; starting material for the manufacture of polyester 
fibers or used in antifreeze formulations due to its low melting point and high boiling point. 
EG is toxic. Children and animals often consume large amount due to its sweet taste leading to 
EG toxicity. EG is non-volatile and odourless and thus inhalation exposure is not considered a 
health hazard. However, absorption of EG through the skin is considered a health hazard 
especially if there are any skin lesions. EG is rapidly and completely absorbed from the 
intestinal tract upon ingestion. It is oxidised to glycolic acid and then into oxalic acid which is 
toxic, affecting the central nervous system, the heart and then the kidneys. It is fatal if left 
untreated (Roy, 2016, Pohanish, 2017, Carney, 2011, Dasgupta and Klein, 2014, Dasgupta and 
Wahed, 2014). 
 
 
 
 
 
 
 
 
 
Figure 2. 12: Structure of EG. 
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2.1.7.2 Deionised water (D.I water) 
D.I water is natural water which has had all of its mineral ions removed. The ions include: 
sodium, calcium, iron, copper, chlorides and sulphates. D.I water is used for chemical processes 
where the minerals present may interfere with the chemicals, therefore D.I water has a low 
chemical reactivity. Pharmaceuticals are made with D.I water for this reason. To create D.I 
water, natural water is exposed to electrically charged resins which attract and bind to the 
mineral ions and thus they are removed from the water. Although D.I water is deemed highly 
pure, it still may contain bacteria or viruses. In microbiology and fields where sterile water is 
required, the D.I water is cooked in an autoclave prior to use to kill of the bacteria and viruses 
within. 
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2.2 Methods 
2.2.1 Determination of Material Properties  
2.2.1.1 Viscosity 
Viscosity is a property of a liquid relating to the resistance of flow. A sine-wave vibro 
viscometer is used to quantify the viscosity of all formulations (Figure 2.13). The mechanism 
for the viscometer involves determining the driving current to resonate two gold-plated sensors 
maintained at constant frequency of 30 Hz. The driving current is determined as the difference 
in the viscous drag between the two plates and the sample. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 13: Digital image of an A&D SV-10 sine wave vibro viscometer. 
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2.2.1.2 Surface tension 
The surface tension of the formulations was measured using the DuNuoy ring method (Figure 
2.14). It is measured by the force required to remove the platinum ring from the surface of the 
liquid phase into the gas phase.  
 
The ring is placed onto the surface of the liquid and upon external forces, the ring is lifted up 
off the liquid surface. The amount of force required to remove the ring from the liquids surface 
correlates to the surface tension of the liquid using the equation: 
 
σ =  FL cosθ 
Where: 
 σ = surface tension (N/m) F = force (N) L = wetting length of the ring (m) cos θ  = contact angle between the liquid and the ring 
 
Equation 2. 1: Equation for surface tension. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 14: Digital image of a White Electrical Instrument Co. OS torsion balance. 
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2.2.1.3 Electrical conductivity 
An electroconductivity meter is used to measure the ability of a liquid to pass an electrical 
current through itself (Figure 2.15). The electroconductivity meter is a probe withholding four 
electrodes. An alternating current is initiated by the probe once placed in the sample and the 
current is passed between the four electrodes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 15: Digital image of a Mettler Toledo FiveGo electrical conductivity meter. 
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2.2.2 Electrohydrodynamic atomisation (EHDA) 
The EHDA technique is a simple set-up consisting of 5 components; syringe filled with the 
formulation, syringe infusion pump, stainless steel processing needle, high voltage supply and 
a grounded collector plate (Figure 2.16). 
 
The formulations are filled into the syringe and the infusion pump controls the flow rate of the 
formulation throughout the procedure. The formulation is fed through a silicon tube and into 
an electrically conducting processing needle. A high voltage is applied across the processing 
needle where the formulation is held by its surface tension inducing a charge. When the 
intensity of the electric field overcomes the repulsive electrostatic force of the surface tension 
of the formulation a charged jet of fluid is ejected from the Taylor cone. The solvent within 
formulation evaporates as the fluid is ejected causing the production of particles or fibers. The 
resulting particles or fibers are collected on a grounded plate. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 16: Digital image of the EHDA set up. 
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2.2.3 Scanning electron microscope (SEM) 
SEM is a microscopic technique used to reveal information about the surface morphology, 
chemical composition, structure and the alignment of the materials making up the sample 
(Figure 2.17). SEM uses beams of electrons to image a surface, which are of high energy with 
a very small equivalent wavelength. The resolution of the SEM is better than one nanometer 
and the interaction of the electron beam with the surface of the sample can give rise to X-ray 
emission which can allow chemical characterization of the materials making up the sample. By 
using SEM, highly detailed images over a wide range of magnifications from the samples 
surface can be produced. The interaction between the surface of the sample and the electron 
beam forms an image which is created by the electrons emitted from the surface – either 
secondary electrons or backscattered electrons. Secondary electrons are emitted by the atoms 
on the samples surface when they become excited and withhold sufficient energy to leave the 
surface. Secondary electrons within the top 10 nm of the surface are likely to escape and be 
detected. These electrons have a high resolution and carry information about the samples 
surface which are used to create the images in SEM. Backscattered electrons are high energy 
electrons which originate from the electron beam and are reflected and provides contrast 
reflecting differences in rough composition within the sample. This is due to the atomic mass 
of the nuclei – the greater the atomic mass, the greater the scattering which appears brighter 
than lighter elements. Different detectors collect either secondary or backscattered electrons. 
Typically, the sample is coated with a thin layer of gold which makes the sample conductive. 
The sample is then affixed onto aluminum stubs by copper tape and then mounted onto the 
stage in the chamber. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 17: Digital image of Carl Zeiss Evo 15 SEM. 
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2.2.4 Differential scanning calorimetry (DSC) 
DSC is a thermal analytical method used to measure the energy changes within a sample upon 
heating and establishes the thermal stability of the sample (Figure 2.18). DSC measures the 
difference in the amount of heat required to increase the temperature of a sample and reference 
measured as a function of temperature. Upon the application of the heat, the sample may 
undergo chemical (hydrolysis) or physical (melting) changes, which may emit energy 
(exothermic) or require energy to take place (endothermic), which can be seen in the 
thermogram of the DSC. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 18: Digital image of a Jade differential scanning calorimeter. 
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2.2.5 Thermogravimetric analysis (TGA) 
TGA is thermal analytical technique used to observe the physical mass changes of a sample 
when subjected to heating at a constant rate (Figure 2.19). It determines the materials thermal 
stability and its fraction of volatile components through monitoring the mass change. The 
sample is placed in an inert atmospheric chamber typically with nitrogen and the changes in 
mass is measured as a function of temperature. Loss of mass can be due to decomposition 
(bonds breaking) or due to evaporation of volatile solvents. However, weight gain can be due 
to oxidation or absorption, which can be seen on the thermogram of the TGA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 19: Digital image of a PerkinElmer Pyris 1 TG analyser. 
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2.2.6 Attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR) 
FTIR spectroscopy is used to identify or confirm the samples compositional molecules based 
on the samples unique infrared absorption spectrum (Figure 2.20). The samples can be either 
solid, liquid or gas. The FTIR spectrometer collects high spectral resolution data over a wide 
spectral range simultaneously. The infrared beam passes through a sample and parts of the 
spectrum is absorbed and some is transmitted. The absorbed radiation by selective molecules 
and then causes changes in dipole moments of the sample. The vibrational energy level of the 
sample transitions to an excited state. The transfer to excited state from ground state is shown 
as an absorption peak of the sample and the intensity is correlative to the change in the dipole 
moment and this is presented as the molecules unique fingerprint. Attenuated Total Reflection 
(ATR) is a technique conjugated with FTIR which uses a dense crystal. The beam of infrared 
light is passed through the ATR crystal and the internal reflectance causes an evanescent wave 
which passes through the sample and reflection radiation is returned to the detector as it exits 
the crystal, establishing a unique fingerprint for the sample. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 20: Digital image of Bruker FTIR Platinum-ATR spectrophotometer. 
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2.2.7 X-ray diffraction (XRD) 
X-ray diffraction (XRD) is a non-destructive technique which is uses large area X-ray detectors 
which are capable of probing deep into the lattice structures in order to characterise micro-
crystalline materials (Figure 2.21). This method provides information on the crystal structure, 
orientation (texture), average grain size, crystallinity, strain, stress, multilayer composition, 
morphology, phase identification and any structure defects.  
 
X-rays are produced from to the sudden deceleration of high-speed electrons as they collide 
with a metal target. During the deceleration process, most of the electron energy is converted 
into heat and about less than 1% is converted into X-rays. X-ray diffraction occurs as incident 
beams of monochromatic X-rays constructively interfere with the atomic planes at specific 
angles as they leave the crystal. X-rays excite atoms at different positions along a time period 
– this excitement introduces secondary X-rays which form interference patterns.  
 
The sharper the peaks on the peak graph the more crystalline the material. However, amorphous 
materials like glass do not produce sharp peaks. The peak intensity presents the distribution of 
atoms within the lattice. Therefore, the X-ray diffraction pattern is the unique fingerprint which 
combines the presence and intensity of the atomic elements that make up a material. In order 
to identify an unknown sample, a database of X-ray diffraction patterns in the ICDD 
(International Centre for Diffraction Data) is available for the phase identification. XRD is 
advantageous as it is a non-destructive technique and provides quantitative measurements of 
phase and texture orientation. There is little sample preparation required prior to the use of 
XRD and ambient conditions are acceptable for analysis. 
 
 
 
 
 
 
 
 
 
 
Figure 2. 21: Digital image of a Bruker 2nd Generation D2 Phaser. 
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2.2.8 Raman spectroscopy 
Raman spectroscopy is a technique used to provide highly chemical specific information about 
the samples based on their fundamental vibrations of the molecules (Figure 2.22). Through the 
absorption of light (using a laser), the molecules get excited causing them to vibrate and 
through measuring the inelastic scattering of photons information is presented regarding the 
properties of the molecules. The interactions provide information on the functional groups, 
chain orientation and structural changes (Rinke-Kneapler and Sigman, 2014, Goh et al, 2017, 
Gomes et al, 2018). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 22: Digital image of a Foster+Freeman Foram-2 Raman spectrometer. 
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2.2.9 Zeta potential 
Zeta potential is the surface charge of the particle (Figure 2.23). Most liquids contain ions 
which are attracted to the surface of the suspended particle. Ions close to the surface of the 
particle are bound strongly, however ions further away are loosely bound forming a diffuse 
layer. When the particle moves in the medium, any ions in this boundary will move with the 
particle, however particles outside this boundary will remain stationary. Through measuring 
the velocity of the particle moving in a cell under the influence of an applied electric field 
allows the zeta potential to be obtained. It is the potential difference between the moving 
dispersion medium and the stationary layer of the dispersion medium attached to the dispersed 
particle. The pH of the medium strongly affects the zeta potential, along with the ionic strength, 
concentration, temperature and any additives (Harmata and Guelcher, 2016, Krstić et al, 2018, 
Lu and Gao, 2010).  
 
 
 
 
 
 
 
 
 
 
Figure 2. 23: Digital image of a Brookhaven NanoBrook Omni zeta potential analyser. 
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2.2.10 In-vitro drug release 
In-vitro refers to tests carried out in a controlled laboratory environment to mimic physiological 
conditions. In-vitro drug release measures the release of the API released from the carrier in an 
environment stimulating physiological conditions. The dosage form is subjected to a set of 
conditions that would induce drug release and quantitating the amount of drug released under 
those conditions. The typical conditions for this test to be carried out is in a water bath at 37°C 
with a pH of 7.1-7.4 (Figure 2.24). Personalised dosage forms may require elevated or dropped 
temperature and/or pH. Samples are taken in intervals over an extended period of time and 
measured using ultraviolet-visible spectroscopy to calculate the concentration of drug released 
at that time point (Singhvi and Singh, 2011) (Figure 2.25). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 24: Digital photo of a Stuart SBS40 Shaking water bath. 
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2.2.11 Ultraviolet–visible spectroscopy (UV-vis) 
UV-vis spectroscopy is a simple, fast and low-cost analytical technique (Tuhkanen and Ignatev, 
2018) (Figure 2.25). It refers to the absorption spectroscopy which relies on the sample 
containing species that absorbs light within the near-UV (180-390 nm) and visible (390-780 
nm) spectral regions in solution or in gas phase. A beam of light excites the species from a 
grounded state to an excited state, undergoing an electronic transition (Holmes-Hampton, 
2014). However, UV-vis is not a technique commonly used for identification purposes. 
Although all species have their own unique fingerprint region, it is not sufficient enough to 
show fine structures, therefore, it is mainly used for quantitative analysis (Worsfold and 
Zagatto, 2017). The concentration of the analyte in the sample can be calculated through 
measuring the absorbance at the selected wavelength and applying the Beer-Lambert law 
(Hameed et al, 2018, Mäntele and Deniz, 2017).  
𝐴𝐴 = −log𝑇𝑇 = log10 𝐼𝐼0𝐼𝐼1 = 𝜀𝜀𝑐𝑐𝑑𝑑 
Where: 
A = absorbance 
T = transmission 
I0 = intensities of the incident light 
I1 = intensities of the transmitted light 
ε = molar absorption coefficient 
c = concentration 
d = path length of the sample 
Equation 2. 2: Beer-Lambert law equation. 
 
 
 
 
 
 
 
 
 
 
Figure 2. 25: Digital image of a UV-Vis spectrophotometer 
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2.2.12 Disk diffusion testing 
The disk diffusion test is the test of antibiotic sensitivity of bacteria. Antibiotic disks are placed 
on an agar plate where bacteria has been spread; the plate is then incubated. The test measures 
the extent to which bacteria are affected by the antibiotics. If the antibiotic is successful and 
stops the bacteria from growing or kills the bacteria, there will be no colonies of bacteria 
growing in the area around the disk; this is the zone of inhibition. The diameter of the zone 
depends on multiple factors; 1) how effective the antibiotic is at stopping the growth of the 
bacterium; 2) diffusion of the antibiotic in the agar medium depending on the molecular 
configuration of the antibiotic; 3) the concentration of antibiotic in the dose. The concentration 
of antibiotic will be highest next to the disk and decrease as the distance increases (Christenson 
and Korgenski, 2012, Sandle, 2016). 
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2.2.13 Ex-vivo cell culture 
Cell culture is the reproduction and survival of cells in an controlled artificial environment 
(Uysal et al, 2018). The cells of interest are isolated from living tissue and then maintained 
under carefully controlled conditions. Conditions vary for varying cell types but it generally 
consists of a suitable vessel filled with a medium which supplies essential nutrients (amino 
acids, carbohydrates, vitamins, minerals), growth hormones, gases (oxygen, carbon dioxide) 
and regulates the physiochemical environment (pH buffer, osmotic pressure and temperature). 
The growth of the cells can be characterised by cell division or through processes such as 
differentiation, where the cells can change into specific types which are capable of functions 
equivalent to tissues or organs in the whole organism (Lynn, 2009). The cell culture laboratory 
must be a sterile environment. Contamination is the most common issue in the cell culture 
studies which can lead to serious loss of samples and wasted time. Good cell culture practice 
occurs when necessary appropriate conditions are met and contamination factors are removed. 
Using macroscopic and microscopic techniques to follow-up the culture environment is 
important. The reproduction of the cells is reliant on the free space in the culture vessel and the 
amount of nutrients in the medium to support growth (Singhvi and Singh, 2011). 
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2.2.14 Optical density 
The optical density measurement is the intensity ratio between the light falling onto a material 
to the light being transmitted through a material, governed by: 
 
𝐴𝐴 (𝜆𝜆) =  − log10 𝐼𝐼0𝐼𝐼1 
Where: 
A = absorbance 
I0 = intensities of the incident light 
I1 = intensities of the transmitted light  
 
Equation 2. 3: Equation for optical density. 
 
The absorption spectra provides an array of information of the sample including concentration, 
geometry and size of particles and biological activities. The absorbance is reliant on the 
incident wavelength. An optical density measured at a wavelength of 600 nm (OD600) is 
commonly used for estimating the concentration of bacteria in a liquid. This concentration can 
be correlated to signpost the stage in the bacterial growth curve; log phase, exponential phase, 
stationary phase or death phase. Optical density (Figure 2.26) is preferred to UV spectroscopy 
as UV light has the ability to kill or damage the cells of interest (Zhang and Hoshino, 2019). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 26: Digital image of a SpectraMax Plus 384 Microplate Reader. 
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Chapter 3 – Synthesis of metallic nanoparticles 
 
3.1 Introduction  
In this new age of antibiotic resistance, it is imperative that research is carried out to discover 
new materials with broad spectrum antibacterial activity. Poor intracellular bioavailability and 
a non-target specific mode of action reduces efficacy of antibiotics. Of the many materials that 
can be used as antibacterial agents those most promising (based on already published 
experimental data) are metallic particles, these are easy to synthesise and readily reproducible 
(Rai et al, 2012). Discoveries from experimental data have shown metallic nanoparticles 
display antibacterial activity, combining such materials with an antibacterial active drug can 
only augment efficacy and overcome resistant strains. Research into this combined drug 
therapy is now being explored. Major application for these formulations is the antibacterial 
activity, they decrease bacterial growth through blockage of the food source or can kill bacteria 
through disruption of cell wall (Wang et al, 2017).   
The synthesis and use of metallic nanoparticles as antibacterial is on the rise due to the 
numerous advantages including, the increased surface area to volume ratio and crystalline 
structure of the nanoparticles leading to them being more effective than there ionic 
counterparts, as well as being significantly less toxic to surrounding cells (Chatterjee et al, 
2014), furthermore, the different types of metallic compounds that can be synthesised, 
including gold, silver and copper nanomaterials, also different shapes of these metals can be 
synthesised and each variation in morphology may influence efficacy against bacteria. 
The mechanism related to metallic nanoparticles efficacy however, is still under investigation, 
probable mechanisms have been proposed: (I) dissolution of the metal molecules from the 
surface of the nanoparticles that lead to increase in the free metal ion toxicity and (II) generation 
of a reactive oxygen species on the surface of the nanoparticles stimulate an oxidative stress 
leading to the antimicrobial effect (Besinis et al, 2014, Dizaja et al, 2014). 
Moreover, accumulation and dissolution of the nanoparticles at the cell membrane changing its 
permeability, uptake of the metallic ions derived from nanoparticles into cells followed by 
depletion of ATP production, generation of ROS and corresponding ions from nanoparticles 
with subsequent oxidative damage to cell structure. (Chatterjee et al, 2014) 
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Inorganic materials such as metals and metal oxides have demonstrated antimicrobial activity 
toward various microbes. Metallic nanoparticles are effective as growth inhibitors for different 
microorganisms. Accordingly, they have the advantage to be used in medical devices and 
antimicrobial control systems against multi-drug resistant bacteria (Kim et al, 2007). For 
example; gold nanoparticles and silver nanoparticles are frequently used for their antimicrobial 
activity. For instance, 2 nm core cationic monolayer protected gold nanoparticles are able to 
interact with both gram-negative and gram-positive bacteria cell membrane inducing blebbing, 
distinct aggregation patterns and lysis of bacterial cell wall (Li et al, 2014). Silver is a broad-
spectrum antibiotic with high toxicity toward microorganisms due to the generation of free 
radicals of sliver nanoparticles (Kim et al, 2007) that attack the lipid membrane on the bacteria 
accordingly breaking down its functions (Mendis et al, 2005). For example, the minimal 
inhibitory concentrations (MIC) of silver nanoparticles (13.5 ± 2.6 nm) against E. coli and yeast 
are estimated in the range of 3.3 to 6.6 nM and 6.6 and 13.2 nM, respectively (Kim et al, 2007).  
Other examples of metallic nanoparticles are zinc oxide (Xie et al, 2011), titanium dioxide 
(Santhoshkumara et al, 2014), copper oxide (Meghana et al, 2015) and iron oxide (Behera et 
al, 2012). These nanoparticles have better efficiency against resistant bacteria and have a 
selective toxicity toward bacteria, however demonstrating less efficacy upon mammalian cells 
(Reddy et al, 2007), when compared to conventional antibiotics.  
Copper nanoparticle are also popular, due to acquisition and synthesis of these nanoparticles 
being financially viable, as well as being effective. Furthermore, due to the increased surface 
area to volume ratio at the nano size range, greater interactions with bacteria was demonstrated. 
A study by (Bogdanović et al, 2014) demonstrated the antibacterial activity of copper 
nanoparticles, after 2 hours of contact with bacteria, a 98% reduction of tested strains was seen, 
at high copper nanoparticle concentration (32 ppm). E. coli was completely eradicated and 
almost full inhibition against C. albicans at this concentration of copper nanoparticles.  
Moreover, a study conducted by (Jahangiri and Jamshidi, 2014), has demonstrated that after 2 
hours of incubation, almost all treated bacteria cells of E. coli were severely inhibited when a 
concentration of 150 μg mL-1 copper nanoparticles were used. This study used varying 
concentrations of copper and showed that varying concentrations vary in efficacy against 
bacteria, with higher concentrations of the copper nanoparticles more bacterial death was seen 
at a much faster rate.   
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Data has been published on the effect of copper nanoparticles upon gram-negative bacterium 
E. coli K12 and the gram-positive bacteria Bacillus subtilis and Staphylococcus aureus. Results 
from this study showed that when 12.0 µg mL-1 of the copper nanoparticles were added to the 
bacterial species, 18h after incubation no E. coli was present, the initial concentration before 
incubation of E. coli was 3×107. Besides E. coli, the antibacterial properties of copper 
nanoparticles were also studied on the bacterial species B. subtilis and S. aureus. From the 
viability assay of cells in the presence of different concentrations of copper nanoparticles, the 
MIC and minimum bactericidal concentration (MBC) values of copper nanoparticles for B. 
subtilis were determined to be 3.0 and 9.0 µg mL−1, respectively, whereas for S. aureus the 
values were 4.5 µg mL−1 and 9 µg mL−1, respectively. Moreover, as in the case of E. coli, 
copper nanoparticles-induced cell filamentation was also observed in B. subtilis. This then 
proves the ability of copper nanoparticles to kill both gram-negative and gram-positive 
bacterial cells at such low concentration, meaning further investigation of copper nanoparticles 
as potential antibacterial agents is needed (Chatterjee et al, 2012).  
Metallic nanoparticles synthesis can be controlled, to produce varying sizes and morphologies, 
silver nanoparticles have been synthesised, as nanorods or wires, triangular and octahedral, the 
synthesis of a specific shape depends on the reaction conditions. Kanwal et al, 2019 synthesised 
varying sizes and shapes of nanoparticles through the citrate reduction method, to test efficacy 
against bacteria, in their study they synthesised three different types of silver nanoparticles, 
larger diameter, smaller diameter and triangular shaped nanoparticles, results showed the 
smaller sized spherical particles to be more antiseptic, than those shaped triangularly, as for the 
larger particles they were found to be less efficient in bactericidal action than the triangular 
shaped nanoparticles. Data collected confirms that with an optimized size and shape of silver 
nanoparticles, and with a higher surface area, action as potential antibacterial agents is possible.  
 
3.2 Aims & Objectives 
With the increase in antibacterial resistance, novel methods of antibacterial drug delivery are 
being researched and tested, one such method is the use of antibacterial metallic nanoparticles.  
In this chapter synthesis of metallic nanoparticles, varying in their morphology and size, was 
attempted. Shapes of the metallic nanoparticles included spherical silver nanoparticles (AgNP), 
silver nanowires (AgNW), polygonal silver nanoparticles (AgP), spherical gold nanoparticles 
(AuNP) and spherical copper nanoparticles (CuNP). Upon synthesis characterisation was 
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required to determine the identity and chemical properties of synthesised nanoparticles, the 
characterisation techniques used included SEM/EDS, ATR-FTIR, Raman, UV-Vis, XRD and 
Zeta Potential.   
 
3.3 Materials and methods 
3.3.1 Materials 
Metallic nanoparticles were synthesised in-house. 
All of the chemicals used in this work were of analytical grade and used as they were without 
any additional purification. The precursors used for synthesis of the metallic nanoparticles 
included AgNO3, CuSO4, HAuCL4 x 3H2O, Na3C6H5O7 and PVP Mw 40,000. NaBr was used 
as a reducing and capping agent in many of the silver nanomaterials synthesis, moreover 
ascorbic acid was used for the CuNP synthesis and help prevent rapid oxidation of copper 
particles. D.I water and ethylene glycol (EG) were used for the preparation of all the solutions 
in the capacity of a vehicle.  
 
3.3.1.1 Silver nanoparticles (AgNP) 
AgNP were prepared through a citrate reduction method (Frost et al, 2017), a 1 % w/v solution 
of Na3C6H5O7 was prepared, 42.5 mg of AgNO3 was added to 50 mL D.I water, this solution 
was brought to the boil, to this the reducing agent was added dropwise, after certain amount of 
time the final colour of solution observed was yellow indicating the end point of synthesis 
(Gakiya-Teruya et al, 2018). Upon synthesis nanoparticles were centrifuged at speed of 4600 
rpm and washed with acetone once and D.I water three times to eradicate any impurities and 
unreacted precursors. 
The particles were produced through the following reaction: 
4Ag+ + Na3C6H5O7 + 2H2O → 4AgO + C6H5O7H3 + 3Na+ + H+ + O2↑  
Equation 3. 1: Equation showing the synthesis of spherical AgNP. 
 
3.3.1.2 Silver nanowires (AgNW) 
AgNW synthesized by reducing AgNO3 with EG in the presence of PVP as the capper agent. 
Two solutions, 127 mg of AgNO3 in 7 mL of EG and 127 mg of PVP in 7 mL of EG were 
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added concurrently, to 5 mL of EG refluxed for an hour at 160 oC. Colour changes observed 
were from a darkish black colour to a final colour cloudy grey indicating end point of the 
synthesis. Upon synthesis nanoparticles were centrifuged at speed of 4600 rpm and washed 
with acetone once and D.I water three times to eradicate any impurities and unreacted 
precursors (Sahin Coskun et al, 2011).  
 
3.3.1.3 Polygonal silver nanoparticles (AgP) 
The name polygon is attributed to any 2-dimensional shape formed with straight lines, hence 
why these nanoparticles were called AgP. To synthesize AgP or non-spherical silver 
nanoparticles with edges, 3 mL of two EG solutions were added, first contained 144 mM of 
PVP with 0.11 mM NaBr, the second contained 94 mM AgNO3, these were added dropwise 
via a two-channel syringe pump to 5 mL of EG refluxed in a condenser at 160 °C one after the 
other. An additional 30 µL drop of 10 mM NaBr was added to the pre-heated EG. The solution 
turned yellow in a few seconds upon the addition of AgNO3 and PVP which confirmed the 
formation of AgNPs. After 10 minutes, the yellow colour faded in intensity due to oxidative 
etching and remained a light-yellow colour for approximately 10 minutes before turning to 
brown and then to darker grey as the nanoparticles increased in size. Upon synthesis 
nanoparticles were centrifuged at speed of 4600 rpm and washed with acetone once and D.I 
water three times to eradicate any impurities and unreacted precursors.  
2HOCH2CH2OH→ 2CH3CHO + 2H2O 
2Ag+ + 2CH3CHO→ CH3CO-COCH3 + 2Ag +2H+ 
Equation 3. 2: Equation showing the synthesis of AgP. 
 
The presence of mediating species such as NaBr, play a role in the etching of the particle seeds, 
enabling the formation of particles with edges. The PVP also works as a shape-control agent 
encouraging the reduction of AgNO3 onto specific crystal faces while stopping reduction onto 
others.  
 
3.3.1.4 Gold nanoparticles (AuNP) 
For preparation of the AuNP, 2.2 mM sodium citrate of 150 mL D.I water was placed in a 
beaker over hot plate for 20 minutes under continuous stirring. After boiling (100 °C) 1 mL 
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drop of 25 mM of HAuCL4 x 3H2O was added to the solution. The colour of the solution 
changed from yellow to dark wine red after a few minutes, indicating the end point. Upon 
synthesis nanoparticles were centrifuged at speed of 4600 rpm and washed with acetone once 
and D.I water three times to eradicate any impurities and unreacted precursors. 
 
3.3.1.5 Copper nanoparticles (CuNP) 
The CuNP were prepared, through formulation of a solution by adding 1.59 g of CuSO4, 1 g 
PVP and 4.36 g of ascorbic acid all in 100 mL of D.I water. PVP was used as a surfactant and 
ascorbic acid as a reducing agent. It was then mixed with the use of a stirring magnetic bar and 
maintained at 80 °C. CuNP are highly unstable as they oxidise rapidly but this can be inhibited 
by the use of ascorbic acid. The formation of CuNP was confirmed with the presence of 
nanoparticles brick red in colour formed and could be seen, the colour changes observed were 
from blue to dark green and then brick red. Upon synthesis nanoparticles were centrifuged at 
speed of 4600 rpm and washed with acetone once and D.I water three times to eradicate any 
impurities and unreacted precursors.  
CuSO4 primarily dissociates to Cu2+ and SO42- in water, and Cu2+ ions are hydrolysed into Cu 
(OH2) as a precursor. 
Moreover, further reduction of Cu (OH2) takes place in the presence of ascorbic acid to form 
Cu2O. Lastly, Cu2O is further reduced to form Cu. The reaction can be represented as the 
following. CuSO4→ Cu2+ + SO42−          
2H2O→2H+ + 2OH−          Cu2+ + 2OH− → Cu(OH2)          
2 Cu (OH2)  + C6H8O6 →Cu2O + C6H6O6+ 3H2O Cu2O +C6H8O6→ Cu + C6H6O6+ H2O                      2H+ + SO42−→ H2SO4  
Equation 3. 3: Equation showing the synthesis of CuNP. 
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3.3.2 Methods 
3.3.2.1 Morphological observation through scanning electron microscopy (SEM) 
Imaging of samples was done using a Zeiss Evo HD15 SEM (Carl Zeiss, Cambridge, UK). 
Samples after centrifugation were pipetted on to microscope slides and allowed to dry, these 
were then analysed to study the size and morphology of the structures produced. Prior to 
assessing coated microscope slides; the samples were sputter coated with gold (S15OB, 
Edwards, Crawley, West Sussex UK) under vacuum to prevent charging. SEM images were 
captured at a working distance of 12 mm at varying low and high magnifications.  
 
3.3.2.2 Elemental analysis through energy dispersive spectroscopy (EDS) 
EDS analysis indicated the key elements present making up the synthesised material. The 
microstructural characterization was conducted with SEM-EDS in backscattering electron 
imaging mode using a scanning electron microscope with a conventional tungsten filament 
(Zeiss DSM 962). This equipment has an energy dispersive spectrometer Oxford Instruments 
INCAx-sight. The analyses were performed at a working distance of 25 mm, with an 
accelerating voltage of 20 kV, a filament current of approximately 3A and an emission current 
of 70 μA. In order to obtain the EDS spectra peaks, samples were not sputter-coated with gold. 
 
3.3.2.3 Particle size analysis through size distribution 
Size distribution histograms were plotted, SEM related software smart tiff was used, the 
particles displayed in the images measured using the tools available from the smart tiff 
software, giving exact measurements of size in nm or µm. Particle size recorded and a 
histogram displaying frequency in numbers of particle size was plotted.  
 
3.3.2.4 Attenuated total reflectance Fourier transform infrared spectroscopy (ATR-
FTIR)   
ATR-FTIR spectrums collected confirmed through vibration or excitation the bonds present 
within samples, through analysis of peaks at certain wavenumbers, which in turn help confirm 
the identity of the material based on previous literature. The metallic nanoparticles were 
collected upon drying as powder samples and analysed over a scanning range of 400–
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4000 cm−1 using FTIR Platinum-ATR fitted with Bruker Alpha Opus 27 FT-IR at an average 
of 10 scans at resolution 4 cm−1 at ambient temperature. 
 
3.3.2.5 Raman spectroscopy 
Raman spectra were collected using a FORAM® Raman spectrometer equipped with a 785 nm 
laser, using 30 scans at a resolution of 4 cm− 1. Raman spectra were collected between 200 cm− 1 
to 3300cm-1. The samples were prepared on glass slides, spectra were generated through laser 
hitting part of the sample, the part of the sample to be analysed appears through an optical 
microscope image at certain magnification. Thereafter, the spectra were produced. Similar to 
ATR-FTIR the peaks at different wavenumbers represent bonds present within the samples, 
which in turn identify the metallic particles. This technique was used to further confirm the 
ATR-FTIR results for the samples.  
 
3.3.2.6 Ultraviolet-visible spectroscopy (UV-Vis) 
UV-vis spectroscopy is an analytical technique where the absorbance of material is studied as 
a function of wavelength. The near-ultraviolet region of the spectrum falls in the wavelength 
region of about 200 nm, while the visible region of the spectrum falls in the wavelength of 
between 380 nm (violet) to 740 nm (red). Therefore, in material characterization, the UV-
visible spectrophotometer analyses in a wavelength range of between 200 nm and 900 nm. 
Samples after centrifugation were suspended in water, then pipetted into a glass quartz UV 
high precision cuvette to be analysed in a UV-Vis spectrophotometer.  
 
3.3.2.7 X-Ray diffraction (XRD) 
Sample crystallinity was evaluated using XRD analysis performed on a Bruker D8-Advance 
diffractometer, operating at 40 kV and 40 mA whilst using Cu Ka1. A scanning rate of 
0.20 s/step was used. Spectra were collected in 2θ from 20° to 80°. Samples were used after 
drying, the powder samples collected were placed upon powder specimen holders, and run at 
set operating parameters.  
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3.3.2.8 Zeta potential 
Zeta potential values play a crucial role in deciding the colloidal suspension stability of 
prepared nanoparticles or nanocomposites. Higher level of stability for colloidal suspension of 
nanoparticle depends on the value of zeta potential ranging from −25 mV to +25 mV. A nano-
brook omni zeta sizer was used, samples were prepared as a suspension, placed in plastic 
cuvettes a probe was inserted into the sample, readings were taken in triplicate and data tables 
collected.     
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3.4 Results and Discussion 
3.4.1 Synthesised metallic nanoparticle images 
Figure 3.1 displays the end point colours of each of the synthesised metallic nanoparticles, 
which were then centrifuged at 4600rpm three times and washed with D.I water to remove any 
impurities and unreacted precursors. For Figure 3.1Ai the end point is indicated by the cloudy 
yellow colour this is in correlation with literature for the end point of silver nanoparticle 
synthesis as beyond this no further colour change was observed (Dong et al, 2009). For Figure 
3.1Bi the colour observed is a cloudy grey colour this signifies the end point for nanowire 
synthesis through the polyol method (Guo et al, 2015), Figure 3.1Ci the colour of final solution 
can be described as a dark cloudy grey colour similar to that of Figure 3.1Bi but darker as the 
synthesis method the polyol method is similar, moreover literature for polygon shaped or edge 
shaped silver particles show similar colour. Figure 3.1Di shows the distinct dark wine-red 
colour indicating the synthesis of AuNP (Tyagi et al, 2016), as for Figure 3.1Ei CuNP presence 
is confirmed through the appearance of particles brick red in colour (Khan et al, 2016). 
Thereafter, the samples were centrifuged at 8000rpm for 5 minutes, the nanoparticles 
sedimented to the bottom, as can be seen by Figure 3.1(Aii-Eii) they were then extracted, dried 
and used for further characterisation. 
 
 
 
 
 
 
 
 
 
 
Ai 
Aii 
Bi Ci Di Ei 
Bii Cii Dii Eii 
Figure 3. 1: digital images of end-point synthesis of metallic nanoparticles and their respected 
centrifuged nanoprecipitates. (Ai) synthesised AgNPs (Aii) collected precipitate of centrifuged AgNPs 
(Bi) synthesised AgNWs (Bii) collected precipitate of centrifuged AgNWs (Ci) synthesised AgPs (Cii) 
collected precipitate of centrifuged AgPs (Di) synthesised AuNPs (Dii) collected precipitate of 
centrifuged AuNPs (Ei) synthesised CuNPs (Eii) collected precipitate of centrifuged CuNPs.  
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3.4.2 SEM/EDS 
Figure 3.2 shows the SEM images of the samples, at high and low magnifications, the 
corresponding EDS spectrums generated and the size distribution histograms for each metal 
synthesised.  
Figure 3.2Ai shows the spherical AgNP, the particles present at x5 kV have similar 
morphologies and appear monodispersed but quite sparse, at high magnification Figure 3.2Aii 
x50 kV this is confirmed as particles appear uniform with some slight differences in size and 
morphology, overall size of particles can be said is increasing, this leads to particles with a 
variable size distribution shown in Figure 3.2Aiv. The average particle size was 69.4 nm, from 
the histogram it can be seen many of the particles were between 61-70 nm and 71-80 nm in 
size.  
Ranoszek-Soliwoda et al, 2017 reported synthesis of spherical AgNP using a single reagent in 
this case sodium citrate results in a broader size range of particles, with variations in 
morphology. As sodium citrate is a weak reducing agent it does not allow the control of the 
AgNP morphology, changes in the reaction temperature where the synthesis occurs at 100 °C 
still does not produce uniform AgNP. EDS analysis on this sample Figure 3.2Aiii confirmed 
the presence of silver. Pillai and Kamat, 2004 confirmed the variation in morphology and larger 
particle size (50-100 nm) is due to the use of sodium citrate as the reducing agent. Gakiya-
Teruya et al, 2018, has also shown that AgNP produced through the regular Turkevich citrate 
reduction method produces particles with a wider size distribution.  
Successful synthesis of nanowires is observed in image Figure 3.2Bi, at low magnification x5 
kV nanowires are surrounded by colloidal silver particles, the size and morphology of the wires 
varies, with some longer in length and wider in diameter than others. The presence of colloidal 
silver particles is due to the synthesis method, as (Sun et al, 2002) report if during synthesis 
the AgNO3 and PVP solutions are added simultaneously then a mixture of silver wires with 
colloidal particles will occur. Prabukumar and Bhat, 2018, determined centrifugation alone 
may not be enough to remove the particles attached to the nanowires. The polyol method has 
shown to be one of the easiest and efficient ways to produce nanowires of such high yield and 
with similar morphologies.  
AgNWs displayed an average particle diameter size of 317.4nm and an average length of 
1138.4nm. The histogram Figure 3.2Biv shows in blue the diameter sizes (nm) of the particles 
and in red the size (nm) in length of particles, most particles measured showed a diameter size 
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between 301-400 nm and a length between 1101-1200 nm. Chen et al, 2008, produced 
nanowires with an average diameter of 400 nm through utilization of the polyol method. 
Findings published showed similar results in nanowire sizes, when using the same polyol 
synthesis method used here. Coskun et al, 2011 described the effects of temperature on size 
and morphology of nanowires produced, the particle diameter at around 160 °C is around 350-
400 nm which is similar to the particle diameter of the nanowires synthesized in Figure 3.2Bi. 
Nghia et al, 2012, explained that a low amount of PVP and a medium amount of silver seeds 
gives rise to nanorod or nanowire structures. Silver seeds form through the small amounts of 
precursor material added e.g. NaBr or NaCl. Gebeyehu et al, 2017, explained the final 
morphologies of AgNWs at the end of the polyol process are strongly dependent on the PVP 
to AgNO3 ratio and the molecular weight of PVP originally used.  
Jang et al, 2018, describe the steps involved in the polyol synthesis of nanowires in steps, an 
initial seeding step producing octahedral silver seed crystals and a growth step producing 
pentagonal wires, this is followed by a nucleation step were Ag+ ions are reduced by EG acting 
as the reducing agent. These silver nuclei grow and function as Ag seed crystals. In the presence 
of AgNO3 PVP acts as a capping agent kinetically controlling the growth rate of Ag. The 
capping process leads to the growth of wires, through selective absorption of PVP onto 
different crystal faces, hence showing control of the silver seed crystal structure is key to 
controlling size of the wires formed. EDS spectra Figure 3.2Biii confirms the presence of 
silver. 
Figure 3.2Ci is that of the polygonal shaped particles, as can be seen the shape of these 
particles differ to those in Figure 3.2Ai (spherical in shape), with clear edges observed in many 
of the particles at high magnification x25 kV Figure 3.2Cii but varying in number of sides. 
The morphologies of the particles observed are similar, the average particle size is around 427.6 
nm much larger than the spherical AgNP synthesised. The histogram Figure 3.2Civ shows a 
larger number of particles between 401-500 nm in size, and the overall range of particles 
between 201-600 nm, which suggests a wider size distribution. The shape in particles size and 
morphology is highly dependent on the synthesis method, as described the polyol method was 
utilised with concentrations of precursors altered.  
The morphology of the particles observed arises through the growth of multiple twinned 
particles (MTP), these are best described by (Wiley et al, 2006), who have shown that before 
growth into fully fledged nanowires, MTP`s form shaped as polygonal particles, as the method 
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of synthesis is similar, the end morphology varies by controlling the crystal structures of the 
seeds. Figure 3.3, shows that the presence of EG helps reduce the silver ions, which form 
clusters that are fluctuating in their structure, as growth continues fluctuation decreases, until 
it evolves into a single-crystal, single twinned, or multiple twinned seed. The presence of the 
multiple twinned seed is before the synthesis of the wire and can be seen with a shape similar 
to that of a polygon with closed sides. Xiao-Yang Zhang et al, 2018, explain the formation of 
five twinned pentagonal seeds occurs before the growth of nanowires, and if the size of these 
seeds can be controlled size of nanowires can also be.  
These five twinned pentagonal seeds are similar to the shape of particles observed in Figure 
3.2Cii, and forms before the formation of the nanowire, (Sun et al, 2002) also confirm 
nanowires form through the evolution of multiple twinned silver particles. Al-Thabaiti et al, 
2013, described the precursors needed for the development of AgP, it was found that the 
presence of PVA led to the synthesis of polygonal shaped particles, it was reported that PVA 
may act as PVP does in binding to crystal faces and yielding different shape growth. Cuya 
Huaman et al, 2018, synthesised copper nanowires using a similar polyol method, what was 
observed showed that the copper ions are reduced to copper seeds, which lead to the formation 
of copper nanowires, these seeds take the polygonal shape, similarly here the silver seeds have 
the shape of a polygon and form before the eventual nanowire formation.  
EDS analysis Figure 3.2Ciii again confirms the presence of silver, however the element arsenic 
(As) can also be detected on the EDS spectrum, as this does not appear in any of the other 
spectra’s this can be noted as an anomaly.  
Figures 3.2Di and Dii are of the synthesised AuNP, at low and high magnification respectively. 
At low magnifications x5 kV the particles appear spherical and similar in morphology, at a 
higher magnification the particles can be seen clumped together in a colloidal arrangement with 
many of the particles appearing charged throughout. The average particle size was 104.7 nm, 
with Figure 3.2Div showing that a larger number of particles are observed between 101-120 
nm. Kumar et al, 2007, confirm the coagulation of nanoparticles occurs due to higher presence 
of citrate ions as well as the existence of salts. The precursor HAuCL4 x 3H2O is a salt that is 
reduced by sodium citrate, together this may have led to increased coagulation of particles. Ji 
et al, 2007, found that the relationship between the gold salt and sodium citrate is key, with 
increased amounts of gold salt the particle size increases, however when reducing gold salt 
concentration and increasing sodium citrate concentration particle size reduces and becomes 
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more uniform, furthermore, they found that the pH has a key part to play in aggregation of gold 
particles, and that as well as being a reducing and stabilizing agent sodium citrate can also alter 
reaction pH, hence deciding if coagulation occurs or not.  
Spherical CuNP are observed at high magnification x50 kV Figure 3.2Eii, particles appear 
similar in size and morphology, they appear monodispersed. An average particle size of 
44.8nm, with many of the particles between 41-50 nm. Khan et al, 2015, demonstrates the 
CuNP synthesised tend to coagulate and form clusters, moreover the presence of ascorbic acid 
not only helps in preventing rapid oxidation but also in reducing particle size and maintaining 
narrow size distribution. EDS spectrum Figure 3.2Eiii confirms the presence of copper. 
Figure 3.2 Fi, shows the successful synthesis of hexagonal shaped particles, with 6 clear sides, 
the particles were synthesised following a method described by (G. Cynthia Jemima 
Swarnavalli et al, 2011), the size of the particles however is too large, as shown in Figure 
3.2Fiv the size is above 1 micron, and continues to rise above 2 micron, EDS spectrum in 
Figure 3.2Fiii confirms the presence of silver, however these particles were not used due to 
not appearing at the nano-size range, also with the larger size and increased density, 
formulations formed in future chapters became too viscous and unable to spray, hence why the 
synthesis was abandoned.  
 
 
 
 
 
 
 
 
 
 
 
Ai Aii 
Aiii Aiv 
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Figure 3. 2: SEM ((i)images at low magnifiaction); ((ii) images at higher or equal magnifications); 
(iii) EDS analysis; (iv) particles size distribution histogram using (ii) SEM images. (A) AgNP; (B) 
AgNW; (C) AgP; (D) AuNP; (E) CuNP; (F) hexagonal silver nanoparticle not used.  
 
 
 
 
 
Figure 3. 3: Pathway describing the growth multiple twinned seed particles prior to nanowire 
formation.  
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3.4.3 ATR-FTIR 
Evidence of the surface functionalisation of AgNP and AuNP by citrate ions was obtained 
through FTIR measurements Figure 3.4. The peaks at 1388 cm-1 for AgNP and 1372 cm-1 for 
the AuNP correspond to the symmetric and anti-symmetric stretching of COO. As there are no 
peaks at 1417cm-1 which is the peak for free citrate molecules this indicates citrate molecules 
are bound to the surface of AgNP and AuNP. Additionally, there is an O-H stretch present in 
both spectra, indicated through a broad spectrum from 3321 cm-1 to 3373 cm-1 for AuNPs and 
between 3184 cm-1 to 3396 cm-1 (Frost et al, 2017).  
 
Ranoszek-Soliwoda et al, 2017, synthesised AgNP through citrate reduction mechanism and 
FT-IR analysis of the sample showed characteristic peaks at 1196 cm-1, 1397 cm-1, 1583 cm-1 
and 1690 cm-1. AgNP shown in Figure 3.4 shows peaks at similar wavenumbers, 1137cm-1, 
1388 cm-1, 1537 cm-1 and 1638 cm-1. The peak at 1583 cm-1 indicates a C=O stretch, and the 
signal at 1397 cm-1 indicates COO- peak, these values are characteristic for free citrate 
molecules, in Figure 3.4 the spectrum for AgNP shows slight peak shifts at these wavenumbers 
indicating citrate molecules are no longer free and now attached to the surface of the metallic 
nanoparticles.  
 
The spectrum shown in Figure 3.4 for AuNP displays, a small broad peak at 1238 cm-1, a broad 
but sharper peak at 1389 cm-1 and a sharp peak at 1628 cm-1, which are all similar to those in 
literature reported by (Yadav and Jyoti, 2018) who shows AuNP synthesised through the citrate 
reduction method have similar characteristic peaks at 1231 cm-1 1474 cm-1 and 1637 cm-1.   
 
FT-IR spectra for AgNW and AgP, display peaks at very similar wavenumbers but at different 
intensities. AgP spectra shows sharp peaks at 1035 cm-1 and 1083 cm-1 indicative of a C-O 
stretch, the sharp peak at 1638 cm-1 describing a C=O stretch and two shoulder peaks around 
2878 cm-1 and 2937 cm-1 displaying CH3 stretch. As for the AgNW the spectra show peaks in 
similar areas 1034 cm-1, 1076 cm-1, and 1623 cm-1, and a slight broad peak at around 2941 cm-
1, both spectra again show a broad peak between 3100-3400 cm-1 indicating presence of an O-
H group (Zhijie Zhang et al, 2017). The intensity in peaks between these two spectra may vary 
due to the concentration of precursors used to synthesise the metallic particles or because of 
the amount of material used during analysis.   
As for the spectra of CuNP, it shows a small broad peak between 1020 cm-1 and 1140 cm-1, 
and a sharp peak at 1630 cm-1 indicating a (C=C) bond, a larger broader peak between 3132 
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cm-1 and 3447 cm-1, indicating the presence of an (O-H) group, the broadness of the peak is 
due to the increase in hydrogen bonding, this spectrum is in correlation with previous literature 
(Zafar et al, 2015). All metallic particle spectra`s show variation, due to synthesis method 
utilised which can be visualised through peak differences, as peaks for shaped silver 
nanoparticles are not present in spectra of AgNP, AuNP and CuNP, as stated metallic particles 
are synthesized through a chemical reduction method and shaped AgNP are formulated through 
the polyol synthesis method.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 4: ATR-FTIR spectra of synthesised metallic nanoparticles; AgNP, AgNW, AuNP, AgP and 
CuNP. 
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3.4.4 Raman spectroscopy  
Figure 3.5 shows the Raman spectra for synthesised metallic nanoparticles. AgNPs have 
numerous small shoulder peaks between 200 and 862 cm-1 indicative of C-H peaks, there are 
two sharp peaks at 922 cm-1 showing deformation of C-O-H and at 1410 cm-1 which shows 
CH3 and CH2 deformations. The sharpest peak appears at 3102 cm-1 indicating an aromatic 
compound (benzene ring). Interestingly, the surface enhanced Raman spectroscopy (SERS) 
intensity of the analyte increases gradually with the increase of the size of the AgNPs. 
AgNW have a sharp peak at 1386 cm-1 indicating CH3 and CH2 deformations, and the sharpest 
peak at 3100 cm-1. A broad sharp peak at 1902 cm-1 and the sharpest intensity peak at 3100 cm-
1 displaying an aromatic ring. AgP spectrum results follow a similar pattern to that of the silver 
nanowires, which again may be due to similarity in the synthesis method, peaks are observed 
at 1386 cm-1 again indicating CH3 and CH2 deformations, a broad peak at 1902 cm-1 and the 
peak of highest intensity at 3100 cm-1 displaying an aromatic ring. Furthermore, just as shown 
in related FT-IR spectra the peak intensity for the AgP particles is much higher than that of 
AgNW.  
The AuNP spectrum shows peaks at 1390 cm-1 related to CH3 and CH2 deformations, with the 
peak at 3104 cm-1 indicating an aromatic ring. The CuNP show a very different spectra, may 
be due to the difference in precursor materials used, as it has no sharp peaks until 3100 cm-1 
indicating an aromatic ring, and shows small broad peaks between 320-1220 cm-1 mainly 
suggesting presence of CH groups.  
 
 
 
 
 
 
 
 
Figure 3. 5: Raman spectra of synthesised metallic nanoparticles; AgNP, AgNW, AuNP, AgP and 
CuNP. 
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3.4.5 UV-vis spectroscopy 
Figure 3.6 displays the UV-Vis analysis of the synthesised nanoparticles illustrates differing 
results between the types of metal synthesised. Displaying differences in wavelengths and 
sharpness of peaks related to size and shape of nanoparticles synthesised as well as synthesis 
method utilised, between the citrate reduction method and the polyol synthesis method, 
generating particles varying in shape.  
The AuNP and AgNP solutions prepared by the citrate reduction method displayed 
characteristic absorption spectra with LSPR absorbance maxima at values of 523 nm and 
415.5 nm respectively (Frost et al, 2017). Synthesised AuNP show a sharper band at the 
maximum absorbance in comparison to the spherical AgNP which display a broader band from 
370 to 470 nm, this may be due to a decrease in particle size in correlation with size quantum 
theories, whereas the sharper peak area is related to aggregation of particles, and a reduced 
amount of space between particles leading to larger particle size (Desai et al, 2012). The AuNP 
synthesised show broad sharp peak between 517-532 nm and in correlation with literature, 
(Huang et al, 2018) synthesised AuNP with a maximum absorbance at around 523 nm. The 
AgNP show a broad peak between 380-446 nm which correlates with data found by (Ranoszek-
Soliwoda et al, 2017).    
As for the synthesised AgNW, a broad but short band with a maximum absorption at 311nm 
correlates with previous literature (Prabukumar and Bhat, 2018), the similarity between this 
maximum and to that of the AgP which has a maximum at 325nm may be due to the similarity 
in synthesis method. The CuNP UV-vis curve is not displayed as the metallic nanoparticles 
present sedimented to the bottom of the cuvette therefore any attempt at creating a curve was 
ineffective. From literature it was found copper nanoparticles display a maximum wavelength 
between 550-600 nm (Thi My Dung Dang et al, 2011).  
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Figure 3. 6: UV-vis spectra of synthesised metallic nanoparticles; AgNP, AgNW, AuNP and AgP  
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3.4.6 XRD 
Diffractograms displayed in Figure 3.7 confirm the crystallinity of synthesised nanoparticles. 
CuNP display the sharpest intensity peaks, sharp peaks observed at the 2θ values of 36.44, 
29.74, 43.17, 50.38, 61.45 and 74.04. Peaks observed at 2θ values of 43.17, 50.38 and 74.04 
correspond to (111), (200) and (220) planes of metallic copper (Khan et al, 2015). These three 
peaks were quite consistent with those of the standard JCPDS Card No. 04-0836 for the 
standard spectrum of the pure face centred cubic (FCC) metallic copper. Besides the metallic 
copper peaks, several other diffraction peaks appeared at 2θ values of 29.74, 36.44, 61.45 
indicating the formation of copper (I) oxide nanocrystals.  
 
The spectrum of AgPs displayed, peaks similar to those of AgNWs a sharp peak at the 2θ value 
of 43.65 (111), with further smaller peaks at the 2θ values of 37.45 (200) and 64.11 (220). 
From the spectra for AgNWs numerous peaks were observed, at 2θ of 37.80, 43.55, 64.15, 
77.11, two diffraction peaks at 37.80 (111) and 43.55 (200) are matching with standard 
diffraction data for silver (JCPDS 04-0783). The relative intensity of (111) with that of (200) 
plane is attributed to preferred (111) plane growth of silver nanowires (Prabukumar and Bhat, 
2018), the use of a capping agent promotes this preferred growth. Moreover, peaks at 64.15 
and 77.11 correspond to planes (220) and (311) as shown in previous literature in accordance 
with JCPDS card 04-0783 (Lin et al, 2015). XRD diffractograms published by (Guo et al, 2015) 
further confirm the peaks seen in Figure 3.7, correlate with synthesised AgNWs. Gao et al, 
2005, also published an AgNW diffractogram with similar peak positions and intensities.  
 
Peaks for AuNPs show the sharpest peak at 2θ value of 37.21 further peaks were seen at 2θ 
values of 43.89 63.76 and 77.23. Peak at 2θ values of 37.21 corresponds to the (111) plane, 
43.89 63.76 and 77.23 correspond to the planes at (200), (220), (211) respectively. 
(Krishnamurthy et al, 2014) (Mohamed et al, 2017). 
 
Spherical AgNPs exhibited peaks at 2θ values of 38.26, 44.01, 64.39 and 77.33. These values 
correspond to planes at (111), (200), (220) and (311) respectively, the intensity of the peak at 
the plane (111) indicates this is preferred plane of growth, similar to the findings of other silver 
nanoparticles synthesised (Raza et al, 2016) (Wang et al, 2018).   
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Figure 3. 7: XRD diffractograms of synthesised metallic nanoparticles; AgNP, AgNW, AuNP, AgP 
and CuNP. 
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3.4.7 Zeta Potential Values 
Zeta potential values are used as a measure of colloidal suspension stability, the higher the 
value either negative or positive means greater stability of nanomaterials synthesised within a 
suspension, the stability of these nanoparticles in colloidal suspensions is important based on 
further analysis. Zeta potential values cannot be obtained directly, it is calculated through 
experimental data such as the electrophoretic mobility of particles, this in turn helps determine 
values of zeta potential, as the rate at which a charged particle moves in response to an electric 
field is recorded. Particles that possess a zeta potential will migrate toward the opposite-
charged electrode. Root mean squared (RMS) residual is displayed as a measure of how spread 
out data points are and allows for verification of results.  
From Table 3.1 it can be observed that synthesised AgNPs have an average zeta potential value 
of -31.38 mV, a value high enough to indicate colloidal stability, also indicating that the 
particles are less likely to aggregate (Haider and Mehdi, 2014), Table 3.2 for the AgNWs show 
a higher mean value at -36 mW showing colloidal stability, Table 3.3 with the AgPs at -
31.03mV also indicating stability in a suspension, Table 3.4 AuNPs show a decrease in zeta 
potential values which may be due to aggregation of particles (Saeb et al, 2014) also observed 
in Figure 3.2Dii. Table 3.5 for CuNPs the zeta potential value is again higher at -29.47mV 
indicating good colloidal suspension stability, and less likely to agglomerate. 
  
Table 3. 1: Zeta potential values of spherical AgNP. 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
AgNP - 1 -34.96 -2.73 4.81E-02 
AgNP - 2 -35.91 -2.81 5.14E-02 
AgNP - 3 -23.27 -1.82 1.05E-01 
Mean:   -31.38 -2.45 6.82E-02 
Std Err:   4.06 0.32 1.84E-02 
Std Dev:   7.04 0.55 3.18E-02 
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Table 3. 2: Zeta potential values of AgNW. 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
AgNW - 1 -20.46 -0.04 1.02E-02 
AgNW - 2 -41.50 -0.08 9.85E-03 
AgNW - 3 -46.03 -0.09 2.58E-02 
Mean:   -36.00 -0.07 1.53E-02 
Std Err:   7.88 0.02 5.25E-03 
Std Dev:   13.65 0.03 9.09E-03 
 
Table 3. 3: Zeta potential values of AgP. 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
AgP - 1 -31.39 -2.45 5.21E-02 
AgP- 2 -33.46 -2.61 1.86E-02 
AgP - 3 -28.24 -2.21 3.71E-02 
Mean:   -31.03 -2.42 3.59E-02 
Std Err:   1.52 0.12 9.68E-03 
Std Dev:   2.63 0.21 1.68E-02 
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Table 3. 4: Zeta potential values of AuNP. 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
AuNP - 1 -23.86 -1.86 7.54E-02 
AuNP - 2 -11.08 -0.87 7.39E-02 
AuNP - 3 -12.45 -0.97 5.78E-02 
Mean:   -15.80 -1.23 6.90E-02 
Std Err:   4.05 0.32 5.64E-03 
Std Dev:   7.01 0.55 9.76E-03 
 
Table 3. 5: Zeta potential values of CuNP. 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
CuNP - 1 -11.71 -0.92 3.73E-02 
CuNP - 2 -35.12 -2.74 1.84E-01 
CuNP - 3 -41.59 -3.25 1.21E-01 
Mean:   -29.47 -2.30 1.14E-01 
Std Err:   9.07 0.71 4.25E-02 
Std Dev:   15.72 1.23 7.37E-02 
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3.5 Conclusion 
In this chapter, five different metallic nanoparticles have been successfully synthesised, 
spherical silver nanoparticles, silver nanowires, polygonal silver nanoparticles, spherical gold 
nanoparticles and spherical copper nanoparticles. EDS analysis confirmed the presence of each 
metal synthesised, and size distribution confirmed the nano-size range of all metallic 
nanoparticles. The smallest size metallic nanoparticles were the CuNPs with an average size 
distribution of 44.8 nm, followed by the AgNPs with an average size of 69.4 nm, then the 
AuNPs with an average size of 104.7 nm, thereafter the AgPs with an average size distribution 
of 427.6 nm and finally the AgNWs which had an average diameter of 317.4 nm and an average 
length of 1138.4 nm. ATR-FTIR confirmed the molecular bonds present within each type of 
metallic nanoparticle, results varied depending on the synthesis method, between the chemical 
reduction method and polyol synthesis method. Raman data further confirmed the data from 
ATR-FTIR and peak intensities gave an indication of nanoparticle size. UV-Vis analysis 
displayed results that are characteristic of the metallic nanoparticle synthesised, AgNPs 
displayed a maximum at 415.5 nm, the AuNPs with a maximum at 523 nm, the AgNWs with 
a small broad peak, the maximum at 311 nm and AgP with a sharp peak point at 325 nm. The 
XRD diffractograms presented sharp peaks for each metallic nanoparticle, peaks at positions 
which correlated to the metallic nanoparticle synthesised based on previous literature. The zeta 
potential results were all greater than -25 mV indicating good colloidal stability, apart from 
AuNPs with an average value at -15.80 mV.   
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Chapter 4 – Synthesis of polymeric composites 
 
4.1 Introduction 
Antibiotic resistance has now reached an epidemic level. A wide variety of bacterial pathogens 
have developed resistance their antibacterial agents and thus render them ineffective. The 
WHO has advised that if the issue of antibiotic resistance is not effectively addressed and 
controlled, the phenomenon has the capability to change the health care systems as we know 
them today. The potential for an array of infectious diseases to have no feasible antibiotic 
therapy is an ever looming and an impending reality. Various conventional drug dosage forms 
have been developed and used to overcome such resistance synergistically with the use of APIs. 
However, limitations arise with many of these drug dosage forms, additionally at the same 
time, the growth in resistant bacterial strains continues into epidemic proportions. Today, there 
is more need for continued research into novel antibacterial drug delivery methods than ever 
before. One novel method withholding numerous advantages compared to its traditional drug 
delivery approach is the EHDA process which allows the manufacture of formulations holding 
antibacterial properties. Through this method, API particles are encapsulated within a 
polymeric matrix, and the antibacterial effect augmented further through the addition of 
metallic nanoparticles. EHDA also permits for the encapsulation of insoluble drugs, an easy 
fast one-step process means it is relatively low-cost. 
Drug-loaded microspheres fabricated with biodegradable polymers typically form a matrix 
structure in which the drug is theoretically molecularly dispersed, which results in amorphous 
properties. Drug distribution with in the microspheres depends on the miscibility of the drug 
with the polymer and the drug loading of the particles.  
In biodegradable microparticle systems, the drug-release kinetics can be controlled partly by 
altering the polymer composition such as molecular weight or the ratio monomers for co-
polymer systems. Also, several studies have shown that the properties of the microparticles 
such as size, morphology and porosity as well as drug loading are important factors in 
determining the drug-release profile of these particles (Adam Bohr et al, 2012). 
Microparticles made from biodegradable polymers for pharmaceutical applications, is an area 
extensively studied, as an alternative for the common antibacterial agents, as active agents are 
continuously released from the particles over time. Electrohydrodynamic atomization 
technique, commonly referred to as electrospraying has many advantages when creating 
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particles in the nano and micro scale, such as improved dissolution rates of poorly water-
soluble drugs, reproducibility, ease of set up and encapsulation of active agents.  Moreover, 
multi-pharmacy or poly pharmacy can be achieved by loading different drugs into multi-
layered particles via electrospraying, and the controlled release of these ingredients has been 
made possible (Muhammet Emin Cam et al, 2019).  
Polymeric nanoparticles with intrinsic antimicrobial properties have gained interest for 
treating infections. Polymers are available in natural and synthetic state. Some of these 
polymers demonstrate an antimicrobial potency by themselves e.g. chitosan nanoparticles 
(Rampino et al, 2013), others need some chemical modification to their conferred 
antimicrobial activity e.g. nanoparticles of polyvinyl caprolactam–polyvinyl acetate–
polyethylene glycol graft copolymer (Soluplus®) modified with chitosan (Takahashi et al, 
2015) or to incorporate organic or inorganic compounds with antimicrobial activity e.g. 
AgNPs. 
 
 
4.2 Aims & Objectives 
In this chapter, the synthesis of polymeric composites was attempted; these were loaded with 
an insoluble drug amoxicillin (AMX) and the metallic nanoparticles synthesised in the previous 
chapter. The EHDA process was used.  Upon synthesis, characterisation was carried out to 
determine polymer-drug interactions and the presence of metallic nanoparticles within the 
composites.  For this, the methods used were SEM/EDS, ATR-FTIR, DSC, TGA, XRD and 
zeta potential.  
The experiments carried out within this chapter were novel, no previous work has been 
published related to using the electrospraying system to generate such antibacterial composites 
as possible alternatives to overcome the rise in bacterial resistance. All data collated from the 
characterisation techniques used, have not been found in any previously published literature 
related to this research.  
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4.3 Materials and Methods 
4.3.1 Materials 
Materials purchased from Sigma Aldrich UK included PLGA resomer RG 503 H, lactide: 
glycolide 50:50, Mw 24,000-38,000; AMX with a potency > 900 µg per mg; and acetone with 
a purity > 99.9%. DCM > 99% was purchased from Fisher Scientific UK. The metallic 
nanoparticles; AgNP, AgNW, AgP, AuNP and CuNP used were synthesised in-house as 
detailed in the previous chapter.  
 
4.3.2 Methods 
4.3.2.1 Formulation preparation 
Several preliminary experiments were performed in order to govern the optimal concentrations 
of excipients. All formulations follow the same concentration of excipients whilst only the type 
of vehicle and metallic nanoparticle used changes amongst them (Table 4.1 shows the 
formulation compositions). The formulations were stirred with the US152D magnetic stirrer 
(Stuart, Staffordshire, UK) for 1 hour in an ambient environment (23 °C at 45% relative 
humidity) to allow for the homogenous distribution of particles throughout. The formulation 
was covered with parafilm ‘M’ laboratory film (Bemis, Lincolnshire, UK) to prevent the 
evaporation of the vehicles during the stirring process. Images of all formulations were taken.  
 
Table 4. 1: General composition of all formulations 
 Composition 
Polymer (% 
w/v) 
Drug (% w/w 
of the 
polymer) 
Vehicle (mL) Metal nanoparticles (% w/w 
of the drug) 
 
 5 5 10 5 
Excipient 
alternatives 
PLGA AMX • Acetone 
• DCM 
• AgNP 
• AgNW 
• AgP 
• AuNP 
• CuNP 
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4.3.2.2 Formulation characterisation 
The viscosity of the formulations was measured using the SV-10 sine-wave vibro viscometer 
(A&D, Oxfordshire, UK). The surface tension of the formulations was measured using the OS 
torsion balance (White Electrical Instrument Co. Ltd, Worcestershire, UK) using the 4 cm 
diameter platinum DuNuoy ring. The electrical conductivities of the formulations measured 
using the FiveGo electrical conductivity meter (Mettler Toledo, Leicestershire, UK) which was 
standardised using a calibration medium. All measurements were done in triplicate in an 
ambient environment (23 °C at 45 % relative humidity). 
 
4.3.2.3 EHDA set-up 
Figure 2.18 shows the set up for the single needle electrospraying system. A BD Medical™ 
Plastipak™ Plastic Concentric Luer-Lock syringe (Fisher Scientific, Loughborough, UK) 
contained 5 mL of formulation and was mounted on to an SP100IZ infusion pump (WPI, 
Hertfordshire, UK) to control the flow rate of the formulation through the EHDA system. The 
syringe was connected to a BD Microlance™ 3 needle (Fisher Scientific, Loughborough, UK) 
and inserted into a silicon tubing of known length. From preliminary testing it was found using 
a longer length of tubing could lead to evaporation of solvent before reaching the capillary 
needle exit, therefore tubing of a shorter length 8cm was used. The silicon tubing was attached 
to an electrically conducting processing capillary needle (size 330 µm).  A high voltage power 
supply (Glassman High Voltage Supply, New Jersey, USA) was attached to the capillary needle 
for the atomisation of the formulation. The collector plate was covered with greaseproof paper 
and microscope slides to collect the samples for analysis. A depth of 9 cm was maintained 
between the capillary needle tip and the collector plate. All procedures were carried out in an 
ambient environment (23 °C at 45 % relative humidity). 
Optimising the spraying of the formulation was achieved through recording the effect of 
varying the flow rate and applied voltage. Each known formulation was sprayed at flow rates 
15, 20, 25, 30 and 40 µL/min, with an applied voltage between 10-17 kV in order create a 
stable jet for each formulation. Jetting maps for each formulation to show the areas of dripping 
mode, stable jet and unstable jet can be plotted from this. 
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4.3.2.4 Scanning electron microscopy (SEM)/ Energy dispersive spectroscopy (EDS)  
Particle size and morphology were measured using the Zeiss Evo HD15 SEM (Carl Zeiss, 
Cambridge, UK). Samples collected onto glass microscope slides were coated with 15 nm gold 
using the Q150RS gold coater (Quorum Technologies, Sussex, UK). Images were taken at low 
and high magnification from x5,000 and upwards at an accelerated voltage of 10 kV, along 
different points on the coated microscope slide.  
EDS analysis indicated the elemental composition of the synthesised material, and the 
components present within. The microstructural characterization was conducted with SEM-
EDS in backscattering electron imaging mode using the SEM. 
 
4.3.2.5 Attenuated total reflectance Fourier transform infrared spectroscopy (ATR-
FTIR) 
For the study of interactions between PLGA and AMX, along with the metal nanoparticles 
ATR-FTIR was used. FTIR Platinum-ATR (Bruker, Coventry, UK) spectrophotometer and 
Bruker Alpha Opus 27 software was used for the analysis of the formulations. Spectra was 
generated over the range 400-4000 cm-1 for both raw materials and full formulations.  
 
4.3.2.6 Differential scanning calorimetry (DSC) 
Thermograms were generated using the Jade Differential Scanning Calorimeter (PerkinElmer, 
USA). Both raw materials and full formulations were analysed to understand the interactions 
of the materials used. Samples of 5-10 mg were added and sealed into aluminium pans. A 
heating range of 20-300 °C with a heating rate of 20 °C per minute was used. 
 
4.3.2.7 Thermogravimetric analysis (TGA) 
Thermograms presenting the weight loss (%) of both the raw materials and full formulations 
were analysed using the Pyris 1 TGA Thermogravimetric analyser (PerkinElmer, USA). 
Samples of 5-15 mg were added and sealed into aluminium pans. A heating range of 20-600 
°C with a heating rate of 10 °C per minute was used. 
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4.3.2.8 X-ray diffraction (XRD) 
Sample crystallinity was measured of both the raw materials and full formulations, to determine 
the nature of the sample using the 2nd Generation D2 Phaser (Bruker, Warwickshire, UK), 
operating at 20 kV and 5 mA. The diffraction pattern was collected between 5-40° with a step 
size of 0.04° changing steps every 0.4 seconds. Samples were scraped of microscopic glass 
slides and loaded into powder specimen holders.  
 
4.3.2.9 Zeta potential 
Measurements for zeta potential were carried out using a Brookhaven NanoBrook Omni 
Particle Size and Zeta-Potential Analyser with Microrheology (Brookhaven, New York, USA). 
Measurements were carried out at the 15° detection angle minimising diffusion broadening. 
Known weight of samples were placed in a cuvette, suspended in water for analysis. Analysis 
was undertaken at neutral pH of 7.4 with a temperature of 25°C.  
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4.4 Results and Discussion 
4.4.1 Formulation characterisation 
Physical properties of liquids have a paramount effect on the size and morphology of particles 
that are produced from the EHDA system and hence they can be predicted and manipulated 
based on the properties of the formulation used. Moreover, the choice of vehicle is crucial in 
the EHDA process as it influences the jetting and stability of the spray, hence the reason 
viscosity, surface tension and electrical conductivity are important parameters. Particles 
fabricated through the EHDA process are a result of the interplay between viscosity, surface 
tension and electrical conductivity (Browne et al, 2019, Wahyudiono et al, 2019).  
 
4.4.1.1 Viscosity 
Table 4.2 displays the viscosity results of the solvents and formulations F1-F14. The 
viscosity results of both vehicles acetone and DCM matched values found in literature 
(Mohammadi and Hamzehloo, 2019). Formulations, F1 and F8 show similar viscosities as 
they consist of only polymer in solvent forming a solution. Upon the addition of the drug 
AMX F2 and F9 the viscosity increased accordingly as it is now formed a suspension. 
General trend showed formulations F9 to F14 were apparently more viscous which is due to 
the solvent DCM, in comparison to the F2 to F7 formulations which use acetone as the 
solvent. The formulations containing the metallic particles also increased in viscosity, as 
there is a higher concentration of material within the suspensions. Ghozatloo, 2015, described 
that the increase in concentration increases viscosity, but also the morphology of particles, as 
the metallic nanoparticles are shaped differently this can also lead to variation in viscosity. 
From Table 4.2 it can be seen that formulations F4 and F11 both have the highest viscosity 
values, these formulations contain the metallic nanowires, which indicates these may have a 
higher density leading to overall increase in viscosity.  
The effects the viscosity differences have on the electrospraying system are observed through 
SEM images. Too high a viscosity can lead to fibres forming or spraying of particles clumped 
together, whereas a lower viscosity allows for good flow of sample through syringe and good 
shaped particles forming. It is known that viscosity can differentiate between the types of 
spraying between electrospinning and electrospraying, as well as the stability of the spray. A 
viscosity too high can lead to blockage or impede the flow of the formulation within the syringe 
causing no spray to occur (Ardila et al, 2018).  
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4.4.1.2 Surface Tension 
Surface tension results for all formulations F1-F14, are displayed in Table 4.2. For 
electrospraying to occur, atomisation must occur, this is when the electrical field applied 
overcomes the surface tension of the formulation, moreover, the cone jet breaks into small 
charged droplets by the electrostatic forces. The values for the surface tension remained low 
for all formulations F1 to F14, and hence it can be determined that it had no significant effect 
on the type of spray or morphology of particles. A lower surface tension of liquid can allow 
the flow rate to be reduced therefore yield smaller particles, however reducing the surface 
tension too low has its pit falls, as it prevents a stable cone from forming (Marin et al, 2012).  
 
4.4.1.3 Electrical Conductivity 
A sizeable difference in electrical conductivity values of the two vehicles is observed in Table 
4.2, with acetone being highly conductive, many more times more conductive than DCM 
(Jahangir et al, 2017). All formulation utilised in the EHDA system must be electrically 
conductive as the main element of EHDA is the use of an electric field. The electrical 
conductivity of the formulations varied; overall the formulations which contained acetone were 
more electrically conductive and further increased with the addition of metallic nanoparticles, 
whose electrical conductivity increases with a decrease in particle size (Yuliza et al, 2014). F7 
contains copper nanoparticles which had the smallest average in particle size when compared 
to other metallic nanoparticles synthesised and thus the result correlates with the literature. F4 
and F5 contain metallic nanoparticles of a larger particle size and it reflects in electrical 
conductivity values when compared to F7. Similar patterns are observed for formulations F10 
to F14, at lower overall electrical conductivity values. Electrical conductivity influences the 
particle size in electrospraying; moreover, a stable spray is dependent on the electrical 
conductivity, formulations with a higher electrical conductivity lead to the production of more 
uniform particles. (Ardila et al, 2018) (Faraji et al, 2017).  
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Table 4. 2: Table of characterisation displaying values for viscosity (mPa.s), surface tension (γ) and 
electrical conductivity (µs/cm) of solvents DCM and Acetone, and all formulations F1-F14. All 
experiments performed in triplicate. 
Material Viscosity (mPa.s)  Surface Tension (γ) Electrical Conductivity 
(µs/cm) 
ACETONE 0.35 ±0.03 0.041 ±0.020 1.48 ±0.05 
PLGA+ACETONE 
(F1) 
0.51 ±0.02 0.037 ±0.003 4.71 ±0.01 
PLGA+ACETONE+
AMX (F2) 
0.67 ±0.02 0.042 ±0.002 10.63 ±0.77 
PLGA+ACETONE+
AMX+ AGNP (F3) 
1.41 ±0.07 0.024 ±0.002 54.71 ±0.74 
PLGA+ACETONE+
AMX+AGNW (F4) 
1.76 ±0.10 0.044 ±0.002 61.41 ±0.78 
PLGA+ACETONE+
AMX+AGP (F5) 
1.62 ±0.15 0.055 ±0.005 48.93 ±0.75 
PLGA+ACETONE+
AMX+AUNP (F6) 
1.16 ±0.01 0.041 ±0.002 6.71 ±0.12 
PLGA+ACETONE+
AMX+ CUNP (F7) 
1.31 ±0.02 0.038 ±0.004 84.01 ±1.47 
DCM 0.41 ±0.01 0.015 ±0.002 0.13 ±0.02 
PLGA+DCM (F8) 0.64 ±0.02 0.038 ±0.003 7.97 ±0.05 
PLGA+DCM+AMX 
(F9) 
1.54 ±0.07 0.022 ±0.001 2.97 ±0.03 
PLGA+DCM+AMX+
AGNP (F10) 
2.47 ±0.03 0.043 ±0.002 0.62 ±0.02 
PLGA+DCM+AMX+
AGNW (F11) 
2.85 ±0.06 0.037 ±0.002 1.59 ±0.05 
PLGA+DCM+AMX+
AGP (F12) 
2.13 ±0.02 0.034 ±0.002 1.77 ±0.07 
PLGA+DCM+AMX+
AUNP (F13) 
1.95 ±0.04 0.029 ±0.002 3.94 ±0.11 
PLGA+DCM+AMX+
CUNP (F14) 
1.66 ±0.02 0.047 ±0.003 13.21 ±0.22 
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4.4.2 Images of solution and suspension preparations 
The appearance of solutions and suspensions remained the same for both solvents used acetone 
and DCM, for this reason in Figure 4.1 acetone was used as the solvent for all images. As can 
be seen in Figure 4.1A is the polymer solution beaker appears clear, as the polymer is 
dissolved. In 4.1B the appearance of the liquid becomes cloudy, as a suspension with PLGA 
and AMX has now formed, Figure 4.1C with the introduction of AgNPs the suspension 
becomes darker in colour as suspension concentration has increased, concurrent with AgNPs 
present in Figure 3.1Aii, as for 4.1D the colour turns lighter and more light grey similar to the 
AgNW centrifuged image from Figure 3.1Bi, with the AgPs added the formulation turns darker 
grey in correspondence with the colour of centrifuged AgP particles in Figure 3.1Cii, with 
addition of AuNP Figure 4.1F the suspension becomes more red characteristic of the AuNP 
colour, the colour also indicates better dispersity of the AuNP throughout the suspension, and 
with the addition of CuNP the suspension turns yellow to red with brick red nanoparticles 
suspended within the centre of the beaker seen in Figure 4.1G.  
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Figure 4. 1: Digital images of solution and suspension preparations in acetone; A) F1, B) 
F2, C) F3, D) F4, E) F5, F) F6, G) F7. 
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4.4.3 Jetting modes 
Figure 4.2A shows the formation of a droplet at the end of the capillary needle. Figure 4.2B 
is when a low voltage has been applied and the jet is in dripping mode. Figure 4.2C shows the 
formation of a Taylor cone, the jetting is stable and particles will be collected, this is achieved 
when all parameters and conditions related to the liquid characteristics and the relationship 
between voltage and flow rate are favourable. However, with further increase in voltage or the 
optimum altering, the spray will become unstable (as seen in Figure 4.2D)  
 
 
 
 
Figure 4. 2: Digital images of jetting modes through electrospraying. (A) initial droplet with no voltage 
applied, (B) dripping mode, (C) stable jetting mode, (D) unstable jetting mode. 
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4.4.4 Jetting maps 
The type of jetting mode created through the EHDA system is determined by the way in which 
the liquid formulation leaves the capillary needle. Different combinations of parameters have 
a paramount effect on the type of spray and material collected (i.e. particles or fibers). Upon 
setting up the formulation in the EHDA system, liquid is emitted from the capillary needle in 
the ‘dripping mode’ (Figure 4.2A). Upon applying electrostatic forces to the dripping mode, a 
Taylor cone arises to provide a stable spray. 
To give rise to a stable Taylor cone, conditions have to be at an optimum, this relates to the 
relationship between the voltage and flow rate. When conditions are at an optimum you enter 
into ‘stable jetting mode’. However, if you were to increase the flow rate further past this point, 
the spray enters into ‘unstable jetting mode’ as the formulation is flowing faster through the 
system, and therefore insufficient voltage is applied to the system preventing a stable cone from 
forming and non-uniform particles are produced. Increasing the voltage beyond this point can 
cause a more unstable spray, however voltage should not be increased beyond 20 kV for safety 
reasons.    
Jetting mode maps for each formulation were plotted to determine the ideal conditions for 
‘stable jetting mode’ and the creation of the Taylor cone Figure 4.3. Each formulation was 
synthesised and tried through the EHDA system; voltage values and flow rates were varied to 
find the ideal conditions for stable jetting. Each formulation has to be assessed individually due 
to the differences in solvents, insolubility of AMX, as well as type of metallic nanoparticles 
added, as differing shapes led to differing viscosity and electrical conductivity values.  
The flow rates used ranged from 15 to 40 µL/min, below 15 µL/min all the formulations were 
in dripping mode regardless of voltage applied. The voltage applied ranged from 10-17 kV, as 
this was sufficient for a stable spray; any higher led to an unstable spray in correlation with the 
flow rate used. As well as this, another important parameter was the working distance between 
the capillary needle and the collector plate, a distance too high meant a percentage of the 
created particles are lost and are not landing on the collector plate; a distance too short prevents 
the solvents from evaporating sufficiently. Moreover, the morphology of particles can change 
depending on distance used. Upon experimental work alongside the jetting mode maps, it was 
determined that 9 cm is the ideal distance to use between the capillary needle and the collector 
plate.      
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Figure 4. 3: Jetting maps of electrospraying process to show the relationship between flow rate and 
applied voltage, at which corresponding value of each parameter leads to stable or unstable jetting for 
all formulations F1-F14.  
F8 F9 
F10 F11 
F12 F13 
F14 
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The mode maps for formulations from F1-F7, overall showed larger zones of stable jetting, 
which is attributed to the use of acetone, when characterised it shows high electrical 
conductivity therefore leading to easier spray. The suspensions F3-F7 and F10-F14 were a lot 
harder to spray, as the metallic nanoparticles sedimented to the bottom of the syringe due to 
difference in densities, so re-suspending the particles was important and had to be carried out 
regularly to ensure uniform spray of all particles present. Individually it was found that 
formulation F6 formed a stable cone quickly and held a stable uniform spray, this may be due 
to the electrical conductivity or viscosity, but more so with how well the AuNP particles 
dispersed within the formulation during synthesis as observed in Figure 4.1F. For formulations 
F8-F14 the spraying was a lot harder, stable jetting zones were a lot smaller, this is relative to 
the poor electrical conductivity value of DCM and the slightly higher viscosity. Furthermore, 
the differences between sprays of formulations can be analysed through the SEM images, as 
stability of spray effects morphology and size of particles. For formulations F4 and F11 which 
displayed the highest viscosity, it can be noted the zones of stable jetting are smaller in 
comparison to other formulations using metallic nanoparticles.   
 
 
 
 
 
 
 
 
 
 
 
114 
 
4.4.5 SEM 
Formulations synthesised were then sprayed, using optimum flow rate and voltage as shown in 
the mode maps above, the particle size and morphology of samples collected was then analysed 
using SEM. 
The SEM images of the electrosprayed formulations, are shown in Figure 4.4 at both low and 
high magnification and at different points along the same sample. One issue related to 
magnification was the electron beam, at high magnifications particles would break up and 
deform due to intensity of the electron beam, this was a common theme for most of the samples 
using DCM as the solvent, moreover some of the metallic formulations would be disrupted at 
higher magnifications, this may be due to the charge these particles carry already.  
Figure 4.4Ai shows the production of PLGA particles in acetone. The particles are large in 
size, show a uniform donut shape and correlate to images of PLGA found in literature 
(Parhizkar et al, 2017). Particles exhibit a collapsed porous structure due to rapid evaporation 
of solvent (Ahmad et al, 2008). The size distribution histogram shows the majority of particles 
were 3-4 micron in size, the average particle size was 3.3 micron. (Bock et al, 2011), has shown 
that morphology of particles sprayed at 5 % w/v is flat and donut shaped, for more spherical 
particles a higher concentration of around 9-10 % w/v is required. Furthermore, flat shaped 
particles with irregular morphologies also form due to incomplete solvent evaporation, this 
occurs more often with polymers used at low concentrations as solvent content is higher. As 
for Figure 4.4Bi spherical particles of polymer in DCM, particles have similar morphologies 
and appear spherical, corresponding to similar images observed by (Nath et al, 2013). The 
particle size varies between 2.5 to 6 microns, with an average particle size of 3.4 micron.  
Particles observed in Figures 4.4 Ci and Cii are for the drug AMX electrosprayed in solvents 
DCM and acetone respectively, from observation particles appear brighter and more charged, 
as oppose to polymer particles, this may be due to the increased crystallinity of the drug 
particles. The particles appear monodispersed and spherical in shape, particle size varies 
between 200-400 nm, with an average particle size of 236 nm.  
Figures 4.4Di and Ei are of PLGA and AMX electrosprayed in both acetone and DCM 
respectively, the drug (AMX) was insoluble in both solvents used, so images may show AMX 
particles embedded upon PLGA, or complete encapsulation of AMX. Figure 4.4Di shows 
particles with a smaller size range from 1.2-2 microns, with an average particle size of 1.6 
micron, this may be due to the addition of excipients to the formulation, as incorporating more 
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excipients leads to an overall particle size reduction (Prabhakaran et al, 2015). (Kumari et al, 
2010) explained encapsulation by biodegradable materials occurs through entrapment of drug 
within the polymeric matrix, or adsorption onto the surface of the polymer. This is observed in 
Figure 4.4Ei were smaller drug particles can be seen embedded on to the polymeric matrix. 
As for Figure 4.4Di it is assumed particles have been encapsulated as particle size has reduced 
and particles appear more charged. Smaller fibres can also be observed in Figure 4.4Di this 
may be due to the increased viscosity as a suspension has formed. The particle size in Figure 
4.4Ei is a recurring theme throughout the SEM images for all formulations F8-F14 as these 
contain the solvent DCM, larger particles are observed with no clear morphology, this may be 
due to the difficulty of spraying a suspension using DCM as the vehicle, as electrical 
conductivity is lower and viscosity higher. This also may be attributed to the incomplete solvent 
evaporation.  
EDS analysis was introduced, seen in Figures 4.4Diii and Eiii, these samples contained no 
metallic nanoparticles which is shown in the related EDS spectra, the reason for this was to 
compare and confirm the presence of metallic nanoparticles in the following EDS spectra to 
come. Moreover, for Figure 4.4Ei the solvent used DCM which is made up of two chlorine 
groups, Cl groups are present in Figure 4.4Eiii.  
Figures 4.4Fi and Fii, are high and low magnification images of F3, the particles again appear 
donut shaped, some appear more spherical. The particle size ranges from 800 nm to 2 microns, 
with an average particle size of 1.3 micron. Some of the particles appear charged this may be 
due to drug encapsulation or metallic nanoparticles. The presence of metallic nanoparticles 
runs in tandem with an increase in electrical conductivity of the suspension Table 4.2, allowing 
for easier spray, which may be responsible for the better morphology of the particles and more 
uniform size distribution observed, this may also lead to more successful encapsulation of drug 
and metal present. EDS Figure 4.4 Fiii confirms the presence of silver within the sample, 
confirming successful electrospraying of the suspension formulated. Detecting the presence of 
metallic nanoparticles through SEM images has proven to be difficult, hence why EDS is 
utilised as the spectra generated is more of an indicator than the SEM images themselves, as 
(Almajhdi et al, 2013) electrosprun PLGA and AgNP, but the metallic particles upon the 
surface of the fibres were only observed through TEM images. (Abdelrazek Khalil, 2013) also 
show that confirmation of silver presence occurs through EDS, to visually see the metallic 
particles TEM analysis is required.  
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For the formulation F10 SEM images in Figure 4.4Gi and Gii, display smaller particles settled 
upon larger particles, these smaller particles may be drug particles, or metallic nanoparticles 
embedded upon the surface of the polymeric matrix, (Chaubey et al, 2014) displayed TEM 
images of interactions between PLGA and AgNPs, in this case AgNPs were deposited upon 
the surface of the polymer, this indicated dispersity of the AgNPs throughout the polymeric 
matrix. The larger spherical particles which appear charged upon the surface of the polymer 
may be AMX particles or the metallic nanoparticles, due to them appearing charged. EDS 
analysis confirms the presence of silver as well as chlorine.  The size of particles ranges from 
1.2-2.2 micron with the larger sized particles being the polymeric composite particles. Average 
particle size was shown as 1.7 micron. The morphology of the larger particles again may be 
due to the use of DCM which as mentioned has its drawbacks including incomplete 
evaporation.  
For the formulation F4 the key was to spray the AgNWs alongside the polymeric composites, 
as is shown in Figure 4.4Hi and Hii both images were at low magnifications, the AgNWs were 
successfully sprayed, the morphology and size varies from the AgNWs shown in Figure 3.1Bi, 
the AgNWs appear more 3D like and layered, this may be due to the conditions applied during 
synthesis of suspension or the electrospraying process, from Figure 4.4Hi it can be seen that 
polymeric composite particles have deposited upon the AgNW, and some embedded within, 
there also appears to be coating of the AgNW by the polymeric composites. The related EDS 
spectra confirms the presence of silver, which also confirms successful electrospraying of the 
AgNW. Size distribution here was carried out for the particles and nanowire separately, the 
particle size varies between 800 nm to 2.4 micron, the nanowire width is recorded at around 
4.1 micron.  
For the formulation F11 in Figure Ii AgNWs are formulated here using DCM as the vehicle, 
Figure 4.4Ii and Iii show the morphologies of sprayed particles as well as the AgNW, here 
results are more interesting, the AgNW seem to be present embedded within the polymeric 
matrix, as no clear present nanowire is present, instead particles observed exhibit an elongated 
morphology as oppose to spherical, and the topography upon the surface of these particles 
appears to be coated with polymeric composite particles. (Homan et al, 2011) synthesised 
colloidal star shaped AgNP upon PLGA via a facile two-step reduction process, SEM images 
showed the star shape of silver-polymer composites, where polymeric particles were deposited 
and coated the star shaped AgNPs particles.  
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As for Figure 4.4Iii the nanowire is clearly present, from the image polymeric composite 
particles can be seen wrapping around the nanowire, indicating encapsulation of the nanowire 
is possible, polymer drug particles can be seen surrounding the nanowire, smaller particles can 
be seen deposited upon the larger polymeric particles this may be the drug particles embedded 
onto the polymer. EDS analysis again confirms the presence of silver meaning successful 
electrospraying of the AgNW, and as F11 was formulated with DCM as the vehicle EDS 
spectrum displays the presence of chlorine within the sample. The particle size of the particles 
was taken as well as the width of the elongated microparticles present. The size of particles 
was roughly between 1-3 micron but the width of the elongated particles was higher between 
4.5-7 micron, this may indicate encapsulation of metal within polymeric composite.  
Figure 4.4Ji and Jii for F5 taken at similar magnifications, show highly charged particles, this 
may be due to the encapsulation of drug and metallic nanoparticles, or due to the intensity of 
the electron beam. The presence of smaller charged particles upon the polymeric particles is 
again evidence of drug and metallic nanoparticles being embedded within the polymeric 
matrix, which also indicates successful electrospraying of the suspension. The particles appear 
to have similar spherical morphologies and a narrow size distribution, and in correlation with 
previous images using acetone as the vehicle having the donut or ring-shaped appearance. The 
particle size varies from 1.2-2 micron, with an average particle size of 1.6 micron. EDS 
spectrum confirms the presence of AgNP.   
Formulation F12 displayed in Figures 4.4Ki and Kii are at different magnifications, the SEM 
images show polymeric composite particles of varying shapes and sizes. Charged particles are 
present which again may validate the presence of the drug and silver particles, which is further 
confirmed by the EDS analysis results as well as the presence of chlorine. The particle size 
ranges from 600nm to 2.2 micron, with an average particle size of 1.3 micron. A similar average 
particle size to from Figure 4.4Kii particles with more defined edges can be seen, these may 
be the polygonal shaped nanoparticles present within the sample, or encapsulation of these 
within the polymeric matrix. However, to have full confirmation of AgNPs presence within all 
samples visually then TEM images are required. 
Figure 4.4Li and Lii for formulation F6 show uniform spherical particles monodispersed, the 
SEM image shows uniform spherical particles, which also exhibit charge which may indicate 
the presence of drug and metallic nanoparticles. The size range of particles varied between 400 
nm to 1.1 micron, the particles appear smaller and more uniform which may be due to the 
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uniform polydispersity of particles observed in Figure 4.1F.  (Alkilany et al, 2018) showed it 
is possible to completely encapsulate AuNP within the PLGA matrix, also described PLGA as 
being one of the few biodegradable polymers capable of encapsulating metallic material. 
Moreover, (McKeon-Fischer and Freeman, 2010) displayed SEM images and explained 
detection of metallic particles was through spotting brighter spots in SEM images. EDS 
analysis confirms the presence of gold within the sample. 
Figure 4.4Mi for F13 displays larger particles with spherical morphologies, upon which many 
smaller particles have deposited, particles appear charged, a lot of fibres are also visible 
indicating a highly viscous formulation. When comparing the morphologies with F6, particle 
size is a lot bigger, no uniform dispersity of nanoparticles, instead particle size ranges from 1-
2 micron. The reasons for the differences in morphologies is associated with choice of solvent, 
as the AuNPs dispersed well in formulation preparation seen in Figure 4.1F, this led to very 
uniform spherical particles in Figure 4.4Li, however this was not the case here. EDS analysis 
confirms the presence of AuNPs and chlorine. (Corbierre et al, 2001) synthesised polymer 
stabilised gold nanoparticles and showed complete dispersion of AuNP throughout the polymer 
matrix.  
Figure 4.4Ni and Nii for F7, particles appear flatter, may be due to insufficient solvent 
evaporation, more spherical with similar morphologies. This may be due to the high electrical 
conductivity this formulation demonstrates. EDS spectra confirms the presence of copper. 
Particle size varies between 1.2-2.2 micron with an average particle size of 1.7 micron. 
(Prabhakaran et al, 2015) showed at higher concentrations of polymer around 10% w/v in DCM 
the particles appear more spherical and uniform, with a smaller size distribution, however in 
this case this was not possible as the formulation would become too viscous to spray.  
The corresponding formulation F14, displayed in Figure 4.4Oi and Oii, display smaller sized 
particles deposited upon larger particles, the smaller particles appear embedded within the 
polymeric matrix and appear charged, seen better in Oii, in correlation with previous 
formulations using DCM as the vehicle the morphology of the larger particles is hard to make 
out, therefore size distribution was carried out on the spherical particles present. Size range of 
particles was between 300-700 nm, with an average particle size of 420 nm. EDS analysis 
confirms the presence of copper and chlorine. (Kampuri and Dolui, 2010) synthesised copper-
polystyrene nanocomposite particles and showed complete dispersion within the polymeric 
matrix. 
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Figure 4. 4: SEM ((i) low magnifiaction); ((ii) images at higher or equal magnifications); (iii) EDS 
analysis; (iv) particles size distribution histogram using (ii) SEM images of all formulations F1-14. (A) 
F1; (B) F8; (C)AMX in DCM and acetone; (D)F2; (E)F9; (F)F3; (G)F10; (H)F4; (I)F11; (J)F5; 
(K)F12; (L)F6; (M)F13; (N)F7; (O) F14. 
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4.4.6 ATR-FTIR 
The FTIR spectra for PLGA in Figure 4.5 show sharp peaks at 1088 cm-1and 1168 cm-1 which 
correspond to a C-O stretch, a sharp peak at 1750 cm-1 for a C=O stretch, further smaller peaks 
can be seen between 2949-2963 cm-1, relating to CH-CH2-CH3 stretches (Nath et al, 2013, 
D’Avila Carvalho Erbetta, 2012). The FTIR spectra of AMX in Figure 4.5 shows sharp peaks 
at 1519 cm-1 and 1686 cm-1 assigned to the two amide bonds of AMX, peaks at 1022 cm-1 1585 
cm-1 and 1766 cm-1 can be attributed to the stretching vibration of C-S group, absorption band 
of benzene ring and the vibration of a carboxyl group respectively (Zheng et al, 2013, 
Abdelmalek et al, 2018).    
Figures 4.6 and 4.7 show all spectrums for the final formulations, F1-F7 utilising the vehicle 
acetone and F8-F14 synthesised with DCM as the vehicle. F1 and F8 are for the polymer in 
solvent formulations, both spectra have peaks similar to the spectrum described in Figure 4.5 
for the PLGA material, sharp peaks at 1080 cm-1 1158 cm-1 and 1746 cm-1 show similar 
intensity. The difference between F1 and F8 is described through a sharp peak at 730 cm-1, this 
indicates the presence of a C-CL bond (Deepashree et al, 2013), bonds present in the molecular 
formula of DCM, furthermore, this is a recurring theme for all formulations F8-F14, with all 
spectra showing sharp peaks at around 730 cm-1. The presence of this peak indicates the solvent 
has not fully evaporated, and may be one of the reasons as described above, for the SEM images 
to not have clear, defined morphologies. 
Results differ however for F2 and F9 with the inclusion of the antibacterial agent AMX, peaks 
can be seen at similar positions but with less intensity. For F2, some variations are present; 
there is no peak at 563 cm-1 and between 705 cm-1-738 cm-1, the small broad peak at 901 cm-1 
is no longer present, there is no longer a dip at around 936 cm-1 and the sharp drop from 992 
cm-1 to 1042 cm-1 is not so prominent. The decrease in peak intensities indicates interactions 
between components within the sample. Moreover, at 1746 cm-1 and 3000 cm-1 the peaks seem 
to have become flatter and wider indicating hydrogen bond enhancement (Sun et al, 2015).  
Spectrums for F3 and F10, show peaks at similar positions with similar intensities, peaks 
appear with more intensity at 1079 cm-1, 1158 cm-1 and 1743 cm-1, moreover the peak at 2949 
cm-1 appears broader and more defined. These spectra follow similarly to the spectra of F6 and 
F13 respectively, this may be due to similarity in synthesis of the metallic nanoparticles 
included in these formulations.  
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In comparison with F4 and F5, peaks appear with less intensity, perhaps indicating more 
interactions between compounds present, moreover, peaks appear at 1642 cm-1 and at 1539 cm-
1, representing a C-O stretch and C=C stretch respectively. These peaks are only observed in 
F4 and F5 as well as F11 and F12. These formulations all contain shaped AgNP synthesised 
through a similar polyol method.  As for F7 and F14 spectra follow a similar pattern to that of 
PLGA, with no real differences, aside from intensity of peaks. Zhang et al, 2017, synthesised 
AgNW-PVA nanofibers; results suggest that at increasing concentrations of nanowires within 
the fibers did not change ATR-FTIR spectra significantly. 
The spectra overall from F1-F14, show peak positions at similar positions, in comparison to 
raw PLGA with the only major difference being in peak intensities, and the presence of C-CL 
peak in formulations F8-F14, (Abdelrazek Khalil, 2013) electrospun PLGA with AgNP, plotted 
FTIR spectra showed no real difference between raw PLGA and PLGA with silver 
formulations, with the only difference in transmittance intensity. Furthermore (Shams et al, 
2018), electrosprayed drug encapsulated microparticles, FTIR peaks for the synthesised 
formulations, showed spectrums similar to the raw polymer used, indicating drug polymer 
interactions.  
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Figure 4. 5: ATR-FTIR spectra of raw materials PLGA and AMX. 
 
 
Figure 4. 6: ATR-FTIR spectra of formulation F1-F7 using the solvent acetone. 
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Figure 4. 7: ATR-FTIR spectra of F8-F14 using the solvent DCM. 
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4.4.7 DSC 
DSC thermograms of all formulations including the raw materials are presented. Thermal 
stability analysis is important to determine if the electrospraying technique has an effect on the 
physical stability of the actives used as well as further confirming interactions between the drug 
and polymer. Figure 4.8 displays thermograms for raw materials, AMX shows a melting peak 
at 160 °C, with PLGA showing a glass transition temperature at 56.5 °C (Yandrapu and 
Kompella, 2013); the polymer being amorphous doesn’t exhibit a melting point. For the 
synthesised formulations F2 and F9 in Figure 4.9, there is no endothermic peak at 160 °C 
suggesting incorporation of the drug within the polymeric matrix, hence crystallinity of the 
drug has been reduced to a more amorphous state within the polymeric matrix (Sun et al, 2015). 
Moreover, when comparing the glass transition peak size, between F1 and F2 as well as F8 and 
F9, peaks decrease in intensity for F2 and F9, (Abdelrazek Khalil, 2013) reported the reason 
for this may be due to increased interactions between polymer chains and drug particles. 
Furthermore, (El-Houssiny et al, 2016) described the interactions between drug and polymer 
through DSC thermograms, the endothermic peak for the drug at 218.65 °C indicating 
crystallinity, was no longer present in the diffractogram for polymeric microspheres containing 
the crystalline drug material, again suggesting entrapment or dispersion of drug material within 
the polymeric matrix.   
As for formulations F3-F7 in Figure 4.10, the glass transition temperature for PLGA is 
observed, no sharp melting peak at around 160 °C is evident, indicating the drug is now 
embedded or encapsulated within the polymeric matrix, however the thermograms can be seen 
to continue rising beyond 200 °C, which is very different to formulations without metallic 
nanoparticles in Figure 4.9, therefore this may be due to the metals present within the 
formulation. From literature it has been established that the smaller the size of metallic 
nanoparticles, the lower the melting point; for silver particles nano in size the melting point is 
around 450 °C (Asoro et al, 2009, Luo et al, 2008). (Abdelrazek Khalil, 2013) published 
thermograms, of the raw polymer PLGA, electrospun PLGA and electrospun PLGA 
incorporated with AgNP, the data followed similar endothermic peak patterns to that of the raw 
PLGA, displaying the the capability of PLGA to encapsulate. DSC thermograms published by 
(Shams et al, 2018) showed similar results, for drug and polymer concentrations, to confirm 
interactions between drug and polymer used. Thermograms for F3-F7 and F10-F14 were 
similar, due to the concentration of materials used to make up the formulation being the same, 
with a higher concentration of polymer compared to the other excipients seen in Table 4.1. 
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The differences between solvents here are negligible, due to rapid evaporation at such high 
temperatures. The presence of metallic nanoparticles maybe the reason for the continued rise 
in the thermograms when compared to raw PLGA, successful encapsulation of drug within the 
polymeric matrix was shown as the melting peak for AMX at around 160°C was no longer 
present in the formulations with AMX present. 
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Figure 4. 8: DSC thermograms of raw material. Figure 4. 9: DSC thermograms of formulations without 
metallic nanoparticles.  
Figure 4. 11: DSC thermograms of formulations containing 
metallic nanoparticles in acetone. 
Figure 4. 10: DSC thermograms of formulations 
containing metallic nanoparticles in DCM. 
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4.4.8 TGA 
Figure 4.12 shows the TGA thermograms for the raw materials. The thermogram for PLGA 
shows a sharp endothermic weight loss peak from 242.4 °C to 412.6 °C between which around 
96.1 % of weight is lost, the thermogram follows those found in previous literature (Silva et al, 
2015). As for AMX two different phases of endothermic weight loss can be observed, the first 
begins at temperatures of 86.7 °C to 122.9 °C, may be due to water loss, where weight loss is 
around 10 %, the second phase is from 182.6 °C to 600 °C were the percentage weight lost is 
around 58 % attributed to degradation of material (Roy Biswas et al, 2014).  
Figures 4.13 and 4.14 presenting the weight loss of all formulations F1-F14, display similar 
thermograms to that of PLGA in Figure 4.12, encapsulation of drug material within polymeric 
matrix has been successful through presence of a single endothermic weight loss peak. F1 
shows a very similar weight loss thermogram to that of pure PLGA, whereas the following 
formulations to F7, start weight loss at slightly lower temperatures. This may be due to more 
interactions between polymer and excipients, as more drug particles may be present within the 
polymeric matrix. Moreover, F8 and F9, show more weight loss (%), when compared to the 
AMX weight loss thermogram, this also suggests the drug particles have become dispersed 
within the polymeric matrix. As AMX reduced to 29% weight loss overall, after reaching the 
maximum temperature, however all formulations fall below this value, similar to that of PLGA, 
again demonstrating encapsulation and dispersity of AMX within PLGA.  
TGA data published by (Gomathi et al, 2014) showed curves for the raw polymer, drug alone 
and drug loaded polymeric particles, the characteristic endothermic peak for the drug particles 
was not observed when analysing the drug loaded polymeric particles, which confirmed the 
amorphous nature of the composite sample. Broadening of the exothermic peak area also 
indicates loading of drug in polymer, overall this increases the amorphous nature of the 
polymeric composites which is important as it increases the efficiency of drug delivery and 
gives better stability.   
The presence of metallic nanoparticles, may have slightly varied the thermograms, as in Figure 
4.13, formulations F4, F5 and F7 display slightly higher weight loss (%) plateaus when 
compared to PLGA alone. A similar trend is observed for F12 in Figure 4.13, both F5 and F12 
contain the AgPs, which may have had an effect on the final peak position for weight loss.  
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Figure 4. 12: TGA thermograms showing weight loss of raw materials AMX and PLGA 
 
 
  
 
 
 
 
 
 
 
 
Figure 4. 13: TGA thermograms showing weight loss of formulations F1-F7 in the solvent acetone. 
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Figure 4. 14: TGA thermograms showing weight loss of formulations F8-F14 in the solvent DCM. 
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4.4.9 X-ray diffraction (XRD) 
XRD spectra help us understand the properties of the raw materials (PLGA and AMX) as well 
as the interactions between these materials after electrospraying through diffractograms.  
Figure 4.15 shows the diffractograms of the raw materials; pure AMX showed various intense 
peaks characteristic of the drug as it is crystalline (Awasthi et al, 2011), as for the polymer it 
is amorphous as previously known but confirmed through lack of peaks (Russo et al, 2016).  
The absence of sharp peaks for the diffractograms of formulations F2-F7 and F9-F14 in 
Figures 4.16 and 4.17 at the same 2θ values indicates an amorphous dispersion of the drug 
throughout the polymer. Vedha Hari et al, 2015, published diffractograms, of raw drug which 
showed crystallinity through numerous peaks, once introduced into the polymeric matrix peaks 
disappeared as drug has now become more amorphous, through reduction in particle size, this 
can lead to better dissolution and bioavailability in the body. Further evidence of drug polymer 
interactions shown through XRD diffractograms is published by (Vedha Hari et al, 2018) as 
peaks for polymer composite particles were no longer present compared to raw drug material.  
Further evidence of drug polymer interactions is seen through intensity of broad peaks, 
formulations F1 and F8 display broad peaks with highest intensity between 2θ values of 15 and 
22, when compared to F2 and F9 the intensity of the broad peak is lower, indicating interaction 
of the drug and polymer increasing the amorphous nature of the composites.  
The introduction of metallic nanoparticles which themselves are highly crystalline had no real 
impact on the diffractograms, indicating metallic particles may be dispersed throughout the 
polymeric matrix. Although slight variations are observed, diffractogram for F3 in Figure 4.16 
shows a slight peak rise at 2θ of 38.78 (111), this is correlated with 2θ peak values of raw 
AgNPs in Figure 3.7, which may indicate complete encapsulation of metallic nanoparticles 
may not have been achieved. Similar differences can be observed for all formulations F3-F7 
and F10-F14 as these composites contain metallic nanoparticles, which may indicate presence 
of metallic nanoparticles within the sample. Alexander S Pozdnyakov et al, 2016, synthesised 
polymeric composites containing silver nanoparticles, upon XRD analysis of the raw polymer 
and composites, small peaks appeared at the 2θ values characteristic of silver nanoparticles, at 
planes (111) and (200). Xiaoyi Xu et al, 2006, synthesised PLGA/AgNP composite nanofibers 
through electrospinning, XRD data showed at very high concentrations of AgNPs (32%), 2θ 
values characteristic of silver nanoparticles appear at all planes (111), (200), (220) and (300). 
At lower concentrations 8%, one of these peaks appear in the (111) plane similar to the peak 
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observed in Figure 4.16, the concentration of metallic nanoparticles used for formulations F3-
F7 and F9-F14 was 5% of the polymer, hence why for some formulations small crystalline 
peaks did not appear and were not as sharp as those reported in literature.  
Previous literature published supports results displayed, reduction in intensity of drug peaks 
and absence of sharp peaks, indicate interactions between drug and polymeric particles (Sun et 
al, 2015).  
 
 
 
Figure 4. 15: XRD diffractograms of raw materials PLGA and AMX 
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Figure 4. 16: XRD diffractograms of formulations F1-F7 in the solvent acetone. 
 
Figure 4. 17:  XRD diffractograms of formulations F8-F14 in the solvent DCM. 
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4.4.10 Zeta potential values 
Zeta potential (ζ) values give an indication of the surface charge of particles. The significance 
of zeta potential is that its value can be related to the short- and long-term stability of 
suspensions. Suspensions with high zeta potential (negative or positive) are electrically 
stabilized while suspensions with low zeta potentials tend to coagulate or flocculate, possibly 
leading to poor physical stability. In general, when the zeta potential of a suspension is high, 
the repulsive forces exceed the attractive forces, resulting in a relatively stable system. 
For formulation F1 a zeta potential average value of -61.12 mV indicates excellent colloidal 
stability within suspensions, when compared to F8 with an average value of -18.90 mV the 
difference is quite high indicating the use of solvent may have had an effect on zeta potential 
values. The factors affecting zeta potential include the pH of the medium, ionic strength, the 
concentration of any additives, and temperature. The pH was maintained at 7.4 at the 
temperature set at 25 °C, the ionic strength may vary depending on the formulation analysed.  
Therefore, differences in average zeta values may be due to concentration or nature of 
additives. The general trend observed shows the average zeta values for formulations F1-F7 
were higher than F8-F14, this may be due to the use of solvent. Moreover, decrease in zeta 
potential values is observed with increase in excipients within the suspension, leading to lesser 
stability of particles. The difference in zeta potential values with addition of excipients may 
arise from adsorption of the added drug and metallic nanoparticles to the surface of the polymer 
resulting in increased thickness of the diffuse double layer and hence lowering zeta potential 
(Ali, 2014). Increase in concentration of suspension can lead to reduction of zeta potential 
values, as the metallic particles added vary in size and morphology this can lead to differences 
in suspension concentration therefore effecting zeta potential values (Giacomo Fontana et al, 
2001).   
F13 with an average zeta potential value of -2.72 mV indicates reduced stability, this may be 
due to the lesser zeta potential value of pure AuNPs, as shown in Table 3.4, due to increased 
agglomeration of synthesised nano-particles. F4 and F11 showed lower zeta potential values 
when compared to the other formulations containing silver particles, previous data has shown 
electrospraying of this formulation was difficult due to higher viscosity, this may have led to a 
reduced zeta potential value indicating lesser colloidal suspension stability. 
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Table 4. 3: Zeta potential values of F1.   Table 4. 4: Zeta potential values of F2. 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F1 -51.41 -4.02 3.60E-02 
F1 -64.09 -5.01 1.96E-02 
F1 -67.87 -5.30 1.87E-02 
Mean:   -61.12 -4.78 2.48E-02 
Std Err:   4.98 0.39 5.62E-03 
Std Dev:   8.62 0.67 9.73E-03 
 
Table 4. 5: Zeta potential values of F3.    Table 4. 6: Zeta potential values of F4. 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/c
m) 
RMS Residual 
F3 -35.03 -2.74 6.88E-02 
F3 -43.15 -3.37 1.54E-02 
F3 -43.68 -3.41 1.75E-02 
Mean:   -40.62 -3.17 3.39E-02 
Std Err:   2.80 0.22 1.75E-02 
Std Dev:   4.85 0.38 3.03E-02 
 
Table 4. 7: Zeta potential values of F5.    Table 4. 8: Zeta potential values of F6. 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/c
m) 
RMS Residual 
F5 -35.49 -2.77 2.43E-02 
F5 -36.28 -2.84 2.19E-02 
F5 -38.16 -2.98 3.90E-02 
Mean:   -36.65 -2.86 2.84E-02 
Std Err:   0.79 0.06 5.34E-03 
Std Dev:   1.37 0.11 9.24E-03 
 
 
 
 
 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F2 36.85 2.88 5.22E-02 
F2 36.45 2.85 3.08E-02 
F2 40.56 3.17 1.69E-02 
Mean:   37.95 2.97 3.33E-02 
Std Err:   1.31 0.10 1.03E-02 
Std Dev:   2.27 0.18 1.78E-02 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F4 -12.49 -0.98 2.83E-02 
F4 -11.34 -0.89 1.67E-02 
F4 -10.39 -0.81 2.25E-02 
Mean:   -11.41 -0.89 2.25E-02 
Std Err:   0.61 0.05 3.35E-03 
Std Dev:   1.05 0.08 5.81E-03 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F6 -21.22 -1.74 1.93E-02 
F6 -19.73 -1.54 2.07E-02 
F6 -21.62 -1.77 2.22E-02 
Mean:   -20.86 -1.68 2.07E-02 
Std Err:   0.90 0.07 8.16E-04 
Std Dev:   1.57 0.12 1.41E-03 
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Table 4. 9: Zeta potential values of F7.   Table 4. 10: Zeta potential values of F8. 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F7 -22.51 -1.76 2.16E-02 
F7 -17.30 -1.35 3.72E-02 
F7 -23.34 -1.82 1.90E-02 
Mean:   -21.05 -1.64 2.59E-02 
Std Err:   1.89 0.15 5.69E-03 
Std Dev:   3.27 0.26 9.86E-03 
 
Table 4. 11: Zeta potential values of F9.   Table 4. 12: Zeta potential values of F10. 
 
 
Table 4. 13: Zeta potential values of F11.   Table 4. 14: Zeta potential values of F12. 
 
 
 
 
 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F8 -20.54 -1.60 2.57E-02 
F8 -18.95 -1.48 1.49E-02 
F8 -17.23 -1.35 2.61E-02 
Mean:   -18.90 -1.48 2.22E-02 
Std Err:   0.96 0.07 3.65E-03 
Std Dev:   1.65 0.13 6.32E-03 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F9 -18.20 -1.42 2.51E-02 
F9 -16.36 -1.28 1.48E-02 
F9 -18.93 -1.48 2.02E-02 
Mean:   -17.83 -1.39 2.00E-02 
Std Err:   0.76 0.06 2.97E-03 
Std Dev:   1.32 0.10 5.14E-03 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F10 -17.70 -1.38 2.91E-02 
F10 -11.89 -0.93 2.10E-02 
F10 -13.41 -1.05 2.79E-02 
Mean:   -14.33 -1.12 2.60E-02 
Std Err:   1.74 0.14 2.53E-03 
Std Dev:   3.01 0.24 4.39E-03 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F11 -11.34 -0.89 3.44E-02 
F11 -11.66 -0.91 2.63E-02 
F11 -11.56 -0.90 2.04E-02 
Mean:   -11.52 -0.90 2.71E-02 
Std Err:   0.09 0.01 4.06E-03 
Std Dev:   0.16 0.01 7.03E-03 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F12 -14.18 -1.11 2.37E-02 
F12 -12.68 -0.99 2.94E-02 
F12 -11.25 -0.88 6.39E-02 
Mean:   -12.70 -0.99 3.90E-02 
Std Err:   0.84 0.07 1.26E-02 
Std Dev:   1.46 0.11 2.17E-02 
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Table 4. 15: Zeta potential values of F13.   Table 4. 16: Zeta potential values of F14. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F13 -3.67 -0.29 2.03E-02 
F13 -3.24 -0.25 1.56E-02 
F13 -1.24 -0.10 9.96E-03 
Mean:   -2.72 -0.21 1.53E-02 
Std Err:   0.75 0.06 3.00E-03 
Std Dev:   1.30 0.10 5.19E-03 
Sample 
ID 
Zeta 
Potential 
(mV) 
Mobility 
(μ/s)/(V/cm) 
RMS Residual 
F14 -9.46 -0.74 1.80E-02 
F14 -13.05 -1.02 3.91E-02 
F14 -12.51 -0.98 2.46E-02 
Mean:   -11.67 -0.91 2.73E-02 
Std Err:   1.12 0.09 6.23E-03 
Std Dev:   1.93 0.15 1.08E-02 
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4.5 Conclusion 
In this chapter development of micro and nano particles made up of PLGA composites, which 
contained AMX and metallic nanoparticles was attempted through the EHDA process. Results 
obtained show the use of electrospraying to develop these microspheres was successful. SEM 
results displayed particles varying in morphology and size, but the key was to have successfully 
encapsulated the insoluble AMX drug particles. This was observed through presence of small 
charged particles embedded upon polymeric surface and within the matrix, as polymeric 
particles appeared charged themselves. Furthermore, metallic nanoparticles were successfully 
electrosprayed, and were surrounded by polymeric composite particles, as seen in Figures 
4.4Hi and Ii. Here silver nanowires were present submerged in polymeric composite particles. 
Literature did show however TEM analysis would better confirm the presence of metallic 
compounds.  
EDS analysis was also used and confirmed, for each formulation the metallic compound 
present, including the differentiation between the solvent choice DCM and acetone. ATR-FTIR 
in Figures 4.5 to 4.7 was then used to confirm interactions between PLGA and AMX, the 
variations in peak intensities and positions confirmed possible dispersion of AMX within 
PLGA. However, with the addition of metallic nanoparticles the spectrums did not show ample 
variation, this may have been due to the small concentration of metallic nanoparticles present, 
when compared to the concentration of PLGA. This could also be due to the use of EHDA 
process, as data from literature obtained when using the EHDA process to synthesise polymeric 
metallic nanocomposites, there were no variations between FTIR spectrums, aside from 
intensity of peaks. 
Beyond this DSC analysis Figures 4.8-4.11 confirmed the encapsulation of the drug AMX, as 
the endothermic melting peak for AMX no longer appeared on any of the electrosprayed 
formulations. The presence of metallic nanoparticles may have been confirmed through the 
continued rise of the thermograms, as they exhibit melting points above 400 °C. TGA analysis 
Figures 4.12-4.14 further confirmed the encapsulation and dispersion of the drug, AMX 
displayed two characteristic weight loss peaks, however the electrosprayed formulations 
displayed a single weight loss peak at similar temperatures to PLGA. XRD data Figures 4.15-
4.17 was collected to indicate the crystalline or amorphous nature of AMX and PLGA, as well 
as describing the nature of the electrosprayed formulations. As the electrosprayed 
diffractograms now appeared amorphous, AMX had successfully been dispersed throughout 
the polymeric matrix. The presence of metallic nanoparticles did cause slight rises in the 
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diffractograms at the preferred plane of growth for each metallic particle, however this was not 
as clear due to the low concentration of metallic nanoparticles used. Zeta potential data in 
Tables 4.4-4.15 gave an indication of the colloidal stability of the polymeric composites. 
Results showed an increase in number of excipients reduced the overall stability, metallic 
nanoparticles which tend to aggregate also reduced the zeta potential value. This was evident 
for AuNPs, which tend to agglomerate, hence why zeta potential value was much lower when 
compared to the other formulations.  
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Chapter 5 - Drug release kinetics, microbiological testing and cell 
culture studies 
 
5.1 Introduction 
5.1.1 Antibacterial agents 
An antibacterial agent is a chemically enhanced natural substance with the potential to kill 
(bactericidal effect) or slow down the growth or multiplication (bacteriostatic effect) of a 
bacterial organism without affecting the host functions. Almost all of the different antibiotics 
available currently on the market are based on the structure of antibacterial agents naturally 
found in environmental microorganisms; with many of these antibiotics being synthetic 
derivatives of these discovered microorganisms.   
5.1.2 Antibiotic resistance 
Bacterial resistance itself can be acquired or inherent (characteristic of all species of that 
isolate), an example of inherent resistance is the resistance of Pseudomonas aeruginosa to a 
wide range of antibiotics, acquired bacterial resistance is where bacteria gain the genes 
encoding resistance, through a mutation or due to the transfer of genetic material from other 
bacteria. Mutations cause changes to the gene target of the antibiotic, causing it to no longer 
have an effect on the targeted bacteria.  
The overuse and misuse of antibacterial agents has led to the emergence of antibiotic resistant 
genes (ARGs), which further reduce the therapeutic effect of an antimicrobial agent, and 
renders it ineffective. Some examples include the resistance of all gram-positive organisms to 
colistin, and the resistance of Enterobacteriaceae to glycopeptides and linezolid. The rise in 
bacterial resistance is also attributed to the insufficient understanding of the numerous bacteria 
and their antimicrobial susceptibility patterns, for patients with bacterial infections this poses 
a risk, as knowledge of bacteria is deficient, to counter this the overuse and misuse of broad 
spectrum antibacterial occurs.  At present numerous antimicrobial agents are being synthesised 
through use of differing technologies, which offer a substitute to those currently available in 
drug therapy.  
Development of nanotechnology has unlocked many avenues of further research into 
applications of nanoparticles. Increased efficiency and methods of manufacturing nanoparticles 
has also broadened the type of nanoparticles available. One such method is using composite 
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nano/micro particles in the transport of antibiotics. Of the many metallic nanoparticles 
available silver has shown strong antimicrobial and cytotoxic effects on the body, the 
physiochemical properties of silver such as shape, size and concentration can affect toxicity.  
 
5.2 Aims & Objectives 
Upon successful synthesis and characterisation of (nano/micro) polymeric composite particles, 
it was found that formulations containing acetone and DCM had similar results. However, 
formulations F8-F14 (DCM formulations) showed unstable morphology and large particle size 
distribution, in comparison to F1-F7, therefore were excluded from this chapter; furthermore, 
characterisation results from previous chapters showed the difference in solvents were 
negligible hence why F8-F14 were not used. Instead the focus for this chapter was on the effect 
different types of metallic nanoparticles have on drug release and antibacterial efficacy, as well 
as investigating differences in results generated through morphology variation.  
In this chapter, the polymeric composites synthesised in the previous chapter were assessed for 
their drug loading, encapsulation efficiency, drug release data, bacterial efficacy and cell 
viability capabilities. Experimentally for this in-vitro drug release, bacterial disk diffusion tests, 
optical density kinetic reads and MTT assays were carried out.   
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5.3 Materials and methods 
5.3.1 Materials 
Amoxicillin with a potency > 900 µg per mg, phosphate buffer saline (PBS) and DCM were 
used along with full formulations F2-F7. Mueller Hinton Agar grown and sterilised in-house. 
Gram-negative E. coli NCTC 13919 and a gram-positive S. aureus NCTC 12497 were 
purchased from Public Health England (UK). PBS was used as the vehicle for drug release 
kinetics, and also as a control in antibacterial testing. Whatman 1822-047 GF/C glass 
microfiber filters for disc diffusion.  
Lymphoblastoid cells from the TK6 line, normal horse serum used for media with added L-
glutamine, 3- [4, 5dimethylothiazol-2-yl]-2, 5diphenyltetrazolium bromide (MTT) reagent 
with stock concentration of 5 μL/mL, as well as dimethyl sulfoxide (DMSO) were all purchased 
from Sigma-Aldrich. All formulations were tested as well as the individual metallic 
nanoparticles at (AgNP, AgNW, AgP, AuNP and CuNP) 1 mg/mL stock; polymer PLGA and 
antibiotic AMX (P-Ab) at 1 mg/mL stock and metallic drug polymer composites (metal-P-Ab) 
at 1mg/mL. Hydrogen peroxide was used as a positive control, and just the cells as the negative 
control.  
 
5.3.2 Methods 
5.3.2.1 UV-vis and calibration curve 
The UV-vis spectrum of AMX was plotted using a UV-vis spectrophotometer (Evolution 60S 
Thermo Scientific), the curve determines the maximum wavelength, this value was then used 
as the reference to calculate absorbance values.   
For calibration curve of AMX, a stock solution of 5 mg AMX dissolved in fresh PBS at pH 7.4 
was prepared. The stock solution was used to create a calibration curve with concentrations 
ranging from 12.5 µg/mL to 125 µg/mL. 
 
5.3.2.2 Drug content and encapsulation efficiency  
Electrosprayed coatings 10 mg were weighed and dissolved in 1 mL DCM, and 2.5 mL PBS 
was added. The mixture was vortexed at 2500 rpm for 1 minute then centrifuged at 6000 rpm 
for a further 30 minutes. After centrifugation the supernatant was collected and analysed 
through a UV-vis spectrophotometer (Evolution 60S Thermo Scientific). Drug content (%) was 
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determined using the calibration curve of AMX. Equations used to calculate drug content and 
thereafter encapsulation efficiency (EE%) are shown (Xu et al, 2008). 
 
Drug content in PLGA (%) = (weight of drug in microspheres/weight of microspheres) *100 
Equation 5. 1: Formula for drug content percentage. 
 
EE% = (actual drug encapsulated/theoretical drug encapsulated) *100 
Equation 5. 2: Equation for encapsulation efficiency.  
 
5.3.2.3 In-vitro drug release 
Profiles of drug released from the formulations over 24 hours were plotted. 5 mg samples of 
the electrosprayed formulations were placed in eppendorfs containing 2 mL of PBS. This was 
followed for all formulations F2-F7. These eppendorfs were placed in a water bath at a 
temperature of 37 °C, mimicking that of the human body, at specific time points 1 min, 10 min, 
30 min, 1 hour, 2 hours, 4 hours,8 hours and 24 hours, 1.5 mL of sample was removed after 
centrifugation, making sure no particle aggregates were taken up. Drug release was quantified 
through the use of a UV-vis spectrophotometer (Evolution 60S Thermo Scientific) (λ=229). 
Experiments were carried out in triplicate for all formulations. 
 
5.3.2.4 Bacterial testing 
All investigations were carried out in triplicate on at least two separate occasions.  
The antibacterial activities of the metallic nanoparticles and the full formulations was 
investigated using E. Coli (NCTC13919) resistant to penicillin and methicillin resistant S. 
Aureus (NCTC12497); these were used as models for gram-negative and gram-positive 
bacteria respectively. Bacteria strains were stored in Luria Bertani broth at -80°C; bacteria were 
then cultured in nutrient broth (NB) at 37 °C for 24 hours.  
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5.3.2.5 Disc diffusion 
A disc diffusion method was used to determine the antibacterial activity of multi shaped silver 
nanomaterials, as well as gold and copper particles. The EUCAST standardised method was 
followed, as the zone diameter breakpoints are calibrated to the streamlined European MIC 
breakpoints. In order to produce reliable results, no changes were made to the method.  
In brief, of overnight cultures (100 μL) of E. coli and S. aureus were spread-plated on to 
nutrient agar (NA), a 6 mm paper disc was then impregnated with varying amounts (5 μL and 
10 μL) of multi shaped silver nanoparticles, spherical shaped gold and copper nanoparticles. 
The metallic nanoparticles were dispersed in PBS at a concentration of 125 μg/mL. The plates 
were then incubated at 37 °C for 24 hours. The efficacy of the metallic particles was determined 
through measurements of the zones of inhibition formed upon the agar plate surrounding the 
paper discs. The larger the zones, the more efficacy the nanoparticles showed.  
For the full formulations, F2-F7, the efficacy was determined using similar methods. Overnight 
cultures of (100 μL) of E. coli and S. aureus were spread-plated on to NA, a 2 cm paper disc 
was then impregnated with varying amounts (15 μL and 30 μL) of the formulations. To prepare 
the formulations, 20 mg of each of the formulations were placed in 2 mL freshly prepared PBS, 
these were then left in a 37 °C water bath over 24 hours. This allowed for release of drug and 
leaching of metallic ions into the liquid, this supernatant was then added in varying amounts to 
compare the antibacterial efficacy between formulations.  
 
5.3.2.6 Scanning electron microscope (SEM)/ Energy dispersive spectroscopy (EDS)  
SEM analysis was carried out on samples from the disc diffusion results. The samples used 
were from the metallic nanoparticle disc diffusion results, specifically the AgNP and AgP agar 
plates. Samples were prepared by cutting out 10 mm from the agar plate, and setting upon a 
metallic stub which was stored at 4 °C before analysis. The agar plates used all contained the 
bacteria S. aureus. The images were analysed at varying magnifications, and using both the 
normal scanning electron mode, as well as the secondary back scatter mode. 
 
5.3.2.7 Growth kinetic curves (Optical Density (OD600)) 
The growth curves of E. coli and S. aureus in the presence of different volumes of metallic 
nanoparticles, and formulations F2-F7 was determined using optical density. To investigate the 
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growth kinetic curves of bacterial cells, varying volumes of metallic nanoparticles (5 μL and 
10 μL) at a concentration of 125 μg/mL were added, to 96-well plate cells containing aliquots 
of 100 µl of E. coli and S. aureus. Optical densities (OD) were measured every hour (from 0 
to 24 hour) at 600 nm using a spectrophotometer (Spectra Max Plus 384). As for the 
formulations, preparation was carried out using the method stated previously, volumes of (15 
μL and 30 μL) were added to 96-well plate cells containing aliquots of 100 µl of E. coli and S. 
aureus and the optical density values recorded over 24 hours, to determine the bacterial growth 
curve. Control wells contained bacteria only. 
 
5.3.2.8 Ex-vivo cell culture studies (MTT assay) 
For all cell culture studies target cell count was 40,000 for each well. The initial cell count of 
the culture was averaged at 102.5 via hemocytometry. Total cell count was 1x106 cells. To 
achieve 40,000 cells in each well for 50 wells a dilution factor of 5 was calculated. This 
required 2 mL of cells and 8 mL of media. Once prepared 200 μL of mixture was pipetted in 
to each well and the plate was incubated at 37 °C for 24 hours (5 % CO2).  
24 hours after incubation, 100 μL was removed out of each well and then 100 μL of MTT 
reagent at a concentration of 2 μL/mL was pipetted into each well and the plate was incubated 
at 37 °C for 3 hours. Afterwards 150 μL of DMSO was added and then the plate was incubated 
at 37 °C for 2 hours. Once finished the absorbance values were read. From these values the cell 
viability was calculated for each formulation synthesised using the following formula: 
 
% 𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣 =  𝑣𝑣𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑣𝑣𝑎𝑎𝑐𝑐𝑣𝑣𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 − 𝑣𝑣𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑣𝑣𝑎𝑎𝑐𝑐𝑣𝑣𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏
𝑣𝑣𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑣𝑣𝑎𝑎𝑐𝑐𝑣𝑣𝑐𝑐𝑐𝑐𝑏𝑏𝑐𝑐𝑐𝑐𝑐𝑐𝑠𝑠 − 𝑣𝑣𝑣𝑣𝑎𝑎𝑎𝑎𝑎𝑎𝑣𝑣𝑣𝑣𝑎𝑎𝑐𝑐𝑣𝑣𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏
× 100 
 
Equation 5. 3: Percentage cell viability calculation. 
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5.4 Results and Discussion 
5.4.1 UV-vis and calibration curve 
The UV-vis curve plotted in Figure 5.1, displays the λmax at a wavelength of 229 nm, plotted 
using the most concentrated solution (125 µg/mL), correlating with previous literature for 
AMX (Chaturvedi and Chitlange, 2011). The calibration curve (Figure 5.2) was obtained by 
measuring absorbance values of AMX solutions in PBS, varying in concentration from 
12.5µg/mL to 125µg/mL. The solutions were measured, through UV-vis spectrophotometer at 
a fixed wavelength of 229nm. Absorbance values were plotted against concentration, giving a 
calibration curve, with an (R2) coefficient of 0.9975 indicating good linearity. 
 
Figure 5. 1: UV-vis curve of AMX. 
 
Figure 5. 2: Calibration curve of AMX from 12.5 µg/mL to 125 µg/mL. 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
190 240 290 340 390 440 490 540 590
Ab
so
rb
an
ce
Wavelength (nm)
y = 0.0069x + 0.0242
R² = 0.9975
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 20 40 60 80 100 120 140
Ab
so
rb
an
ce
Concentration µg/mL
152 
 
5.4.2 Drug content/encapsulation efficiency and drug release curve 
Table 5.1 shows the drug loading (%) and EE% of the formulations. For F2 drug loading at 
1.18 %, is very low, but expected as the drug is insoluble, with an EE% of 24.89 %, also lower 
than previously found literature, this may be due to the struggles found in electrospraying 
suspensions (Xu et al, 2008). Furthermore, (Sousa et al, 2010) synthesised AMX loaded PLGA 
microspheres using DCM, results from the study displayed similar drug loading and 
encapsulation values, as drug was insoluble so values remained low.  
Previous data has studied the release from biodegradable polymer PLGA; data has shown 
PLGA is better used for sustained delivery of antimicrobial agents. Grayson et al, 2005, showed 
degradation of PLGA (Mw 24-38000) occurs best at 37°C, over a number of days. For 
sustained drug delivery, drug is released at a predetermined rate over a longer period of time. 
Traditional drug delivery methods are where the drug is circulated throughout the body, 
however in sustained drug delivery, drug is released mostly at the site of infection. Which can 
lead to an increase in therapeutic index as well as therapeutic efficacy (Prasanna and 
Venkatasubbu, 2018). 
From Figure 5.3 the release from F2 over 24 hours was very low compared to the other 
formulations, around 18% of drug was released over this period of time, correlating with 
previous literature.  Zhang et al, 2018, electrosprun PLGA and AMX fibres, at varying 
concentrations, for 5% PLGA AMX release data showed around 48% of drug was released 
from the polymeric fibres after 24 hours, this difference may be due to AMX forming a solution 
before electrospinning, hence more of the drug was encapsulated, however for F2, AMX was 
insoluble and therefore lower drug release was expected. Furthermore, PLGA is a hydrophobic 
polymer, and AMX is hydrophilic, as the drug was embedded and encapsulated within the 
polymer, this may have led to lower release of drug from the polymer and no burst release 
when compared to more hydrophilic polymers. Zheng et al, 2013, synthesised a 1% 
PLGA/AMX formulation, using electrospinning to generate fibres, release studies showed after 
24 hours around 36% of AMX was released, however after 10 days 90% of AMX was released, 
hence showing PLGA is better for sustained release.  
For formulations F3-F5 in Table 5.1 the drug loading and EE% increased to 41%, 48% and 
54% respectively, the reasons for this may be due to the presence of metallic nanoparticles, F4 
and F5 were higher than F3 these formulations contained shaped metallic nanoparticles, which 
may have caused more degradation of polymer through scission, hence increasing the amount 
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of free drug particles in the supernatant. Chae and Kim, 2005, tested the effects of zinc oxide 
nanoparticles on polyacrylonitrile; results showed with increased amounts of zinc oxide the 
structure of the polymer weakened and toughness dramatically reduced. Weaker polymeric 
chains may have caused more release of drug particles into the surrounding environment. 
Furthermore, Gasaymeh, 2010, synthesised Ag/PVP composite particles and described chain 
scission of the polymer, as well as showed cross linking by the silver particles present improved 
optical properties.  
Another reason for increased drug loading and EE% may be due to increased surface area. 
Particle size and morphology have an effect on drug release, the smaller the particles (nano-
size) the larger the surface area to volume ratio, therefore enhancing drug content release 
(Rampersaud et al, 2016).     
In the presence of metallic nanoparticles surface area to volume ratio increases, therefore more 
drug particles are present within the polymeric matrix, hence leading to higher loading and 
encapsulation. Moreover, the shapes of the nanoparticles vary, between spherical, polygonal 
and wire shaped silver. The surface area: volume ratio of a 100 nm sphere can be calculated 
using: 
 
Surface area=4×π×radius2   SA=3.14x105 nm 
Equation 5. 4: Equation for surface area of a sphere. 
  
Volume = 4/3×π×radius3   V=5.24x106 nm 
Equation 5. 5: Equation for volume of a sphere. 
  
Surface area: volume = 0.06  
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A polygonal shaped silver nanoparticle with varying sides, for this we assume the shape is 
more hexagonal as oppose to spherical. Working out the surface area: volume ratio of a 100 
nm hexagonal particle using the equation below.  
 
a= edge length = 33.33 nm b=width=100 nm 
Surface area = 2√3 * (3 + √5) * a²   SA= 2.02x105 nm 
Equation 5. 6: Equation for surface area of a hexagonal particle. 
  
V = 6 a³     V= 2.22x106 nm 
Equation 5. 7: Equation for volume of a hexagonal particle.  
 
Surface area: volume = 0.09  
 
From the surface area: volume results, a hexagonal shape has almost a 50% increase in SA: V 
ratio than a sphere does. The surface area of the hexagonal shaped nanoparticles may be lower, 
but a higher surface area to volume ratio has shown that although a lower surface may affect 
rate of interaction, the ability to increase number of particles because of a smaller volume taken 
by each nanoparticle increases overall reactivity within the system. From this increased surface 
area of F5, drug content may also increase.  
F4 contains nanowires; the increase in surface area again causes an increase in drug loading 
compared to spherical particles, the geometry of the wire shaped nanoparticles improves fluid 
mechanics, due to a smaller drag force and a higher surface area contact. The increased surface 
area contact can allow for more drug loading upon the nanowires, hence leading to higher 
values. Data published by (Loverde et al, 2011) analysed the differences between spheres and 
elongated worm like structures, similar to nanowires and found the worm like structures to 
increase the amount of drug delivered to target tumour sites; this is through the increased 
surface area as well as better movement through the blood stream within the body.  
Drug release data presented in Figure 5.3 for F3 shows a higher release of drug over the 24-
hour time period, initially a burst release of drug was observed as after 60 minutes 29% of drug 
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had been released, beyond this the release steadied and after 24 hours around 34% of drug had 
released almost double the amount of drug release from F2. As for F4 the drug released was 
higher, an initial burst release showed after 60 minutes 38% of drug was released, and at 24 
hours the release was at 41%. For F5 the release rate was the highest over the 24-hour time 
period, an initial burst release of 45% of drug released at 60 minutes, beyond this the drug 
release curve continued rising to 56% after 24 hours. The reason for continued rise, oppose to 
formulations F3 and F4 may be due to continued breakdown of the polymeric chains, or the 
increased amount of drug present as shown in Table 5.1 for drug loading values. Moreover, as 
shown, drug release using PLGA occurs over many days, and will continue rising. Sofokleous 
et al, 2013, synthesised electropsun PLGA AMX fibres for wound dressings, release data in 
PBS showed around 50% of drug was released after 21 days.  
The release profiles for formulations F3-F5 in Figure 5.3 shows a much higher release this can 
be attributed to the release of silver ions, as well as aiding and enhancing the degradation of 
the polymer, which further increases release rate of drug, this can be attributed as the reason 
for the initial burst release, and overall higher release of drug compared to F2. Long et al, 2017, 
published findings showing release of silver ions from AgNP; AgNP synthesised through 
differing methods, were all submerged in a 37 °C incubator. Results showed AgNP synthesised 
using the citrate reduction method released the most ions over 24 hours. This release of ions 
may have led to more break up within the polymeric chain, hence releasing more AMX. Liu 
and Hurt, 2010, prepared citrate reduced AgNP; data showed the release of silver ions occurs 
best at 37 °C, when compared to 4 °C and 20 °C, suggesting the metallic nanoparticles have 
become dispersed and embedded within the polymeric matrix. (Fortunati et al, 2011) 
synthesised PLGA/silver composites and explained release of ions can cause degradation of 
polymer through scission, at 37°C, the polymer is degrading causing the release of ions, as 
degradation increases AgNP becomes exposed, leading to the oxidation and increased ion 
formation. Alimohammadi et al, 2012, synthesised PLGA AMX composites coated with 
magnetic nanoparticles, data shows the release in PBS after 24 hours to be less than 60%. 
Increasing the hydrophilicity of the polymer however increased drug release to over 70%. The 
variation in shape and size had an impact on the drug released, particles with higher surface 
area: volume ratio led to increased amount of drug released. Steckiewicz et al, 2019, 
synthesised three different shapes of AuNPs, spheres, stars and rods which were synthesised 
using reduction method, results obtained show the shape of the particles had an impact on cell 
viability results, out of the three shapes star shaped AuNP exhibited the highest anti-cancer 
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potential but also was the most toxic. Li et al, 2012, synthesised five different multi-shaped 
nanoparticles and incorporated them into polyethylene forming nanocomposites, it was found 
that the octahedron shaped nanoparticles (2 nm) had the greatest interaction with the polymeric 
matrix, and decreased polymeric entanglement, through dispersion within the chains. 
For F5 the shape of metallic nanoparticles, shown in Figure 3.2Ci, shows particles are no 
longer spherical, particles have sides and edges, this may have led to more contact with polymer 
oppose to spherical nanoparticles, increasing the breakdown of polymer enhancing the release 
of AMX. Rampersaud et al, 2016, synthesised spherical and caged shape iron oxide 
nanoparticles to determine whether shape has an effect on drug release; they found the shape 
of nanoparticles has a significant impact on drug release as well as efficacy, as drug release of 
cage shaped nanoparticle was three times higher than its spherical counterpart.  
From Table 5.1, formulations F6 and F7 had similar encapsulation values at 33.03% and 
33.43%, higher than F2 again this can be described by an increase in surface area: volume ratio 
overall, moreover, the presence of metallic particles within the polymer can reduce the 
interlinking between polymeric chains, allowing for more free drug particles, increasing drug 
loading and EE%. Wang et al, 2016, synthesised gold nanoparticles through citrate reduction, 
and stabilised them within PLGA matrix, furthermore, (Alkilany et al, 2018) encapsulated 
citrate reduced PLGA-GNPs composites into PLGA nanocarriers achieving a remarkable 
100% encapsulation. Therefore, it seems AuNPs disperse better within the polymeric matrix, 
forming more stable composite particles, this was observed in Figure 4.1F, as the suspension 
formed showed good dispersion of AuNP throughout the formulation. This may have led to 
better encapsulation of AuNP in the polymeric matrix, this then can be observed though the 
drug release curve (Figure 5.3) for F6 as after 60 minutes only around 18% of drug had been 
released, no burst release was observed and after 24 hours drug release was at 24%. The 
increase in drug loading and encapsulation, therefore can be attributed to higher presence of 
AuNPs within the polymeric matrix, (Wang et al, 2016) also tested the inhibiting capability of 
PLGA-GNP and found over 24 hours cell viability of human breast cancer cells, reduced to 
below 20%. Furthermore, it was explained increasing AuNP concentration would adjust the 
polymer (50:50) composition, enhance effects of AuNP, as well as indicating the use of varying 
shapes of AuNP, nanorods or nano-shells can also enhance efficacy due to varying absorbances 
of infrared light.  
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Cioffi et al, 2005, synthesised CuNP encapsulated within three different types of polymer to 
investigate the release properties of copper ions and to assess antifungal properties, results 
showed when incorporated within a polymeric system, formation of the copper polymer 
suspension Cu-PVMK led to an increased release of copper, this was attributed to the rapid 
formation of copper oxide, in the suspension. Moreover, data showed it is possible to control 
the release of copper incorporated within a polymeric system, as once encapsulated oxidation 
of particles occurs a lot slower than it would in bulk. This can therefore sustain CuNP in the 
original form and reduce toxicity of copper ions. The release curve (Figure 5.3) of F7 shows 
the release of 33% drug after 60 minutes, which indicates a burst release effect, after 24 hours 
39% of drug was released. The reasons for this release being higher than F3 may be due to the 
presence of copper ions, or oxidised copper particles as copper is known to rapidly oxidise. 
Furthermore, it may also be due to the leaching of colour from the CuNP embedded within the 
system, as CuNP are brick red in colour, upon successful electrospraying the red colour 
particles could be observed upon the glass slide coated over, but the slight tinge of red still 
present. When 5 mg of this sample was placed in 2 mL PBS and placed in the water bath, over 
time the colour of this leached out into the surrounding medium, which may have led to an 
increase in absorbance values, hence a higher cumulative release curve.  
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Table 5. 1: Drug loading and encapsulation efficiency values for formulations F2-F7. 
Formulations Drug Loading (%) Encapsulation Efficiency 
(%) 
F2 1.18 ±0.33 24.89 ±0.99 
F3 1.99 ±0.25 41.97 ±1.63 
F4 2.28 ±0.30 48.07 ±2.35 
F5 2.57 ±0.32 54.12 ±2.82 
F6 1.56 ±0.24 33.03 ±2.08 
F7 1.58 ±0.17 33.43 ±2.79 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 3: Cumulative drug release curves for formulations F2-F7. 
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5.4.3 Microbiological testing 
5.4.3.1 Disc diffusion results 
5.4.3.1.1 Metallic nanoparticles 
Results from the disc diffusion tests showed differences that arise from varying types of 
nanoparticles, and more importantly the differences between the type of shape the metallic 
nanoparticles have, as well as showing the differences in volume of suspension added (µL). 
When comparing results, images where 5 µL, of metallic suspension had been added will be 
discussed.  
Results in Figure 5.4 and 5.5 show all metallic nanoparticles synthesised show antibacterial 
efficacy, as clear zones are observed for all types and shapes of metallic nanoparticles used, as 
well as the increase in zone size with the increase in amount of suspension added. However, 
no zones were observed for the AuNP disk diffusion disks (Figure 5.4Di-iv), this is due to the 
inability of AuNP to diffuse through the disk and cause an antibacterial effect, (Kourmouli et 
al, 2018) studied the antimicrobial efficacy of AuNP and AgNP, AuNP were synthesised and 
added to E. coli; results showed no zones of inhibition from the AuNP, this may be an 
indication of no antibacterial properties of AuNP, but more so because AuNP are unable to 
release diffusive ions like AgNP are able to do when oxidised. The release of Ag+ ions have 
the antibacterial efficacy effect.  
As expected the silver nanomaterials had the most effective antimicrobial zones, due to 
presence of silver ions Ag+, with clear zones of inhibition around the discs Figures 5.4Ai-Ci. 
Figure 5.5 showing the average zone sizes in (mm), presents AgNP as the metallic nanoparticle 
with the highest antibacterial efficacy against both gram-negative and gram-positive strains, at 
both volumes 5 µL and 10 µL. The average zone size for AgNP against S. aureus was measured 
at 18.84 mm and the smallest zone size was 16.07 mm from the CuNPs. Increasing the volume 
also increased sizes of zones, however the same result ensued with AgNP displaying an average 
zone size 23.61 mm, moreover AgP particles displayed a zone size of 23.14 mm, showing 
similar efficacy. Between the synthesised silver nanomaterials, the nanowire showed the lowest 
antibacterial efficacy against both S. aureus and E. coli regardless of volume added, this may 
be due to the difference in shape, as the nanowire shape may lead to less interactions with 
bacterial cells, moreover, it could be due to the spherical and polygonal shaped exhibiting 
higher surface area to volume ratio increasing contact with bacteria. Visually, when observing 
and comparing Figures 5.4 Ai, Bi and Ci for S. aureus it is clear to see the zones for Ai are the 
biggest followed by Ci then Bi. Furthermore, when comparing images for E. coli (5 µL), 
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Figures 5.4 Aii, Bii and Cii, it is observed the zones for Aii are the biggest then Cii and then 
Bii. These results remained the same with an increased volume of 10 µL.  
AgNPs exhibit antibacterial effects, through different mechanisms, most of which are well 
known and documented, including the generation of silver ions through oxidation; these ions 
freely bind to the bacterial cell membrane, enhancing the damage to the bacterial cell wall. 
Second proposed mechanism is the formation of ROS, presence of silver ions enhances the 
production of ROS through interactions with thiol groups on the respiratory chain enzyme. The 
final proposed mechanism is direct damage, where AgNPs or silver ions directly bind to 
bacterial cell walls causing an inhibitory effect leading to bacterial cell death (Jones et al, 
2018).   
The antibacterial effect of silver has been well documented and known for many centuries. 
Liao et al, 2019, explained the smaller the size of nanoparticle the better the inhibition, due to 
smaller size binding to the bacterial cell wall better than larger diameter particles, moreover it 
was found when AgNPs are in the presence of bacteria, growth of ROS occurs. ROS develop 
in a time dependant relationship, more so at the beginning of interaction. AgNPs synthesised 
by (Valenti and Giacomelli, 2017), using the citrate reduction method, showed the capping of 
AgNPs varies oxidation results. When capping with citrate, oxidation of AgNPs was 
incomplete, so amount of ROS released can be controlled depending on capping agent used. 
The main difference between gram-negative and gram-positive bacteria is the thickness of the 
peptidoglycan layer. Shrivastava et al, 2007, explained the difference in antibacterial efficacy 
is related to thickness of the layer, as a thicker peptidoglycan layer makes it more difficult for 
silver nanoparticles to attach onto the cell wall. For gram-positive bacteria S. aureus (Li et al, 
2010) published data showing the effects varying concentrations of AgNPs has on S. aureus, it 
was found that an MBC of 20 μg/mL was required. Salomoni et al, 2017, synthesised AgNPs 
to test on Pseudomonas aeruginosa (a bacterium resistant to commonly known antibiotics). 
Results showed a 5 μg/mL concentration had a bactericidal effect on the bacteria, through 
enzyme inhibition, results showed the use of AgNPs as an alternative to antibiotics, which 
bacteria have developed resistance to, is promising and shows results of efficacy and inhibition.  
AgNWs have also shown antibacterial efficacy, as they essentially possess the properties of 
silver, so the bactericidal or bacteriostatic effect still comes from the generation of silver ions. 
The experimental set up was to assess whether the change in shape would show differing 
antibacterial efficacy. Visnapuu et al, 2013, synthesised silver nanowires (70–150 nm diameter 
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and 3–8 µm length), to compare with spherical silver nanoparticles (98 nm diameter). Results 
show the shape did not have an effect on antibacterial efficacy, instead, increased efficacy 
depended on the increased production of Ag+.  Moreover, (Hong et al, 2015) produced silver 
nanocubes, nanospheres and nanowires, antibacterial tests showed bacterial concentration in 
CFU/mL, the MIC of nanocubes, nanospheres, and nanowires were 37.5, 75, and 100 μg/mL, 
respectively. The wire exhibited the worse antibacterial activity compared with the nanocubes 
and nanospheres. AgNPs that exhibit larger effective contact areas exhibit stronger 
antibacterial activity. The antibacterial activity it seems then, depends on both the production 
of silver ions as well as the surface area in contact with the bacteria, (Helmlinger et al, 2016) 
produced spheres (diameter 40–80 and 120–180 nm), platelets (20–60 nm), cubes (140–180 
nm), and rods (diameter 80–120 nm, length over 1µm). Results showed antibacterial activity 
again was highly dependent on production of Ag+, higher surface area did show an increase in 
activity but the effect was not as enhanced as increased production of Ag+ shows.  
For the AgP particles, the antibacterial efficacy is shown to be higher than that of silver 
nanowires, from Figure 5.5 although following a similar method of synthesis, this may be due 
to the increased surface area interactions of the shaped nanoparticles compared to nanowires 
as (Hong et al, 2015) showed the increased antibacterial activity of the nanocubes was the 
increased contact through formation of sides with bacteria that led to an increase in efficacy. 
Pal et al, 2007, synthesised spherical, nanoparticles of many shapes and nanowires. Results 
showed the antibacterial efficacy was higher in nanoparticles of many shapes compared to 
nanowires, this was attributed to the preferred facet growth phase determined from XRD 
diffractograms, data showed the nanoparticles growing in the (111) plane show the most 
antibacterial activity. From Figure 3.7 it can be seen all silver particles synthesised had the 
sharpest peaks in the (111) plane of growth therefore indicating the difference here in 
antibacterial efficacy, was due to production of Ag+ and higher surface area contact with 
bacteria.  
The CuNPs showed a lesser antibacterial effect against both strains of bacteria when compared 
to the silver nanomaterials, as observed in Figure 5.4, when comparing Ai, Bi or Ci to Ei the 
zones for the silver nanomaterials are much larger, the same when results are observed when 
using E.coli, images Aii, Bii and Cii show larger zones of inhibition then Eii does, the reasons 
for this may be due to lower production of copper ions, or due to incomplete oxidation of 
nanoparticles, (Harikumar et al, 2016) synthesised copper nanoparticles using a similar 
reduction technique, and found that the average zone size in disc diffusion against E. coli was 
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16 mm, which is similar to the average zone size shown here. Moreover, (Chatterjee et al, 2014) 
synthesised CuNPs and studied the antibacterial activity using E. coli. They found activity was 
highly dependent on production of ROS, which in turn increases when increasing 
concentrations of CuNPs are added. When comparing AgNPs and CuNPs in regards to 
antibacterial activity, (Nabipour and Rostamzad, 2015) produced AgNPs and CuNPs, using 
them against many strains of bacteria including S. aureus. Optical density results showed, when 
increasing the concentration to 1.5% of silver and copper added, silver induced a higher 
antibacterial effect. Furthermore, (Zia et al, 2018) synthesised CuNPs and AgNPs through the 
reduction method and tested efficacy using the disk diffusion method against S. aureus and E. 
coli. Results showed, at lower concentrations, AgNPs exhibited higher efficacy through larger 
zone sizes (mm). When using S. aureus AgNPs and CuNPs were added at a molar concentration 
of 0.3; for AgNPs zone sizes of 24 ± 0.21 mm were recorded, in comparison CuNPs at the same 
concentration recorded zone sizes of 15 ± 0.28 mm. Against E. coli the difference in 
antibacterial activity again showed silver to be a better antibacterial agent, at a molar 
concentration of 0.7, AgNPs showed zone sizes of 20 ± 0.21 mm, whereas for CuNPs zone 
sizes were 18 ± 0.21 mm. This is further evidence that the AgNPs display better antibacterial 
efficacy than CuNPs and confirms the disc diffusion results observed.  
Figure 5.4Fi displays the antibacterial efficacy of AMX alone against S. aureus, zones of 
inhibition are observed confirming the susceptibility of S. aureus to AMX, E. coli however is 
resistant to AMX, hence no zones of inhibition. The average size of the zone against S. aureus 
displayed in Figure 5.5 shows its at 19.4 mm, this size is slightly larger than the AgNPs zone 
size at 18.8 mm, this is expected as AMX is the antibacterial active agent, at higher volumes 
10 µL zone size for AMX against S .aureus was 25.1 mm.  
Kim et al, 2017, synthesised silver nanoparticles varying in size and shape to test efficacy 
through OD against E. coli. AgNPs 10, 20 and 70 nm in size, were added at varying 
concentrations results showed, the 10 nm size showed better efficacy then 20 nm and 70 nm at 
the same concentrations. For example, at a concentration of 30 ng/mL, the OD value remains 
below 0.1 for the 10 nm sized particles until the 10 hour point where only a slight increase 
occurs, however the 20 nm and 70 nm sized nanoparticles, both show an increase in OD values 
after 8 hours, and the OD value rises to above 0.4. Furthermore, in regards to shape effects 
cube, sphere and plate shaped nanoparticles were synthesised, all used at 70 nm size. Results 
here indicated the cube shape had the highest efficacy, at the same concentration of 150 ng/mL 
the OD value rose after 8 hours slightly and at the 10-hour mark was recorded below 0.2. For 
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the spherical shaped nanoparticle OD value rose sharply at the 8-hour point, above 0.2, and for 
the plate shaped nanoparticles the OD value rose slightly not as high as the spherical particles, 
but just above 0.2. This result suggests shape of nanoparticle may affect efficacy, and the cube 
shape with increased surface area to volume ratio caused increased antibacterial efficacy.  
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Figure 5. 4: Disk diffusion zones against E. coli and S. aureus at varying volumes of metallic 
nanoparticles with the control as AMX. (i) S. aureus and 5 µL of metal suspension; (ii) E. coli and 5 
µL of metal suspension; (iii) S. aureus and 10 µL of metal suspension; (iv) E. coli and 10 µL of metal 
suspension. (A) AgNP; (B) AgNW; (C) AgP; (D) AuNP; (E) CuNP; (F) AMX control. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 5: Size of disk diffusion zones against E. coli and S. aureus at varying volumes of metallic 
nanoparticles with the control as AMX. 
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5.4.3.1.2 Full formulation Results 
The full formulations synthesised, F2-F7 have shown encapsulation of drug, presence of 
metallic nanoparticles and varying drug release depending on the formulation when incubated 
at 37 °C. The next step was to assess the antibacterial properties of the formulations, to 
determine if the EHDA process is a good alternative for synthesising antibacterial composite 
formulations, as it is an easy one step process, allows for encapsulation of poorly soluble drugs, 
and can inculcate many types of antibacterial agents.  
The full formulations were used here, against methicillin resistant S. aureus and penicillin 
resistant E. coli, to determine whether the addition of metallic nanoparticles can enhance the 
effect of the drug AMX, and in the case of E. coli, help overcome the resistance. Figure 5.6 
shows the results of the disc diffusion tests, the images used for comparison are Ai-Fi and Aii 
to Fii, where 15 µL had been added. Figure 5.7 for F2, displays the average disc diffusion zone 
against S. aureus at 28.15mm using, this was used as the base when comparing with the rest of 
the formulations, to see if metallic nanoparticles can enhance the efficacy through a synergistic 
effect, hence zone sizes should increase if this was the case.  
When comparing Figure 5.6Ai for F2 to 5.6Bi for F3 the zones of inhibition increase, from 
Figure 5.7, it is calculated that the average zone size is now recorded at 30.8 mm an increase 
of 1.09-fold. When comparing with F4 Ci in Figure 5.7, the average zone size increases further 
to 34.16 mm an increase of 1.2-fold. As for F5 from Figure 5.6Di it can be observed the zone 
size is a lot bigger than all other formulations present, Ai-Fi. The average zone size is measured 
at 41.21 mm an increase of 1.46-fold.  
The disk diffusion results for F6Ai indicates the inhibition of S. aureus, as it is known AuNPs 
exhibit no disk diffusion efficacy due to its nature, these results then are attributed to the 
presence of AMX, the zone size measured in Figure 5.7 gives an average zone size of 29.2 
mm, the average zone size is slightly higher than F2, which may be due to the presence of 
AuNPs dispersed amongst the polymeric matrix, therefore increasing surface area, leading to 
an increased amount of drug particles released into the medium. For disk diffusion image F7 
Ei the zone sizes measured were smaller than those observed by formulations F3-F5, the 
average zone size had reduced to 20.97 mm, an average smaller than that for F2 Ai.  
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The results here overall, indicate a synergistic effect of silver nanomaterials and AMX does 
exist, as increase in zone sizes is evident with addition of silver nanomaterials, compared with 
AMX alone. However, when comparing with the penicillin resistant E. coli, results are 
inconclusive, for F2 in Figure 5.6Aii as expected no zones of inhibition were recorded, when 
analysing F3 Bii the image in Figure 5.7, shows a zone of inhibition at an average size of 
17.48mm, this zone size is smaller than the zone AgNPs displayed against E. coli, in Figure 
5.4Aii, therefore the zone of inhibition observed here in F3 Bii may be a result of the silver 
ions present in the supernatant of the sample as oppose to a synergistic effect of AgNP and 
AMX.  
For F4 Cii in Figure 5.7 the zone of inhibition is measured at 15.22 mm, when comparing this 
zone size to that of AgNWs against E. coli in Figure 5.5 the zone has reduced, in the presence 
of AMX, this therefore indicates no synergistic efficacy against E. coli. For F5 Dii the zones 
of inhibition are at an average size of 25.1mm, when comparing to AgP against E. coli, in 
Figure 5.5 the zones of inhibition have increased, this may be due to a synergistic effect, where 
the bacteria and AMX may have increased efficacy working together, one possible reason for 
this result is the surface area to volume of the AgP particles being much larger than the other 
silver nanomaterials, this is evident through better drug loading, and a higher AMX cumulative 
release curve after 24%, the reasons for this were attributed to the increased hydrolysis of 
polymer chain, releasing more of the drug particles, along with more silver ions when 
compared to F3 and F4. Another benefit of the particle possessing sides and a varying 
morphology, may be increased interactions with polymeric matrix, which destabilises the 
matrix, making it less rigid and more degradable.  
Figure 5.6Eii no zones of inhibition were observed, as expected, AuNP shows no efficacy in 
disk diffusion testing, and E. coli is resistant to AMX. For Figure 5.6Fii again there are no 
zones present, however, when comparing with Figure 5.4Fii, zones were present averaging 
15.8 mm this indicates no enhancement of efficacy against E. coli.  
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Increasing the efficacy of commonly used antibiotics through addition of metallic nanoparticles 
is still relatively novel and reasons for activity still not yet understood, (Kaur and Kumar, 2019) 
tested the enhanced efficacy of polymer stabilised AgNP in conjugation with different 
antibiotics, the bacteria used were S. aureus and E. coli, the antibiotics used where vancomycin 
(Van) and amikacin (Amk), results from disc diffusion method showed zones of inhibition for 
Amk against E. coli and S. aureus were approximately around 9 and 5 mm, respectively for 
three different concentrations whereas the zones of inhibition for Amk with AgNP against E. 
coli and S. aureus was increased up to 20 and 10 mm, respectively.  
Furthermore, it is known E. coli is totally resistant to Van, therefore when Van was added no 
zones of inhibition were observed, however when adding Van with AgNP at different 
concentrations, the bacterial growth was inhibited to some extent. The zones of inhibition with 
Van and AgNP for E. coli increases from 0 to 8 mm and made the bacteria also sensitive to this 
conjugate. In case of S. aureus, bacterial growth inhibition also enhances from 7 to 11 mm. 
These results confirm, increased bacterial efficacy can occur when combining metallic 
nanoparticles with antibiotics, even if bacteria is known to be resistant to specific antibiotics. 
This may help in the race against increasing bacterial resistance against many strains of 
antibiotics.  
The increase in zone sizes for formulations F3-F5 Bi-Di in Figure 5.6, can be attributed to 
enhancement in efficacy, when combining the metallic nanoparticle and AMX. Shahverdi et 
al, 2007, tested the differences in efficacy when using a range of raw antibiotics including 
AMX against known bacterial strains S. aureus and E. coli; and when adding AgNPs to the 
drug. Results showed the zone of inhibition for S. aureus in mm when adding AMX was 7.5 
mm, when adding AgNPs with the AMX the zone size increased to 14 mm, when adding AMX 
to E. coli no zone size was observed however when adding the AMX plus AgNPs the zone size 
increased 0.44 in fold area. This result shows resistance can be overcome with combination 
therapy, combining different antibacterial agents to overcome the resistance of certain bacteria.  
For F5 Di and Dii in Figure 5.6 and 5.7, it is clear average zone sizes are bigger then F3 Bi 
and Bii, when comparing AgNPs and AgPs from Figure 5.5 it is also clear to observe AgNPs 
showed bigger zones of inhibition. The difference then was related to the production of Ag+ 
ions, as through the citrate reduction method increased amount of silver ions are produced. It 
is known citrate degrades at 30 °C (Torres et al, 2018), therefore increasing amount of AgNPs, 
leading to higher formation of silver ions. However, when comparing F3 with F5 it can be 
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explained the increased surface area to volume ratio of AgP particles present, may have led to 
increased contact with drug particles, hence at the right conditions for release at 37 °C more 
drug particles are released. Furthermore, the larger surface area due to presence of edges and 
sides increases contact with polymeric chains, destabilising the polymeric system and 
increasing amount of free drug particles. As more drug particles are free increased efficacy can 
be observed in Figure 5.6Di compared to F3 Bi.  
Zhang et al, 2016, presented a review paper, describing the effects of AgNPs embedded within 
polymers through the electrospinning process, the electrospinning method allows for one step 
encapsulation of the AgNPs, and an increase in antibacterial activity. Zhang et al, 2009, used 
nylon-6 which shows no antibacterial activity, however when adding AgNPs into the polymeric 
matrix a 99.9% efficacy was shown against E. coli, moreover, it is described to increase 
hydrolysis of the bulk polymer inclusion of AgNPs allows for this. Bu et al, 2013, showed 
inclusion of AgNPs loaded onto the graphene–ZnO quasi-shell–core composites significantly 
improved the photocatalytic rhodamine B degradation capability of the graphene–ZnO quasi-
shell–core composite. Zhang et al, 2016, explains further that the AgNPs have strong catalytic 
properties for hydrolysis and electrolysis of organic materials when being added into 
AgNPs/polymer composites, however the catalytic activity is controlled through size of 
nanoparticle, a larger surface area to volume ratio increases the catalytic ability. This then 
explains why F5 showed better drug loading, increased drug release and enhanced efficacy 
against bacteria. As raw metals the Ag+ production dictates the efficacy, however when 
incorporated within a polymeric system the surface area interactions play a bigger role it seems. 
The increased hydrolysis of polymeric chains may have led to release of more Ag+ compared 
to F3, hence why the zone sizes were larger.  
As for F7 Figure 5.6Ei the zone of inhibition was smaller than F2, this may have been due to 
the presence of encapsulated CuNPs not allowing for release of drug as freely as AMX can in 
F2, as the encapsulation of CuNPs reduced oxidation of nanoparticles, therefore less ROS were 
present reducing hydrolysis of polymeric matrix, causing more AMX drug particles to remain 
embedded within the polymer. The increase in surface area increases the amount of drug 
particles present, however if the CuNPs are evenly dispersed and embedded then release from 
PLGA may be over a longer period of time, as these results were taken after 24 hours, increased 
incubation time may have led to increased zones of inhibition.  
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Palza et al, 2015, synthesised polymer composites embedded with copper nano/micro particles, 
results showed release rate of copper ions was better when the copper used was of nano-size, 
moreover, release of copper ions from the polymeric matrix is affected by the hydrophobic 
nature of the polymer, as a more hydrophobic polymer slows down release rates of ions. This 
may be another reason for the reduced antibacterial efficacy, as CuNPs in Figure 5.4Ei showed 
smaller zones of inhibition compared to other metallic nanoparticles, hence why in a polymeric 
system efficacy may have been reduced. For F7 when adding, a higher amount of the 
formulation (30 µL) small zones of inhibiton were observed Figure 5.6Fiv. 
Results here show use of EHDA for antibacterial alternatives may have a future, not enough 
data is yet available, but with further research the reasons behind the efficacy shown can be 
explored. Zhang et al, 2017,  synthesised AgNWs through the polyol method, with the polymer 
PVA to form nanofibers, these nanofibers exhibited antibacterial properties, displayed through 
absorbance values against S. aureus and E. coli, concentration of AgNWs used was increased 
and results showed at 100 µL of AgNWs added the absorbance value was below 0.20 for S. 
aureus,  adding the same amount to E. coli the absorbance value interestingly was above 0.25, 
although the gram-positive S. aureus has a thicker peptidoglycan layer the inhibition of this 
bacteria was higher. 
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Figure 5. 6: Disk diffusion zones against E. coli and S. aureus at varying volumes of formulations F2-
F7 (i) S. aureus and 15 µL of metal suspension; (ii) E. coli and 15 µL of metal suspension; (iii) S. aureus 
and 30 µL of metal suspension; (iv) E. coli and 30 µL of metal suspension. (A) F2; (B) F3; (C) F4; (D) 
F5; (E) F6; (F) F7. 
 
 
 
 
 
 
 
 
 
Figure 5. 7: Size of disk diffusion zones against E. coli and S. aureus at varying volumes for 
formulations F2-F7. 
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5.4.3.2.1 SEM analysis of bacterial death 
SEM analysis was carried out to visually assess the cell damage caused by the metallic 
nanoparticles, images were taken from AgNPs and AgP disc diffusion plates. Figure 5.8Ai 
shows the zones of bacterial inhibition, the particles observed are AgNPs particles, at the border 
of the inhibition zone, beyond this as seen in Figure 5.8Bii there is no silver present, this region 
was where the bacteria were growing. Figure 5.8Ci taken from an AgP disc, highlights once 
again the border zones of the diffusion disk, where the AgP particles have accumulated and 
inhibited bacterial growth, however beyond this from Figure Di no silver is present, this is 
where the S. aureus bacteria continues growing. Figure 5.8Ei is an image at a higher 
magnification, which shows clear zones, no presence of S. aureus, and as Figure 5.8Eii 
confirms, silver is present. Figures 5.8F and G are back scatter images taken from SEM, the 
charged particles present here indicate the presence of metallic nanoparticles amongst the 
bacterial cells, the areas circled on both images show where the metallic nanoparticles have 
attached to the bacterial cells and cause disruption of the cells, as is presented bacterial cells 
have lost morphology no longer appear spherical, appearing more stretched out and elongated 
indicating cell death, confirmed through similar morphology found by (Hartmann et al, 2010, 
Zajmi et al, 2015). 
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Figure 5. 8: SEM/EDS analysis of S. aureus cell death. (i) SEM image; (ii) EDS analysis. 
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5.4.4 Optical Density (OD 600nm) 
5.4.4.1 Metal nanoparticle results  
Optical density (OD) results presented, show how the growth curves of chosen bacterial strains 
E. coli and S. aureus, develop over 24 hours, alone and with the addition of metallic 
nanoparticles varying in shape and size, the wavelength chosen to analyse differences in OD 
values was 600 nm. McBirney et al, 2016, described OD measurements as the preferred choice 
to detect bacterial growth, due to its simplicity and rapid answer. Furthermore, for bacterial 
analysis 600 nm is frequently used. Biesta-Peters et al, 2010, also conducted comparative 
studies in detecting bacterial growth and found determining OD measurements as a more useful 
technique when compared to plate counting. Furthermore, (Vukomanovic et al, 2019) 
explained, obtaining more accurate measurements (with fewer preparation steps), of samples 
following the growth curve of bacteria, is best examined by following the gradual change in 
the turbidity at 600 nm using OD600. 
Results obtained from OD curves usually follow the pattern of bacterial growth, with an initial 
lag phase, exponential growth phase, stationary phase and death phase. As shown below in 
Figure 5.9. When adding antibacterial agents, this growth curve should alter, an increase in lag 
time before growth indicates inhibition occurring, a shorter growth phase, or the death phase 
occurring much earlier all may indicate antibacterial properties of your samples.  
 
Figure 5. 9: General bacterial growth curve. 
Figure 5.10 shows the optical density curves for metallic nanoparticles against S. aureus at 5 
µL, results displayed correlate with disc diffusion results in Figure 5.4Ai-Ei. For the S. aureus 
control. the growth curve follows the general bacterial growth curve as shown in Figure 5.9, 
with an initial but short lag phase, exponential growth from 1 hour onwards to around 6-hour 
point. The stationary phase where the nutrients are available for growth have now been used 
up, which leads onto the slow death phase after the 20-hour point. For the metallic nanoparticles 
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used AgNPs again show the highest inhibitory effect, as the optical density drastically reduced 
from 0.26 at 0-hour point to 0.14 after 5 hours. This shows a clear bactericidal effect, as the 
value declined when exposed to the metallic nanoparticles at 37 °C. Moreover, an initial burst 
release of silver ions may have led to the death of bacterial cells. Similar results observed in 
Figure 5.12 with the bacterial strain E. coli, the AgNPs exhibit bactericidal effects reducing 
OD from 0.20 to 0.098, over the 24 hours. Results also indicate the metallic nanoparticles have 
similar effects against both S. aureus and E. coli. 
For the AgP the growth phase (Figure 5.10) the curve follows a similar pattern to the AgNPs 
curves at both 5 µL and 10 µL, again showing an immediate death phase from 0.28 to 0.16 
after 8 hours, followed by a stationary phase for a number of hours, and then further decrease 
in OD values, as for the AgNW, the growth phase follows similar patterns it displays an initial 
death phase, which then leads to a stationary phase, but interestingly at the end a growth phase 
is observed at around the 21 hour mark, AgNW therefore may not have shown a complete 
bactericidal effect, and some of the bacteria began to grow under optimum conditions using 
nutrients available. Against E. coli the AgP show higher antibacterial efficacy reducing the OD 
from 0.24 to 0.11, following a similar pattern to AgNPs, this may be due to the thinner 
peptidoglycan layer in E. coli making it more susceptible to AgP. For the AgNW the results 
against E. coli show a steady decline in OD values indicative of inhibitory effects from 0.15 to 
0.13 after 6 hours of incubation, followed by a steady rise and decrease in OD values, however 
at the 20 hour point the OD begins to rise due to bacterial growth, therefore results of AgNWs 
against both strains of bacteria show reduced efficacy compared to other AgNPs synthesised.  
As disk diffusion did not work for AuNPs, due to its nature, assessment here would show if 
AuNP exhibit any antibacterial activity at all. Results shown in Figure 5.10 display a longer 
lag phase, followed by a slight rise in bacterial growth, thereafter a steady decline, indicating 
AuNP exhibit antibacterial activity, overall the OD value began at 0.22 and after 24 hours was 
recorded as 0.15, the difference may not be as great as what silver nanomaterials displayed, it 
does however confirm the antibacterial properties of AuNP, moreover it seems AuNP exhibit 
bacteriostatic properties, as oppose to bactericidal.  
AuNP against E. coli in Figure 5.12 showed similar results, a longer lag phase is observed with 
OD remaining constant indicating the antibacterial effects of AuNPs with no rise in OD values. 
Mohamed et al, 2017, published findings displaying the antibacterial properties of AuNP, using 
Corynebacterium pseudotuberculosis results showed at a concentration of 100 µg/mL, 
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inhibition of bacterial cell growth did occur, using the colony forming unit (CFU) method. 
Elbehiry et al, 2018, published results of antibacterial activity, comparing efficacy of AgNPs 
and AuNP both synthesised using the citrate reduction method, against a strain of S. aureus, it 
was found at a concentration of 100 µg/mL, AuNPs with a 10 nm diameter inhibited 100% of 
S. aureus growth. Moreover, (Zhou et al, 2012) produced citrate reduced AuNP and tested 
against different strains of bacteria including E. coli, results showed a lesser concentration of 
AuNP used induced a higher antibacterial effect, at high concentration particles are more likely 
to aggregate, therefore decreasing the antibacterial effect, however at lower concentrations, 
particles appear more monodisperse and have a higher chance of interaction with bacterial cell 
walls to induce an antibacterial effect.  
For CuNPs in Figure 5.10, results show a lag time of up to 13 hours, the CuNPs inhibit the 
growth of bacteria as the OD value remains constant, however after the 13-hour point, a steady 
rise is observed as growth of bacteria is occurring, this confirms bacteriostatic properties of 
CuNPs. CuNPs synthesised by (Jamshidi and Jahangiri-Rad, 2014) showed antibacterial 
activity, results of OD against E. coli showed the gradual decrease in OD values over time, at 
concentration of 150 µg/mL the OD value decreased from 0.2 to below 0.1 indicating the 
antibacterial properties of CuNPs.  
For CuNPs against E. coli in Figure 5.12 results show a bacteriostatic effect, as the growth of 
bacteria is prevented through a larger lag time, eventually however after the 14 hour point the 
OD curve begins to rise indicating growth of bacteria. Overall less efficacy is shown of the 
CuNPs, as described previously the ROS generated from silver has a higher efficacy than those 
generated from CuNPs, leading to differences in antibacterial activity. 
For the AgNPs no lag phase was detected, with the first phase being the death phase this may 
have been due to the 125 µg/mL concentration used, (Surwade et al, 2018) described the 
relationship between concentration of AgNPs used (µg/mL) and the cell death (%), the bacteria 
used was methicillin resistant S. aureus, data showed a concentration of 20 µg/mL was enough 
to cause 100% cell death after just 30 minutes of incubation. (Hwan et al, 2010) synthesised 
AgNPs to test against bacterial strains E. coli and S. aureus, results showed at concentrations 
of 100 µg/mL and 150 µg/mL, no lag phase occurred, immediate death of the bacterial cells 
for both strains, was observed as OD values decreased from 0.15 to below 0.1, the 
concentration difference between 100 µg/mL and 150 µg/mL, did not vary the end OD value, 
only the initial death phase was sharper at a higher concentration. Maiti et al, 2014, synthesised 
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AgNPs to test the antibacterial efficacy of E. coli grown in LB, OD curve with an initial value 
of 0.2 showed declined immediately within 1 hour to almost 0, this was obtained using a silver 
nanoparticle concentration of 80 µg/mL.  
Having already determined the bacterial effect of AgNPs, is more due to the presence of ions 
than shape, these results correlate with disk diffusion results shown in Figure 5.4. Data 
published by (Pal et al, 2007) shows the effects of different shaped nanoparticles on growth of 
bacteria, at 100 µg/mL, spherical, triangular and wire shaped AgNPs have inhibited the growth 
of E. coli, more so the spherical and triangular shaped nanoparticles as oppose to nanowires. 
Furthermore, when comparing the effects of varying shapes, it was found, using a colony 
forming unit method showed, at 100 µg/mL both the spherical and triangular shaped 
nanoparticles inhibited growth of E. coli but the wire shaped nanoparticles, still had growth of 
colonies. The overall inhibitory nature of the silver nanomaterials has been enhanced through 
direct contact with the bacteria, as oppose to diffusing through the disk onto the agar plate. 
 
 
Figure 5. 10: Optical density curves of metallic nanoparticles against S. aureus at 5 µL.  
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Figure 5. 11: Optical density curves of metallic nanoparticles against S. aureus at 10 µL. 
 
 
Figure 5. 12: Optical density curves of metallic nanoparticles against E. coli at 5 µL. 
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Figure 5. 13: Optical density curves of metallic nanoparticles against E. coli at 10 µL. 
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5.4.4.2 Full formulation results  
From the full formulation results, for both bacterial strains E. coli and S. aureus all curves 
observed show growth of bacterial cells, which follows the general bacterial growth curve. 
Figure 5.14 shows the growth of S. aureus against formulations F2-F7, to indicate antibacterial 
activity here would be through increased lag times, before the increased exponential growth of 
bacteria occurs, a shorter growth curve or a quicker death rate. F2 shows a steady lag phase, 
however OD value has increased from 0.22 to 0.26 before the exponential growth occurs at the 
6-hour point. For formulations F3-F5 lag times have increased, the exponential growth phase 
appears at the 11, 8, and 14 hour point respectively for F3, F4 and F5.  An increase in lag time 
therefore suggests the enhanced efficacy of the AgNPs and AMX inhibited the growth of 
bacteria. 
When comparing the optical density curve results to Figure 5.6 for the disc diffusion zones, 
results show similar correlation, as once again F5 shows the highest antibacterial efficacy and 
F4 the lowest, when comparing F3-F5. As for F6 the exponential growth phase begins at the 
7-hour point, an increase compared to F2, which may indicate synergistic efficacy, however, 
the exponential growth phase rises higher in F6 up to 0.46, whereas for F2 the highest point is 
0.37, for F6 it remains inconclusive as to whether AMX and the AuNP worked together to 
enhance efficacy.  
Formulation F7 began at a higher OD compared to the other formulations, at 0.29 the reason 
for this may have been leaching of colour from the CuNPs formulated as shown in Figure 
4.1G, into the supernatant this gave it a yellow colour over 24 hours in incubation. The growth 
curve for F7 did not show much inhibition to bacterial growth, as it continued growing and 
seemed to follow the growth curve of bacteria.  
In comparison Figure 5.16 shows the growth curves of formulations in E. coli, the difference 
here is apparent, all formulations display much shorter lag phases, and sharper exponential 
growth phases, which indicates similarly to Figure 5.7, the synergy between metallic 
nanoparticles and AMX against E. coli did not show enough indication of combined efficacy.  
F2 almost mirrored the growth phase of the bacteria, as expected because of the resistance, F3-
F5 displayed lag times, of shorter durations compared to the lag times in Figure 5.14. 
Furthermore, F5 controlled bacterial growth keeping it in the lag phase longer than the other 
formulations, again when comparing the growth curve of E. coli against metallic nanoparticles 
AgP and AgNP in Figure 5.12 results showed AgNPs had better antibacterial efficacy, 
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however here it is evident F5 shows the longest lag time when compared to F3, this may 
therefore be attributed to increased amount of drug and metallic ion particles in direct contact 
with the bacteria. For F3 and F4 lag times are present, with direct contact of metallic ions and 
bacterial cells, inhibition is expected to occur, but unlike Figure 5.14 AMX here is ineffective 
hence why the exponential growth curves begin earlier for both formulations.  
From literature it is known enhancing efficacy of antibacterial agents is possible through 
addition of metallic nanoparticles, the increase in lag times for F3-F5 in Figures 5.14 and 5.16 
compared to the bacteria, is evidence of this enhancement, (Deng et al, 2016) tested the 
antibacterial efficacy when combining silver nanoparticles and common antibiotics, to test 
against Salmonella, six different antibiotics where chosen, the results for β-lactam antibiotics, 
penicillin or ampicillin, showed an increase in inhibition of Salmonella, at higher 
concentrations of the composites, which may indicate synergistic antibacterial efficacy, 
however when compared with other antibiotics used in the study inhibition of bacterial growth 
was greater.  
Silvero et al, 2018, synthesised amoxi@AuNP also through a simple one step process reducing 
the gold by using AMX to form AuNP. When tested against MRSA, efficacy was compared 
between AMX alone and amoxi@AuNP results showed increased antibacterial activity for 
amoxi@AuNP as after only 20 minutes complete inhibition of MRSA colonies was shown, 
however for AMX colonies remained and increased in growth over the time used.  
Guoqing Wan et al, 2016, combined antibiotics polymyxin B and rifampicin with AgNPs and 
found enhanced synergistic therapeutic efficacy, of the AgNPs with both antibacterial agents 
combined against Acinetobacter baumannii. Hair et al, 2018, synthesised AgNPs with 
vancomycin to assess synergistic effects against S. aureus, results showed the two treatments 
work in concert to eliminate biofilm mass. The dual treatment was more effective than either 
treatment alone for the group of MRSA isolates.  
The optical density values are also determined when antibacterial formulation is in direct 
contact with bacterial cells, as opposed to being separated and having to diffuse through a paper 
disk, this was investigated by (Bondarenko et al, 2013) who synthesised AgNPs alone, and 
coated with PVP and a polymer. Results showed direct contact between AgNPs and bacteria 
increased the efficacy of all formulations compared to when membranes are present between 
AgNPs and bacterial cells. Furthermore, as all metallic nanoparticles synthesised in Tables 
3.1-3.5, displayed negative zeta potential values, when in aqueous medium, they then have the 
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potency to attract counter-ions like Ag+ and H+ cations into their diffuse layer, by 
chemisorption. After direct contact with bacterial cells that are negatively charged, the 
increased concentration of both, Ag+ and H+ ions on the particle surface would then lead to 
additional damage upon bacterial cell membranes, because of the higher local concentration of 
Ag ions. The accumulation of ions on the surface of the bacterial cell walls, can lead to 
development of ROS within the bacterial cell leading to cell death.  
 
 
 
Figure 5. 14: Optical density curves of the formulations F2-F7 at 15 µL against S. aureus. 
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Figure 5. 15: Optical density curves of the formulations F2-F7 at 30 µL against S. aureus. 
 
 
Figure 5. 16: Optical density curves of the formulations F2-F7 at 15 µL against E. coli. 
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Figure 5. 17: Optical density curves of the formulations F2-F7 at 30 µL against E. coli. 
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5.4.5 Cell culture studies 
Upon synthesis of novel antibacterial therapies, it is vital to understand the cytotoxicity of 
synthesised samples. To test cytotoxicity the MTT assay is used and is one of quickest and 
most reliable ways of testing cell viability. The MTT assay allows for easy differentiation 
between living cells and dead cells, as living cells contain the enzyme NAD(P)H-dependant 
cellular oxidoreductase which works by reducing the tetrazolium MTT dye which is red to 
yellow in colour, to a purple insoluble colour belonging to formazan (Satyavani et al, 2012). 
Formazan has to be solubilised, for it to have valid absorbance readings and therefore DMSO 
is used; isopropanol can also be used, but here DMSO works better, especially when there is a 
significant amount of residue still left in the wells. Upon incubation the absorbance is ready to 
be recorded by the spectrophotometer (Satyavani et al, 2012).  
Data obtained from the MTT assay, was for each individual metallic nanoparticle, PLGA with 
AMX, and the polymeric drug metallic nanoparticle composites at varying concentrations of 1 
µg/mL, 10 µg/mL and 125 µg/mL. For cell viability results a good result is between 80-100% 
cell viability, a toxic sample exhibits cell viability at 50% or below.  
Tables 5.2-5.6 display the concentrations of each of the formulations added to the 48 well 
plate, the positive control hydrogen peroxide and the negative control of just cells. From Figure 
5.18 at a concentration of 1 µg/mL, the AgNP show a cell viability of 100%, F2 was used for 
all Figures 5.18-5.22 to compare the effects, on the addition of metallic nanoparticles have on 
cell viability. The cell viability in F2 at this concentration reduced to 94%, this may have been 
an anomaly, as when the concentration increased to 10 µg/mL the viability increased.  
Furthermore, for the full formulation F3, as the concentration increased from 10 µg/mL to 125 
µg/mL cell viability reduced, this would have been expected when comparing with AgNPs at 
125 µg/mL, the cell viability reduced to 11%, indicating toxicity of the nanoparticles. Beer et 
al, 2012, synthesized metallic nanoparticles, and used MTT assay to determine the cytotoxicity 
effect at varying silver ion concentrations, this was to determine the effect an increase in silver 
ion concentration has on the cell viability, the cell line used was an A549 human lung 
carcinoma epithelial-like cell line, results showed when increasing ion concentration cell 
viability reduces, the concentration used was 1.5 µg/mL, but the ion concentration increased 
from 39% to 69%, and the cell viability was recorded at 94% and 54% respectively. However, 
this result from Figure 5.18 does indicate encapsulation of the nanoparticles within a polymer 
drug matrix can help reduce the toxicity, and when comparing with previous figures showing 
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the release of drug, and antibacterial efficacy, the positives outweigh the negatives hence why, 
researching further into improving the cytotoxicity of this composite may be useful.  
Results from F2 remained similar in all tests, at high concentrations of 125 µg/mL, the cell 
viability was 100% in Figure 5.21, and overall from all Figures the cell viability does not show 
cell cytotoxicity. Chaubey et al, 2014, synthesized AgNPs loaded PLGA composites, and 
cytotoxicity data confirmed with an increase in concentration of the composites cell viability 
reduces, however data for PLGA on its own showed no cell mortality. Furthermore, when 
testing the efficacy against cancer cells, data obtained showed composites loaded with the 
protein induced cell death against cancer cells when compared to AgNPs alone.   
Figure 5.19 displayed cell viability (%) of synthesised AgNWs alone and the full formulation 
F4. At 1 µg/mL the AgNWs showed a 100% cell viability, F2 here also showed 100% cell 
viability, F4 here was slightly lower at 97%. When concentration increased to 125 µg/mL, 
results presented a decrease in AgNW cell viability to 74%, much different to the result in 
Figure 5.18 for AgNPs at the same concentration. Furthermore, F4 showed an overall cell 
viability of 64% at the same concentration, which when compared to F3 was surprisingly lower, 
when considering the difference between AgNPs and AgNW at the same concentration also.  
Yan et al, 2017, synthesised AgNWs through the polyol method and formed AgNW-loaded 
polydimethylsiloxane and tested the cell viability, when varying concentrations from 0.2-1 mg 
of the nanowires loaded polydimethylsiloxane, the mortality (%) remained between 0.8-1 %, 
showing when metallic nanoparticles are loaded onto polymers or similar materials the 
cytotoxicity can be reduced.  
However, (Polívková et al, 2017) synthesised AgNW arrays supported on laser-treated 
polyethylene naphthalate, cytotoxicity results showed, considerable cytotoxicity of AgNW 
samples increased with time, indicating cytotoxicity varies depending on the type of material 
used as the substrate, upon which AgNW are attached to or embedded upon.   
Figure 5.20 shows the results for AgP nanoparticles as well as F5 at varying concentrations, 
again. At low concentrations 1 µg/mL AgP nanoparticles reduced cell viability to 73%, 
however, at a much higher concentration of 125 µg/mL the cell viability reduced to only 69%, 
this result and the AgNW show similar toxicity, this may be due to the synthesis method 
applied. At higher concentrations 125 µg/mL F5 shows cell viability at 71%, when comparing 
with the other silver nanomaterial formulations, the result is similar, indicating once the 
particles are dispersed within the polymeric matrix toxicity is not as high as it is alone. 
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Figure 5.21 for F6, displays the cytotoxicity of the synthesised AuNP at varying 
concentrations, the cytotoxicity observed is very low compared to the other metallic particles 
synthesised, this is due to the inert nature of AuNP, at higher concentrations of 125 µg/mL the 
cell viability remains high at 87%, much higher than all other metallic nanoparticles at this 
concentration. The full formulation F6 shows a reduced cytotoxicity level of 78%, this however 
is still the highest cell viability when compared to the other formulations. Vijayakumar et al, 
2012, synthesised citrate reduced AuNPs and tested the cell viability through the MTT assay, 
and assessed the cell viability using mammalian Chinese hamster ovary (CHO22) cell line, 
results showed citrate reduced AuNPs showed 76% cell viability at a concentration of 140 
µg/mL. Moreover, when analysing the effects of citrate reduced AuNPs over 72 hours, the cell 
viability remained close to 80%.  
Figure 5.22 shows the cell viability studies of CuNPs, with increasing concentration CuNPs 
exhibit higher cytotoxicity, at 1 µg/mL cell viability is at 90%, with increase in concentration 
to 125 µg/mL the cell viability reduces to 7%, indicating very high cytotoxicity towards cells, 
this reflects for the full formulation F7 as the cell viability reduces to 40%, much lower when 
compared to the other formulations F2-F6, and when comparing with F2 the difference in cell 
viability is almost 67%. This difference may be due to rapid oxidation properties of copper 
nanoparticles, forming copper oxide, upon oxidation higher chance of copper ions leaching and 
contributing to the production of ROS species which in turn can enhance cytotoxicity.  
Ahamed et al, 2010, assessed the cytotoxicity of CuO nanoparticles, results showed at 50 
µg/mL the cell viability had reduced to 48%, using A549 cells. Azizi et al, 2017, synthesised 
CuNPs to assess cell viability against MDA-MB 231 cells and MCF-10A cells, results showed 
at a concentration of 100 µM, which equates to roughly 6.35 µg/mL, the cell viability was 
recorded at below 40% for both cell lines at this concentration.  
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Table 5. 2: Table of reagents in each well for AgNP. 
 1 2 3 4 5 6 7 
A Media 
only 
Media 
only 
Media 
only 
AgNP 
1μg/mL 
AgNP 
1μg/mL 
AgNP 
1μg/mL 
Hydrogen 
peroxide 
B Negative 
control 
Negative 
control 
Negative 
control 
AgNP 
10 μg/mL 
AgNP 
10 μg/mL 
AgNP 
10 μg/mL 
Hydrogen 
peroxide 
C AgNP-P-
Ab 
1μg/mL 
AgNP-P-
Ab 
1μg/mL 
AgNP-P-
Ab 
1μg/mL 
AgNP 
125 μg/mL 
AgNP 
125 μg/mL 
AgNP 
125 μg/mL 
Hydrogen 
peroxide 
D AgNP-P-
Ab 
10 μg/mL 
AgNP-P-
Ab 
10 μg/mL 
AgNP-P-
Ab 
10 μg/mL 
P-Ab 
1μg/mL 
P-Ab 
1μg/mL 
P-Ab 
1μg/mL 
 
E AgNP-P-
Ab 
125 μg/mL 
AgNP-P-
Ab 
125 μg/mL 
AgNP-P-
Ab 
125 μg/mL 
P-Ab 
10 μg/mL 
P-Ab 
10 μg/mL 
P-Ab 
10 μg/mL 
 
F    P-Ab 
125 μg/mL 
P-Ab 
125 μg/mL 
P-Ab 
125 μg/mL 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 18: Cell viability graph of AgNP formulations at different concentrations. 
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Table 5. 3: Table of reagents in each well for AgNW. 
 1 2 3 4 5 6 7 
A Media 
only 
Media 
only 
Media 
only 
AgNW 
1μg/mL 
AgNW 
1μg/mL 
AgNW 
1μg/mL 
Hydrogen 
peroxide 
B Negative 
control 
Negative 
control 
Negative 
control 
AgNW 
10 μg/mL 
AgNW 
10 μg/mL 
AgNW 
10 μg/mL 
Hydrogen 
peroxide 
C AgNW-P-
Ab 
1μg/mL 
AgNW-P-
Ab 
1μg/mL 
AgNW-P-
Ab 
1μg/mL 
AgNW 
125 μg/mL 
AgNW 
125 μg/mL 
AgNW 
125 μg/mL 
Hydrogen 
peroxide 
D AgNW-P-
Ab 
10 μg/mL 
AgNW-P-
Ab 
10 μg/mL 
AgNW-P-
Ab 
10 μg/mL 
P-Ab 
1μg/mL 
P-Ab 
1μg/mL 
P-Ab 
1μg/mL 
 
E AgNW-P-
Ab 
125 μg/mL 
AgNW-P-
Ab 
125 μg/mL 
AgNW-P-
Ab 
125 μg/mL 
P-Ab 
10 μg/mL 
P-Ab 
10 μg/mL 
P-Ab 
10 μg/mL 
 
F    P-Ab 
125 μg/mL 
P-Ab 
125 μg/mL 
P-Ab 
125 μg/mL 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 19: Cell viability graph of AgNW formulations at different concentrations. 
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Table 5. 4: Table of reagents in each well for AgP. 
 1 2 3 4 5 6 7 
A Media 
only 
Media 
only 
Media 
only 
AgP 
1μg/mL 
AgP 
1μg/mL 
AgP 
1μg/mL 
Hydrogen 
peroxide 
B Negative 
control 
Negative 
control 
Negative 
control 
AgP 
10 μg/mL 
AgP 
10 μg/mL 
AgP 
10 μg/mL 
Hydrogen 
peroxide 
C AgP-P-Ab 
1μg/mL 
AgP-P-Ab 
1μg/mL 
AgP-P-Ab 
1μg/mL 
AgP 
125 μg/mL 
AgP 
125 μg/mL 
AgP 
125 μg/mL 
Hydrogen 
peroxide 
D AgP-P-Ab 
10 μg/mL 
AgP-P-Ab 
10 μg/mL 
AgP-P-Ab 
10 μg/mL 
P-Ab 
1μg/mL 
P-Ab 
1μg/mL 
P-Ab 
1μg/mL 
 
E AgP-P-Ab 
125 μg/mL 
AgP-P-Ab 
125 μg/mL 
AgP-P-Ab 
125 μg/mL 
P-Ab 
10 μg/mL 
P-Ab 
10 μg/mL 
P-Ab 
10 μg/mL 
 
F    P-Ab 
125 μg/mL 
P-Ab 
125 μg/mL 
P-Ab 
125 μg/mL 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 20: Cell viability graph of AgP formulations at different concentrations. 
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Table 5. 5: Table of reagents in each well for AuNP. 
 1 2 3 4 5 6 7 
A Media 
only 
Media 
only 
Media 
only 
AuNP 
1μg/mL 
AuNP 
1μg/mL 
AuNP 
1μg/mL 
Hydrogen 
peroxide 
B Negative 
control 
Negative 
control 
Negative 
control 
AuNP 
10 μg/mL 
AuNP 
10 μg/mL 
AuNP 
10 μg/mL 
Hydrogen 
peroxide 
C AuNP-P-
Ab 
1μg/mL 
AuNP-P-
Ab 
1μg/mL 
AuNP-P-
Ab 
1μg/mL 
AuNP 
125 μg/mL 
AuNP 
125 μg/mL 
AuNP 
125 μg/mL 
Hydrogen 
peroxide 
D AuNP-P-
Ab 
10μg/mL 
AuNP-P-
Ab 
10μg/mL 
AuNP-P-
Ab 
10μg/mL 
P-Ab 
1μg/mL 
P-Ab 
1μg/mL 
P-Ab 
1μg/mL 
 
E AuNP-P-
Ab 
125μg/mL 
AuNP-P-
Ab 
125μg/mL 
AuNP-P-
Ab 
125μg/mL 
P-Ab 
10 μg/mL 
P-Ab 
10 μg/mL 
P-Ab 
10 μg/mL 
 
F    P-Ab 
125 μg/mL 
P-Ab 
125 μg/mL 
P-Ab 
125 μg/mL 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 21: Cell viability graph of AuNP formulations at different concentrations. 
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Table 5. 6: Table of reagents in each well for CuNP. 
 1 2 3 4 5 6 7 
A Media 
only 
Media 
only 
Media 
only 
CuNP 
1μg/mL 
CuNP 
1μg/mL 
CuNP 
1μg/mL 
Hydrogen 
peroxide 
B Negative 
control 
Negative 
control 
Negative 
control 
CuNP 
10 μg/mL 
CuNP 
10 μg/mL 
CuNP 
10 μg/mL 
Hydrogen 
peroxide 
C CuNP-P-
Ab 
1μg/mL 
CuNP-P-
Ab 
1μg/mL 
CuNP-P-
Ab 
1μg/mL 
CuNP 
125 μg/mL 
CuNP 
125 μg/mL 
CuNP 
125 μg/mL 
Hydrogen 
peroxide 
D CuNP-P-
Ab 
10μg/mL 
CuNP-P-
Ab 
10μg/mL 
CuNP-P-
Ab 
10μg/mL 
P-Ab 
1μg/mL 
P-Ab 
1μg/mL 
P-Ab 
1μg/mL 
 
E CuNP-P-
Ab 
125μg/mL 
CuNP-P-
Ab 
125μg/mL 
CuNP-P-
Ab 
125μg/mL 
P-Ab 
10 μg/mL 
P-Ab 
10 μg/mL 
P-Ab 
10 μg/mL 
 
F    P-Ab 
125 μg/mL 
P-Ab 
125 μg/mL 
P-Ab 
125 μg/mL 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 22: Cell viability graph of CuNP formulations at different concentrations. 
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5.5 Conclusion 
In this thesis, the hypothesis was to determine if polymeric composites, made up of an insoluble 
drug and metallic nanoparticles can be prepared using the EHDA technique. If these 
composites can demonstrate good drug release data, enhanced antibacterial efficacy through 
synergy and non-toxicity towards mammalian cells, then the use of the EHDA system has been 
successful.  Results presented in each chapter show this hypothesis was achieved. Metallic 
nanoparticles were synthesised varying in morphology and size. These particles were 
incorporated into a polymer drug suspension and then successfully electrosprayed as 
SEM/EDS analysis confirmed. Further analysis including ATR-FTIR, DSC, TGA and XRD 
confirmed AMX had been embedded within the PLGA matrix and now taken a more 
amorphous state. These synthesised composites were then analysed to confirm how much drug 
was present, through release studies of the drug over 24 hours and the antibacterial efficacy.  
Polymeric composites synthesised, showed successful drug loading, with varying 
encapsulation efficiencies, F2 had an encapsulation efficiency of 24.89%, as expected as the 
drug was insoluble therefore drug loading and encapsulation efficiencies would be low. For 
formulations F3-F7 the drug loading and encapsulation efficiencies increased, this was 
attributed to the increase in surface area and increased hydrolysis of polymeric chains; here 
once again formulation F5 as expected showed the highest drug loading due to its morphology 
increasing the surface area. The key point here was to show electrospraying was a suitable 
method to encapsulate an insoluble drug within a polymer to form microparticles.  
Drug release data showed, similar trends to drug loading (%), F2 as expected released the 
lowest amount of drug over 24 hours at 18% and F5 released the most drug over the same time 
frame at 56%. The antibacterial tests showed all metallic nanoparticles synthesised possess 
antibacterial efficacy, apart from AuNPs as shown in disk diffusion images in Figure 5.4. The 
full formulations prepared were also tested and their antibacterial efficacy; the key here was to 
understand if the use of AMX and metallic nanoparticles can enhance antibacterial efficacy. 
Results using the bacteria S. aureus, showed this is possible, as zone sizes increased especially 
for formulations F3-F5, however when using penicillin resistant E. coli results proved 
inconclusive, as no zone sizes increased apart from zone size for formulation F5.  
The optical density (OD) curves for metallic nanoparticles show inhibition of bacterial growth 
over the 24 hours, similar to the disk diffusion results, silver nanomaterials showed the greatest 
efficacy. To determine antibacterial properties of samples, the growth phases upon the curve 
195 
 
were analysed. A longer lag phase, shorter exponential growth phase and a quicker start to the 
death phase, all may indicate antibacterial efficacy. Results presented in Figure 5.10 and 5.12 
were compared for S. aureus and E. coli respectively. Data obtained showed bacterial growth 
inhibition, as curves remained at similar OD values with no curve following the bacterial 
growth curve. The AgNPs once again showed to have the most antibacterial efficacy, as OD 
values were reduced greatly in the presence of AgNPs, this result was consistent against both 
bacteria used. For the full formulations F2-F7, the curves all grew following the bacterial 
growth curve, here antibacterial efficacy was assessed by comparing the length of the lag phase, 
F5 proved to have the most antibacterial efficacy as it extended lag times against both bacteria 
for the longest as seen in Figures 5.14 and 5.16. From the combination of bacterial disk 
diffusion and optical density data, the synergy effect, or enhancement of antibacterial activity 
when combining two antibacterial agents was shown. Formulations F3-F5 showed the most 
promise as possible future novel antibacterial composites. Thereafter, cell culture studies 
namely the MTT assay was carried out to confirm the cytotoxicity of the formulations, as drug 
release and antibacterial results proved promising. MTT assay results showed full formulations 
F2-F7 varied in viability. All formulations were assessed at concentrations of 1, 10 and 125 
µg/mL. F2 was viable as on average the viability remained between 80-90% at the highest 
concentration, the formulations F3-F6 were also viable, as they remained close to the range of 
80-90%, however F7 was toxic, at 125 µg/mL viability reduced to 40%.  
Overall the thesis followed a story, to synthesise polymeric drug composite particles with the 
inclusion of metallic nanoparticles; at each step of the way synthesis was successful, and the 
composites were formulated. Antibacterial tests proved the efficacy and also showed enhanced 
efficacy when combining antibacterial agents, as opposed to when used alone. 
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5.6 Future work 
In the future, the concentrations of excipients will also be varied to develop a bigger range of 
composites with varying amounts of polymer, drug and metallic nanoparticles, in order to 
assess the differences in particle morphologies, drug release data and antibacterial efficacy.  
Another aspect would be to understand the antibacterial effect of polymer and metallic 
composites together - to see their antibacterial effects without the drug and to assess how the 
leeching of ions occurs from metallic particles embedded within a polymer. Formulation F5 
would be tested upon further as it showed promising sustained drug release data and 
antibacterial efficacy. Further testing would include drug release over a prolonged number of 
days, antibacterial efficacy against a bigger range of bacteria and strains and increasing the 
number of days in incubation.  
Furthermore, assessing the effects of different antibiotics aside from amoxicillin to form a 
larger range of drug composites of F5. Upon further research and testing, a scale up method 
would be applied in order to develop an alternative novel antibacterial drug delivery system.  
Results from cell culture studies showed that when incorporating metallic particles like silver 
and copper, known to leach ions within a polymeric system the resulting toxicity towards cells 
can significantly be reduced. This also shows potential as a future study, as toxicity of metallic 
materials remains the main issue preventing use within the body, if such results and further 
research show reduction in toxicity through incorporation then alternative therapies could be 
plentiful.  
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